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Abstract 
The possible involvement of angiopoietins and two endothelial cell-
specific receptor tyrosine kinases (Tie 1 and 2) in the control of testicular 
angiogenesis has not been explored in the past. To set the stage for such an 
investigation, the present study examined the expression and cellular localization 
of angiopoietins and Tie in rodent testes using reverse transcription-polymerase 
chain reaction (RT-PCR), Western immunoblotting and immunohistochemistry. 
Using nested PCR, Ang-1 expression was demonstrated in adult rat and 
mouse testes, and rat testicular blood vessels (TBV). In the study of primary 
testicular cells and cell lines, Ang-1 mRNA expression was again pinpointed to 
Leydig cells and Sertoli cells. Western immunoblotting confirmed the presence 
of Ang-1 protein in adult rat testes, TBV, primary Sertoli cells and interstitial 
cells，and all testicular cell lines (except LC540). Both the non-glycosylated (58 
kDa) and glycosylated (72 kDa) form of Ang-1 were found, but the former 
appeared more abundant. Immunostaining (with another antibody) showed 
positive Ang-1 immunoreactivity in vascular smooth muscle cells of rat testes. 
No alternative spliced variants of Ang-1 mRNA could be identified in any 
testicular cells or tissues. 
For Ang-2, the use of nested PGR demonstrated its mRNA expression in 
adult rat testes, rat TBV, and primary rat Leydig cells, Sertoli cells and germ cells. 
In testicular cell lines, Ang-2 transcripts were found in TM3 Leydig cells and 
TM4 Sertoli cells, again suggesting a major source of testicular Ang-2 from these 
two cell types. Western immunoblotting with a specific antibody confirmed the 
presence of Ang-2 protein in adult rat (and mouse) testes，interstitial cells, Sertoli 
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cells and TBV. Both the non-glycosylated (55 kDa) and glycosylated (68 kDa) 
form of Ang-2 were found. For testicular cell lines, results obtained using an 
antibody that cross-reacts with both Ang-1 and - 2 indicated that in Leydig tumour 
cell lines (i.e. MLTC4, LC540, R2C), the non-glycosylated form of Ang-2 was 
apparently present though Ang-2 mRNA could be demonstrated. In line with the 
Ang2- mRNA expression in rat TBV, specific Ang-2 immunostaining was 
localized to endothelial cells. The use of RT-PCR however failed to demonstrate 
the presence of Ang-2 isoform in adult rat testes. 
Using RT-PCR, Ang-3 mRNA expression was found in adult rat testes, rat 
TBV, primary rat Leydig cells, Sertoli cells and germ cells, mouse testes, rat 
(LC540 and R2C) and mouse (TM3 and MLTC-1) Leydig cell lines，and TM4 
mouse Sertoli cells. In line with the above observation，Ang-3 immunostaining 
was localized to vascular smooth muscle cells and testicular interstitial cells. 
The presence of Tie 1 and 2 transcripts in adult rat testes and TBV was 
demonstrated using RT-PCR. Their association with TBV correlated well with 
their immunolocalization in endothelial cells. 
In conclusion, this study has demonstrated the presence of the full 
complement of angiopoietin-Tie 2 system in the testis. It is likely that through its 
interaction with VEGF and VEGF receptors which are also found in the testis, 
they play an important role in determining the stability of the testicular 




過去的硏究沒有勘探血管形成素（ A n g i o p o i e t i n , Ang) 
和 酪 氨 酸 激 酉 每 ( 具 有 類 似 免 疫 球 蛋 白 及 表 皮 生 長 因 
子 同 種 性 的 區 域 ） 一 型 及 二 型 ( t y r o s i n e kinase with 
immunoglobulin-like and epidermal growth factor homology domains. Tie 1 and 
T i e 2 ) 在 睪 九 血 管 生 成 的 調 節 機 制 中 所 扮 演 的 角 色 。 
本 項 硏 究 藉 著 逆 轉 酶 - 聚 合 酶 連 鎖 反 應 （ r e v e r s e 
transcriptase-polymerase chain reaction, R T - P C R ) 、韋斯屯頁免疫印 
跡術（Western immimoblotting)及免疫組織化學（immimohistochemistry) 
的技術，去考察A n g i o p o i e t i n s和T i e之表達（ e x p r e s s i o n )及細 
胞定位 ( local iza t ion)� 
巢聚合酉每連鎖反應（ n e s t e d P C R ) 的 實 驗 結 果 顯 示 
血 管 形 成 素 一 型 （ A n g - 1 ) 在 成 年 大 白 鼠 畢 九 、 小 白 鼠 
睪 九 及 大 白 鼠 睪 九 血 管 （ r a t testicular blood vessel，TBV)內表 
達。本硏究利用初級睪九細胞（ p r i m a r y testicular c e l l s )及細胞 
株（cdl l i n e s ) 來顯示 A n g - 1 的信使核糖核酸（ m R N A ) 在萊迪 
希氏細胞（Leydig c e l l s ) 及 謝 爾 托 立 氏 細 胞 （ S e r t o l i cells) 
內 表 達 。 韋 斯 頓 免 疫 印 跡 術 確 定 A n g - 1 蛋 白 質 存 
在 於 成 年 大 白 鼠 睪 九 、 T B V � 初 級 謝 爾 托 立 氏 細 
胞 、 初 級 間 質 細 胞 及 所 有 睪 九 細 胞 株 （ 除 了 LC540) 
內。兩種 A n g - 1 的非被糖基化類型（ n o n - g l y c o s y l a t e d ) 
( 5 8 千 道 爾 頓 k D a ) 及 被 糖 基 化 類 型 （ g l y c o s y l a t e d ) (72 
千 道 爾 頓 k D a ) 被 發 現 ， 但 前 者 的 數 量 似 乎 較 
多 。 免 疫 組 織 化 學 的 實 驗 （ 採 用 另 一 種 抗 
體 ） 顯 示 A n g - 1 的 免 疫 反 應 力 存 在 於 大 白 鼠 的 睪 九 血 
管 平 滑 肌 內 。 沒 有 A n g - 1 替 代 剪 接 變 異 體 （ v a r i a n t s ) 的 
m R N A 在 畢 九 細 胞 及 組 織 內 被 發 現 。 
至於血管形成素二型（A n g - 2 )， n e s t e d P C R 的實驗結 
果 闡 述 它 的 m R N A 在 成 年 大 白 鼠 睪 九 、 大 白 鼠 的 T B V � 
及 初 級 大 白 鼠 的 萊 迪 希 氏 細 胞 、 謝 爾 托 立 氏 細 胞 
和生殖細胞（ g e r m c e l l s )內表達。在睪九細胞株中，A n g - 2的 
轉錄本（ t r a n s c r i p t s ) 在 T M 3 萊迪希氏細胞和 T M 4 謝爾托 
立 氏 細 胞 內 被 發 現 ， 這 樣 便 能 說 明 這 兩 種 細 胞 就 
是 睪 九 的 A n g - 2 的 主 要 來 源 。 韋 斯 頓 免 疫 印 跡 術 採 
用 特 定 的 抗 體 來 確 定 A n g - 2 蛋 白 質 存 在 於 成 年 大 
白 鼠 （ 和 小 白 鼠 ） 睪 九 、 間 質 細 胞 、 謝 爾 托 立 氏 細 
胞 及 T B V 內 �A n g - 2 的 非 被 糖 基 化 類 型 （ 5 5 千 道 爾 
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頓 k D a ) 及 被 糖 基 化 類 型 （ 6 8 千 道 爾 頓 k D a ) 亦 被 發 
現 。 至 於 睪 九 細 胞 株 方 面 ， 利 用 同 時 與 A n g - 1 和 A n g - 2 有 
交 叉 反 應 的 抗 體 的 實 驗 結 果 指 出 雖 然 A n g - 2 mRNA不 
存 在 於 萊 迪 希 氏 腫 瘤 細 胞 株 內 （ 即 M L T C - 1 , LC540，R2C), 
但 A n g - 2 蛋 白 質 顯 然 地 存 在 於 這 些 細 胞 株 內 。 除 了 
Ang-2 m R N A 在大白鼠的 T B V 內表達外，特定的 A n g - 2 免疫 
染 色 被 定 位 於 內 皮 細 胞 內 。 R T - P C R 未 能 闡 述 A n g - 2 的 等 
型（ i s o f o r m s ) 存在於成年大白鼠睪九內。 
藉著 R T - P C R ，血管形成素三型（ A n g - 3 ) 在成年大白 
鼠 睪 九 、 大 白 鼠 的 T B V � 初 級 大 白 鼠 萊 迪 希 氏 細 胞 、 謝 
爾 托 立 氏 細 胞 和 生 殖 細 胞 、 小 白 鼠 單 九 、 大 白 鼠 
( L C 5 4 0和R 2 C )、小白鼠（T M 3和M L T C - 1 )萊迪希氏細胞株及 
T M 4 小 白 鼠 謝 爾 托 立 氏 細 胞 株 。 除 了 以 上 的 觀 察 
外 ， A n g - 3 免 疫 染 色 被 定 位 於 血 管 平 滑 肌 及 睪 九 間 質 
細胞內。 
R T - P C R 的實驗結果闡述 T i e 1和T i e 2的 t ranscr ipts在成 
年 大 白 鼠 睪 九 和 T B V 內 存 在 。 它 們 與 T B V 的 聯 繫 與 它 們 
的 免 疫 定 位 於 內 皮 細 胞 內 非 常 吻 合 。 
總括而言，本項硏究闡明 a n g i o p o i e t i n - T i e 2 系 統 內 的 
所 有 補 體 存 在 於 睪 九 內 。 可 能 透 過 它 與 在 睪 九 存 在 
的血管內皮生長素（ v a s c u l a r endothelial factor, VEGF)和 VEGF 的 
受體（ r e c e p t o r s ) 的相互作用，它們在確定睪九血管系統 
的 穩 定 性 或 使 它 進 行 增 殖 （ 即 血 管 生 成 過 程 ） 或 退 化 
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1. Introduction 
1.1 General review of angiogenesis 
1.1.1 Angiogenesis in development and growth 
Angiogenesis refers to the generation of new blood vessels from preexisting 
vessels by remodeling of the primary plexus, thus leading to subsequent 
neovascularization. Angiogenesis plays a crucial role in various physiological 
processes, including embryonic, fetal and post-natal development and growth. 
However, it rarely occurs physiologically in adulthood except under strictly 
controlled conditions and the continuous remodeling of the adult female 
reproductive function. Regarding the control of female reproductive function, 
angiogenesis is mainly responsible for follicular and normal placental development, 
corpus luteum formation and repair of endometrium during the menstrual cycle. 
Normal tissue growth, such as in embryonic development, tissue repair processes, 
and the menstrual cycle, is dependent on new vessel formation for the supply of 
oxygen and nutrients as well as removal of waste products [Kampfer et al., 2001; 
see reviews by Findlay, 1986; Norrby, 1997; Griffioen & Molema，2000]. 
Apart from angiogenesis, vasculogenesis can be considered to be an 
important determinant for early stage of vascular development and this process 
involves the establishment of primitive vascular network and differentiation of new 
endothelial cells from stem cells during embryogenesis from multipotential 
mesenchymal progenitors. In this process, vascular endothelial cell precursors 
(angioblasts) undergo differentiation from mesoderm-derived precursors 
(hemangioblasts), expand, and then coalesce to form a network of primitive tubules 
[Risau, 1997; Kampfer et al., 2001; see reviews by Ferrara, 1999; Geva & Jaffe, 
2000]. Vasculogenesis results in the formation of primary capillary plexus by 
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endothelial cells, which are the only components of this initial lattice. This primary 
capillary plexus is composed of rather homogenously sized interconnected vessels 
and is then remodeled by a process of angiogenesis [see review by Gale & 
Yancopoulos, 1999]. Therefore, vasculogenesis constitutes the early stage of 
vascular development whereas angiogenesis forms the basis for the later stage of 
vascular development [Suri et al., 1998]. 
Angiogenesis is of particular significance not only in the normal growth of 
both embryonic and postnatal tissues and continuous remodeling of the adult 
female reproductive system, but also in a variety of pathological situations such as 
wound healing, diabetic retinopathy, age-related macular degeneration, rheumatoid 
arthritis, psoriasis, cardiovascular diseases, ischemic diseases, chronic 
inflammation, tumour growth and metastasis. In contrast to angiogenesis, 
vasculogenesis is only restricted to early embryogenesis [Ferrara, 1995; Folkman, 
1995; Hanahan & Folkman, 1996; Patan et al., 1996a, 1996b; see review by 
Ferrara, 1999]. 
1.1.2 The process of angiogenesis 
Angiogenesis mainly involves the sprouting, branching, and differential 
growth of blood vessels to form the more mature vascular patterns seen in the adult 
organism. Activation of endothelial cells, which line the vessel wall, is the first 
process to take place either under physiological or pathological conditions, 
regardless of the types of angiogenesis [Mandriota et al, 1998; see reviews by Gale 
& Yancopoulos，1999; Griffioen & Molema, 2000; Gerwins, Skoldenberg & 
Claesson-Welsh, 2000]. The development of a new capillary network requires a 
remarkable degree of interaction between different growth factors and occurs as an 
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orderly series of events. The angiogenic process begins with the disappearance of 
the resting state of endothelial cells and a local proteolytic degradation of the 
basement membrane of the vessel on the side closest to the angiogenic stimulus, 
followed by chemotactic migration of endothelial cells towards the site of 
angiogenic stimulus together with endothelial cell proliferation. Then, lumen 
formation begins, either by curvature of the endothelial cell or vacuole formation in 
the cell, followed by deposition of a new basement membrane and recruitment of 
perivascular cells such as smooth muscle cells and pericytes. Finally, newly 
formed blood vessel tubes are apparently stabilized through the migration of 
pericytes that provide structural support, paracrine signalling and intercellular 
basement membrane matrix production. Subsequently, previously avascular tissues 
and organs undergo vascularization and the initially homogeneous capillary plexus 
undergoes remodeling to form a new microcirculation. Much attention has been 
paid to angiogenesis-activating factors that significantly elicit an angiogenic 
response [Risau, 1997; Enholm et al., 1997; Gerwins et al,, 2000; see reviews by 
Findlay, 1996; Geva & Jaffe, 2000]. 
1.1.3 Types of factors controlling angiogenesis 
The mechanisms regulating vasculogenesis and angiogenesis remain to be 
elucidated. However, several protein factors crucial for regulation of angiogenesis 
have recently been identified, including growth factors, pro-angiogenic cytokines, 
angiogenesis modulators and inhibitors of neovascularization [see review by 
Norrby, 1997]. In general, angiogenesis is thought to be regulated through a 
balance between endogenous positive and negative signals for endothelial cell 
proliferation, migration, differentiation and survival [Joukov et al., 1996; 
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Maisonpierre et al., 1997]. Since the discovery of the first angiogenesis inhibitor in 
1975 and the purification of the first angiogenic factor (basic fibroblast growth 
factor, bFGF) in 1984, at least 21 angiogenic growth factors and at least 27 
angiogenesis inhibitors have been found to regulate angiogenesis (Table 1.1). As 
reviewed by Norrby (1997), angiogenesis inhibitors are those that could inhibit 
angiogenesis in vivo and influence the ability of a cell to produce, interact with, or 
degrade its surrounding matrix. These angiogenesis inhibitors may be differentially 
or combinatorially involved in vascular maturation [Risau, 1997]. 
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Table 1.1 Angiogenic growth factors and angiogenesis inhibitors involved in 
regulation of angiogenesis* 
Angiogenic growth factors , 二 AngiogeheSli'lulG碰 
Angiogenin Angiostatin (plasminogen fragment)  
Angiopoietin-1 Antiangiogenie antithrombin HI  
Del-1 Cartilage-derived inhibitor (GDI)  
Epidermal growth factor (EGF) CD59 complement fragment  
Fibroblast growth factors: acidic (aFQ^) and basic Ehdostatin (collagen XVIII fragment) 
(bCF) 
Follistatin Fibronectin fragment  
Granulocyte colony-stimulating factor (G-CSF) Gro-beta  
Hepatocyte growth factor (HCF) / scatter factor (SF) Heparinases  
Interleukm-3 (IL-3) Heparin hexasaccharide fragment  
Interleukin-8 (IL-8) Human chorionic gonadotropin (hCG)  
Leptin Interferon alpha/beta/gamma  
Midkine Interferon inducible protein (IP-10) 
Placental growth factor Interleukin-12  
Platelet-derived endothelial cell growth factor Kringle 5 (plasminogen fragment) 
(PD-ECCF)  
Platelet-derived growth factor-BB (PPQ^-BB) Metalloproteinase inhibitors (TMPs) 
Pleiotrophin (PTN) 2-Metho?yestradiol  
Proliferin Placental ribonuclease inhibitor  
Transforming growth factor-alpha (TCF-alpha) Platelet factor-4 (PF4)  
Transforming growth factor-beta (TGF-beta) Prolactin 16kD fragment  
Tumor necrosis factor-alpha (TNF-alpha) Proliferin-related protein (PRP)  
Vascular endothelial growth factor (VEGF) / vascular Retinoids 
permeability factor (VPF)  
Tetrahydrocortisol-S  
Thrombospondin-1 (TSP-1)  
Transforming growth factor-beta (TCF-b) 
Vasculostatin  
Vasostatin (calreticulin fragment)  
*In part modified from Klagsbrun (1992); an internet website: 
www. angio. org/understanding/understanding. html 
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Although angiogenesis is driven by numerous mediators produced by 
different cell types under a variety of conditions, only two growth factors, vascular 
endothelial growth factor (VEGF) and placental growth factor (PGF), are 
characterised by their direct influence on endothelial cell behaviour both in vitro 
and in vivo. In contrast to direct angiogenic factors，indirect angiogenic factors 
exert their selective actions on microvascular endothelial cells in vivo and they are 
incapable of inducing capillary formation in vitro [see reviews by Folkman et al., 
1980; Norrby, 1997]. Among proangiogenic factors, only VEGF is currently held 
to be the major endothelial-cell-specific angiogenesis and permeability factor both 
in physiological and pathological conditions [Kukk et al., 1996; Maisonpierre et al., 
1997]. In addition, VEGF differs from other endothelial growth factors (such as 
fibroblast growth factor and platelet-derived growth factor) in that it possesses 
signal sequence for secretion and is mitogenic only to endothelial cells. In this 
respect, VEGF is one of the best studied and the most potent proangiogenic factor. 
It was firstly discovered in the early eighties by Dvorak and colleagues based on its 
ability to induce proliferation and permeability increase of vascular endothelium 
[Senger et al, 1983]. 
1.2 Roles of VEGF and its receptors in the regulation of angiogenesis 
1.2.1 VEGF 
The molecular aspects of signaling cascades critical for endothelial cell 
proliferation and migration are beginning to be delineated but much less is known 
about signaling cascades leading to endothelial cell differentiation. The central role 
of VEGF in the induction of angiogenesis in many physiological processes is now 
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well established [Goede et al., 1998]. 
VEGF is a secreted homodimeric glycoprotein with molecular weight 
ranging from 43-46 kDa (kiloDalton) approximately. Although VEGF is encoded 
by a single gene located on chromosome 6，it is now well established that 
alternative exon splicing generates several isoforms, having, respectively, 121, 145， 
165, 189 and 206 amino acid residues. These isoforms have different heparin and 
heparan-sulphate binding properties but with similar specificity of biological effect 
on endothelial cells [Enholm et al., 1997; Ergun et al., 1997; see reviews by 
Ferrara，1996; Ferrara et cd., 1997; Neeman et al., 1997; Norrby, 1997; Neufeld et 
al., 1999; Ferrara, 1999; Griffioen & Molema, 2000]. Among these different 
VEGF isoforms, VEGF^^^ is the most abundant and best-characterized isoform 
produced by a variety of normal and transformed cells. Transcripts encoding 
V E G F j 2 i and VEGF^g^ are also detectable in normal cells and tissues expressing the 
VEGF gene. However, VEGP206 is a very rare form and VEGF145 expression is 
restricted to cells derived from reproductive organs. Both VEGFjg5 and VEGFj2i 
are secreted soluble glycoproteins even though a significant fraction of VEGF^^^ 
remains bound to the cell surface and the extracellular matrix. The unique 
characteristics of VEGFj2i is its weak binding affinity to heparin or extracellular 
matrix which is due to the lack of the amino acids encoded by exons 6 and 7 of the 
VEGF gene. Conversely, the longer isoforms - VEGFig^ and VEGF206, are more 
basic，bind to heparin with greater affinity than VEGF^^^ and are almost completely 
sequestered in the extracellular matrix [see reviews by Ferrara et al., 1997; Neufeld 
et al., 1999]. All of these VEGF isoforms (also known as VEGF-A), together with 
VEGF-B, VEGF-C, and VEGF-D, constitute the VEGF / platelet-derived growth 
factor (PDGF) superfamily. The ability of VEGF to induce vasodilation via 
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endothelial nitric oxide production and vascular permeability increase are 
additional features of VEGF that give its crucial role in angiogenesis initiation 
[Ziche et al., 1997; Gerwins et al., 2000]. Through these activities, VEGF allows 
plasma proteins to enter the tissue to form a fibrin-rich provisional network 
[Dvorak, 1986]. 
1.2.2 VEGF receptors 
VEGF specifically activates the angiogenic cascade by interaction with two 
different forms of VEGF-specific tyrosine kinase receptors VEGFR-l/Flt-1 (fms-
like tyrosine kinase-1) and VEGFR-2/KDR (kinase insert domain-containing 
receptor). The latter corresponds to Flk-1 (fetal liver kinase-1) in the mouse and 
TKrC (tyrosine kinase C) in the rat [Joukov et al., 1996; Ergun et al, 1997; 
Korpelainen et al., 1998; Goede et al., 1998; Papapetropoulos et al., 1999; Bi, 
Drake & Schwarz, 1999; see reviews by Ferrara et al‘, 1997; Norrby, 1997; 
Yancopoulos et al, 2000; Griffioen & Molema, 2000]. VEGFR-1 is a 180-kDa 
transmembrane glycoprotein and alternative splicing of this receptor generates a 
shorter soluble protein containing only six first extracellular immunoglobulin 
homology domains followed by 31 unique amino acid residues. Interestingly, there 
are two functional VEGFR-2 forms expressed in retinal, as a result of alternative 
splicing and the molecular weight of VEGFR-2 is about 230 kDa in general 
[Petrova, Makinen & Alitalo, 1999; see review by Neufeld et cd., 1999]. Consistent 
with the specificity of action of this growth factor family, these receptors are 
expressed predominantly in vascular endothelium, and to a lesser extent on 
monocytes / macrophages and certain tumor cell types. It was observed that the 
migration of monocytes in response to VEGF was mediated by VEGFR-1 [Suri et 
8 
al., 1998; Korpelainen et al., 1998; see reviews by Ferrara et al., 1997; Ferrara, 
1999; Neufeld et cd., 1999; Yancopoulos et al.’ 2000; Griffioen & Molema, 2000]. 
Besides VEGFR-1 and VEGFR-2, the receptor for VEGF-C and VEGF-D 
has been described: VEGFR-3 (Flt-4) exists as 4.5- and 5.8-kb transcripts resulting 
from alternative 3，polyadenylation signals [Joukov et al, 1996; Petrova, Makinen 
& Alitalo, 1999; see reviews by Ferrara et cd‘, 1997; Yancopoulos et al., 2000; 
Griffioen & Molema, 2000]. The expression of the longer form is detectable in the 
majority of cells and tissues and this longer form is capable of encoding 65 
additional amino acid residues. Compared with VEGFR-1 and VEGFR-2, VEGFR-
3 is mainly expressed on lymphatic endothelium, for which it seems to be critical in 
mediating VEGF action in stimulating proliferation of lymphatic endothelial cells 
[Kukk et al., 1996; see review by Yancopoulos et al., 2000]. 
All of these VEGF receptors constitute type III transmembrane receptor 
tyrosine kinases of the platelet-derived growth factor (PDGF) receptor subfamily, 
and they undergo ligand-induced dimerization to allow the activation of complex 
intracellular signaling pathways [Petrova, Markinen & Alitalo, 1999]. The 
interaction of VEGF-A with VEGFR-2 has been extensively investigated, since the 
angiogenic effect of VEGF in causing porcine endothelial cell proliferation as well 
as chemotactic migration and sprouting activity seems to be mediated largely by the 
VEGFR-2 but not VEGFR-1. The latter appears to play a more important role in 
endothelial organization during development [Joukov et cd., 1996; see reviews by 
Korpelainen et al., 1998; Yancopoulos et al., 2000; Griffioen & Molema, 2000]. 
VEGFR-2 is the most abundant in proliferating endothelial cells of vascular 
sprouts and branching vessels of embryonic tissues, and to a lesser extent in adult 
tissues, but it can also be activated in response to VEGF-C. VEGF-C induced 
9 
autophosphorylation of VEGFR-2 was evident in the investigation of the activity of 
recombinant VEGF-C in vitro by stimulation of VEGFR-3- and VEGFR-2-
expressing cells, followed by receptor autophosphorylation analysis. The possible 
effects of VEGF-C interaction with VEGFR-2 would be to cause striking changes 
in the morphology, actin reorganization and membrane ruffling of porcine aortic 
endothelial (PAE) cells overexpressing VEGFR-2 [Joukov et al,, 1996; Kukk et aL, 
1996]. 
1.2.3 Regulation of VEGF expression by hypoxia and nitric oxide 
Hypoxia has been proposed to play an important role in the regulation of 
VEGF gene expression, both in vitro and in vivo [see reviews by Ferrara et al., 
1997; Ferrara, 1999; Neufeld et al., 1999]. The upregulation of VEGF expression 
by hypoxia is attributable to the induction of VEGF gene transcription by the 
binding of hypoxia-inducible factor-1 (HIF-1) to an HIF-1 binding site located in 
the VEGF promoter. The influence of hypoxia on VEGF gene expression has been 
investigated in numbers of studies and identified the increased VEGF mRNA 
stability as a significant post-transcriptional component in addition to 
transcriptional activation, probably via the binding of proteins to sequences located 
in the 3，untranslated region (UTR) of the VEGF mRNA. The stimulatory effect of 
hypoxia on VEGF gene transcription can also occur as a result of the regulation of 
the translation of uncapped mRNA initiated from an active internal ribosomal entry 
site (IRES) located downstream of an alternative initiation site in the 5' UTR of the 
VEGF mRNA. These phenomena strongly point to an early involvement of VEGF 
in the angiogenic response. 
Neufeld et al (1999) has recently reviewed that hypoxia-induced VEGF 
10 
production is responsible for angiogenesis initiation, using the development of the 
retina and the associated network of retinal blood vessels as a typical example. 
Similar mechanisms of vascular development also operate in other organs. The 
astrocytes respond to hypoxia by producing VEGF, which then initiates an 
angiogenic response during the development of the retina. The resulting VEGF 
concentration gradient stimulates the growth and continuous outward migration of 
new blood vessels toward the VEGF-producing astrocytes. There is a decreased 
VEGF production to a certain threshold concentration by the astrocytes that are the 
sensors of hypoxia upon the arrival of the blood vessels to prevent apoptosis of the 
endothelial cells and stabilize the newly formed blood vessels. Inductions of 
smooth muscle cell/pericyte loss render the remaining blood vessels insensitive to 
the absence of VEGF. 
VEGF partly responds to nitric oxide and cGMP-mediated activation of the 
mitogen-activated protein kinase (MAPK) family by influencing endothelial cell 
proliferation [Risau, 1997; see reviews by Ferrara et al., 1997; Neufeld et al., 1999; 
Griffioen & Molema, 2000]. VEGF has a dual ftinction involving both angiogenesis 
initiation and endothelial cell proliferation. Nitric oxide is known to increase 
vascular permeability and induce vasodilation by mediating the effects of VEGF. 
These influences result from a positive feedback loop between VEGF and nitric 
oxide. In support of the view of the growth-promoting effect of VEGF on vascular 
endothelial cells, it has been shown that nitric oxide synthase (NOS) inhibitors 
inhibit the mitogenic effect of VEGF on human umbilical vein endothelial cells 
(HUVEC) [Papapetropoulos et al, 1997] and bovine endothelial cells isolated from 
coronary postcapillary venules [Morbidelli et al., 1996]. 
The underlying mechanism for MAPK pathway to induce endothelial cell 
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proliferation and migration appears to be due to the activation of NOS upon VEGF 
stimulation, followed by a subsequent increase in cGMP. After the increase in nitric 
oxide level upon VEGF stimulation, there is an increase in intracellular calcium 
levels and an activation of serine kinase Akt/PKB so as to activate endothelial NOS 
(eNOS) and phosphorylate eNOS in a calcium-dependent manner respectively 
(mentioned later in Section 1.2.5). Some adaptor proteins such as Grb2, She, and 
Nek are thought to be involved in the VEGF-promoted activation of MAPK cascade 
in porcine aortic endothelial cells expressing recombinant VEGFR-2 [see reviews by 
Petrova, Makinen & Alitalo, 1999; Neufeld et al., 1999]. VEGF-mediated signaling 
is subsequently able to confer a proliferative signal in endothelium through a 
physical association of the SHP-1 and SHP-2 SH2 protein-tyro sine phosphatases 
with VEGFR-2. This induces endothelial expression of extracellular matrix (ECM)-
degrading enzymes required for the breakdown of the basement membrane of blood 
vessels. Loss of integrity of the basement membrane is critical for the very initial 
phases of angiogenesis, the initiation of cell proliferation and cell migration. 
1.2.4 Signal transduction mechanisms of VEGFR-1 and VEGFR-2 
Current research interest on angiogenesis control involves the elucidation of 
different signal transduction properties of VEGFR-1 and VEGFR-2, and the 
regulation of their expression. Of great importance is the recent findings 
documented by Ferrara (1999), Petrova, Makinen & Alitalo (1999) and Yancopoulos 
et al (2000) that VEGFR-1 might act as a ligand-binding molecule or a decoy 
receptor rather than a signal-transducing receptor during angiogenesis or might 
suppress signaling through VEGFR-2. This notion is supported by numbers of 
previous studies, which demonstrated a lack of direct mitogenic signal in transfected 
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M H 3T3 cells expressing VEGFR-1 upon VEGF stimulation as well as the absence 
of permeability-enhancing properties of VEGFR-1-transfected endothelial cells. 
These can be explained by weak tyrosine phosphorylation of VEGFR-1 and a high 
affinity of placental growth factor (PIGF) to VEGFR-1 but not to VEGFR-2 
respectively. Park et al (1999) have demonstrated a negative regulation of VEGF 
activity on endothelial cells by sequestering and rendering VEGF less available to 
VEGFR-2. In spite of the relatively higher affinity of VEGF for VEGFR-1 than for 
VEGFR-2, research has focused on VEGF-induced signal transduction in endothelial 
cells by both receptors. 
Smdies involving targeted disruption of VEGF, VEGFRl or VEGFR2 genes 
in mice have provided the best evidence for the critical role of VEGF and its 
receptors in the development of the embryonic vasculature. Nevertheless since these 
mutant mice exhibited different developmental defects in their vascular system and 
died at different ages, the data suggested to us that differences exist for the respective 
role of VEGF and its two receptors in endothelial cell differentiation and 
proliferation. Mice lacking even a single VEGF allele exhibit embryonic lethality 
due to severe vascular abnormalities, implicating a simple half-dosage effect on 
embryonic lethality [Suri et al., 1996; see reviews by Ferrara, 1999; Petrova, 
Makinen & Alitalo，1999; Neufeld et al., 1999; Yancopoulos et al., 2000]. VEGFR-
2 knockout mice provide the most elegant demonstration of VEGF as a signal in 
embryonic angiogenesis. Hematoangioblast progenitors are severely disrupted, 
followed by subsequent embryonic lethality between day 8.5 and 9.5，because of 
failure in both endothelial cell differentiation and vascular development. Although 
embryonic lethality around day 8.5 has also been observed in VEGFR-1 knockout 
mice, VEGFR-1 null phenotype is distinct from that of the VEGFR-2 knockouts 
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[Carmeliet et al., 1996; Ferrara et al., 1996]. Consistent with the critical role of 
VEGFR-1 in down-regulating VEGF activity, excess levels in endothelial cells and 
normal hematopoietic progenitors seemingly develop in VEGFR-1 knockout mice 
but they abnormally coalesce into disorganized tubules following migration and 
proliferation. As reviewed by Gale & Yancopoulos (1999) and Yancopoulos et al 
(2000), VEGFR-1 as a decoy receptor was fiarther confirmed by normal vascular 
development in mice engineered to express only a truncated form of VEGFR-1 
lacking its tyrosine kinase domain. 
1.2.5 Anti-apoptotic effect of VEGF on endothelial cells as a result of signal 
transduction ofVEGFR-2 
The protection of endothelial cells against serum deprivation and tumor 
necrosis factor a-induced apoptosis is dependent upon the activation of VEGFR-2. 
The activation of phosphatidylinositol 3'-kinase (PI 3'-kinase) can contribute 
significantly to the signal transduction of such VEGF-induced prosurvival effect in 
endothelial cells, probably via activation of its downstream target serine kinase 
Akt/PKB [see reviews by Ferrara, 1999; Petrova, Makinen & Alitalo，1999]. 
However, the activation of PI 3'-kinase does not seem to induce endothelial cell 
proliferation efficiently. This argument is evident from the studies about the 
requirement of VEGFR-2 activation for the antiapoptotic effects of VEGF for 
HUVEC in serum-free conditions. In addition, the activation of antiapoptotic serine-
threonine kinase (Akt, also known as protein kinase B) was observed in HUVEC 
only upon stimulation with a VEGFR-2-selective VEGF mutant rather than with 
PIGF or a VEGFR-1-selective mutant, demonstrating the crucial role of VEGFR-2 in 
mediating VEGF-induced endothelial cell survival. Akt/PKB pathway can be 
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activated in endothelial cells by the increase in intracellular calcium levels, because 
of VEGF-mediated nitric oxide production (as explained earlier in Section 1.2.3). 
Apart from PI 3'-kinase, recent studies have provided evidence in support of the 
hypothesis for the involvement of VEGFR-2 in a multimeric complex together with 
the adherens junction protein VE-cadherin and P-catenin in regulation of endothelial 
cell apoptosis. 
1.3 Angiopoietins 
Despite a pivotal role of VEGF in the earliest stages of vasculogenesis and 
subsequent angiogenesis, it seems to work in complementary and coordinated 
fashion during vascular development with another family of growth factors specific 
for the vascular endothelium - angiopoietin [Suri et cd., 1998; Valenzuela et al., 
1999; see reviews by Gale & Yancopoulos, 1999; Griffioen & Molema, 2000; 
Yancopoulos et al., 2000]. The Tie (tyrosine kinase containing /mmunoglobulin-like 
loops and epidermal growth factor similar domains) receptors, Tie 1 and Tie 2, 
constitute a second family of endothelial cell-specific receptor tyrosine kinases 
(RTKs) that are specifically expressed in developing vascular endothelial cells. 
Although a functional ligand for the Tie 1 receptor have not yet been identified, the 
Tie 1 receptor is known to be closely related to the Tie 2 receptor. Angiopoietin 1 
(Ang-1) and Angiopoietin 2 (Ang-2) and, more recently, Angiopoietin 3 (Ang-3) and 
Angiopoietin 4 (Ang-4) have been discovered as ligands for receptor tyrosine kinase 
Tie 2. Compared to VEGF, angiopoietins seem to act primarily in the later stages of 
vessel growth and remodeling. Ang-1 induces Tie 2 phosphorylation in cultured 
endothelial cells, whereas Ang-2 does not phosphorylate Tie 2. Alternatively, Ang-2 
inhibits the Ang- 1-induced Tie 2 phosphorylation in vascular endothelial cells. In 
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other words，Ang-2 appears to be a naturally occurring antagonist for Ang-1 and its 
Tie 2 receptor. Mouse Ang-3 and human Ang-4 belong to a novel subfamily of 
angiopoietins and represent the mouse and human counterparts of the same gene 
locus, in which Ang-3 acts as an antagonist and Ang-4 as an agonist of receptor 
tyrosine kinase signaling. Their activities have not been fully explored. 
1.3.1 Angiopoietin 1 (Ang-1) 
Long after the discovery of VEGF, a recent explosion of newly discovered 
growth factors, angiopoietins, specific for the vascular endothelium is especially 
important in understanding the mechanisms that govern the later stages of 
angiogenesis. The normal role of Angiopoietin 1 (Ang-1) has been investigated by 
gene deletion and dominant negative transgenic experiments. Mouse embryos null 
for Ang-1 or a functional angiopoietin receptor, Tie 2，display a picture quite 
different from knockout embryos lacking VEGF or VEGFR-2 expression, with 
development of a rather normal primary vasculature but failure of normal endothelial 
cell adherence and interaction with underlying supporting cells and extracellular 
matrix [Sato et al., 1995; Suri et al., 1996]. Then, normal remodeling events of this 
primitive vasculature are severely perturbed, probably leading to subsequent 
regression. Also, similar heart defects were observed in both Ang-1- and Tie 2-null 
mouse embryos, with detachment of the endocardium from the underlying 
myocardium, failure of trabeculae formation as well as vascular remodelling. 
Therefore, targeted inactivation of the Ang-1 gene revealed its obligatory role in 
proper interactions between endothelial cells and supporting cells, rather than as an 
instructive signal of vascular remodeling, thereby rendering them responsive toward 
other critical signals from their environment. 
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As reviewed by Geva & Jaffe (2000), the human Ang-1 gene has been 
assigned to chromosome 8 and encodes a unique 498-amino acid glycoprotein. Ang-
1 is known to be an endogenously secreted glycoprotein from the pericytes and 
vascular smooth cells around endothelial cells. Based on preliminary biochemical 
analyses, Ang-1 was shown to consist of a coiled-coil domain in the amino terminus 
and a fibrinogen-like domain at the carboxy terminus. In transfection studies, Ang-1 
recombinant protein isolated from COS-7 culture supernatant gives a molecular 
weight in the range of 58-75 kDa (kiloDalton). The amino acid sequence of Ang-1 
appears to contain several potential glycosylation sites, suggesting that the higher 
molecular size product 75 kDa) could represent the glycosylated form of Ang-1 
[Hanahan, 1997; Kwak et cd., 1999; see review by Griffioen & Molema, 2000]. 
Intriguingly, unlike VEGF, Ang-1 does not stimulate endothelial cell 
proliferation nor mediate tubule formation but it likely plays a later role in 
endothelial cell maturation in synergy with VEGF [Mandriota & Pepper, 1998; Suri 
et al, 1998; Huang et al., 2000; Papapetropoulos et al, 2000; Kim et al., 2000b; 
Kwak et al., 2000; see reviews by Gale & Yancopoulos; 1999; Geva & Jaffe, 2000; 
Yancopoulos et al., 2000]. Nevertheless, in vitro studies have revealed that Ang-1 
potently elicits sprouting and chemotactic response of endothelial cells throughout 
the vascular system as well as network formation [Witzenbichler et al., 1998; Kwak 
et al,, 1999]. Consistent with the action of Ang-1 in sprouting and branching in vitro 
are recent observations, transgenic overexpression of Ang-1 results in pronounced 
hypervascularization, probably via the inhibition of normal vascular pruning and 
stimulation of vascular remodelling events [Koblizek et cd., 1998; Suri et al., 1998; 
see reviews by Gale & Yancopoulos, 1999; Yancopoulos et aL, 2000; Geva & JafFe, 
2000]. The mechanisms for Ang-1 to inhibit endothelial cell apoptosis include the 
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recruitment of phosphatidylinositol 3'-kinase (PI 3'-kinase), downstream activation 
of the Akt signal transduction pathway, and/or upregulation of a broad spectrum 
apoptosis inhibitor, survivin [Suri et al., 1998; Kwak et cd., 1999; Kim et al., 1999a; 
Papapetropoulos et aL, 1999; Thurston et al., 2000; Kim et al., 2000b; 
Papapetropoulos et al., 2000; see reviews by Gale & Yancopoulos, 1999; 
Yancopoulos et al., 2000]. 
The recent discovery of four different isoforms of Ang-1 (1.5，1.3，0.9，and 
0.7 kb) has provided greater complexity to the molecular and cellular mechanisms of 
angiogenesis. It has now been well established that alternative exon splicing of the 
full-length Ang-1 gene forms the basis for this molecular heterogeneity. The 
presence of a hydrophobic leader peptide offers the potential for all four isoforms to 
be secreted from cells. Ang-0.7 kb isoform is a truncated form derived from two 
alternatively spliced regions of the full-length Ang-1 but it lacks parts of both the 
coiled-coil and the fibrinogen-like domains. Like Ang-0.7 kb isoform, Ang-0.9 kb 
isoform lacks most of the coiled-coil domain. Interestingly, there is a coiled-coil 
multermerization domain in Ang-1.3 kb isoform even though it lacks its purported 
receptor-binding domain [Huang et al., 2000]. 
The actions of Ang-1 have been found to signal through the endothelial cell-
specific Tie 2 receptor tyrosine kinase, probably via its fibrinogen-like domain 
[Maisonpierre et al., 1997; Hanahan, 1997; Kwak et al., 1999; Procopio et al., 1999; 
Kim et cd., 2000b; Kwak et al., 2000; see reviews by Griffioen & Molema, 2000; 
Yancopoulos et aL, 2000], In addition to the flill-length Ang-1 (Ang-1.5 kb), three 
alternatively spliced species of Ang-1 mRNA have been discovered (Ang-1.3 kb, 
Ang-0.9 kb, and Ang-0.7 kb) in the megakaryocyte cell line CHRF. Ang-1.5 kb 
isoform is the primary activating ligand for this Tie 2 receptor. In agreement to the 
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structure of Ang-1.3 kb isoform, this isoform was found to interact with Ang-1.5 kb 
isoform via its coiled-coil multimerization domain. Similarly, Ang-0.9 kb isoform 
interferes with the binding of Ang-1.5 kb isoform to Tie 2 receptor, suggesting that 
both Ang-1.3 kb isoform and Ang-0.9 kb isoform probably act as dominant negative 
isoforms for the full-length Ang-1.5 kb isoform. A relatively unexplored area of 
study for these isoforms involves their mechanism of action these isoforms in vivo 
and how Ang-1.3 kb and Ang-0.9 kb isoforms can interfere with the binding of Ang-
1.5 kb isoform to Tie 2. Also, it is still unclear as to whether any of the isoforms 
interact (either activate or inhibit) as heteromultimers with related angiogenic species 
[Huang et al., 2000]. 
1.3.2 Angiopoietin 2 (Ang-2) 
Shortly after the discovery of Angiopoietin 1, another factor closely related to 
it, termed Angiopoietin 2 (Ang-2), was cloned from low-stringency screening of 
human and mouse cDNA libraries, using mouse Ang-1 cDNA as a probe. 
Transgenic studies have generated direct evidence for the importance of Ang-2 for 
embryonic vasculogenesis and angiogenesis. Similar to Tie 2- or Ang-1-null mice, 
transgenic mice overexpressing Ang-2 during embryogenesis exhibit embryonic 
lethality as a result of severe disruption of vessel structure and peri-endothelial 
support cells. These observations have clearly established a significant role of Ang-2 
as a natural antagonist for the Ang-1/Tie 2 interaction [Maisonpierre et al., 1997; 
Hanahan, 1997]. Other evidence in support of this argument came from the 
observations involving the inhibition of Ang-1 activity in endothelial cells via a 
fourfold to eightfold molar excess of Ang-2 as well as the blockage of Ang-1 
chemotactic activity for endothelial cells by Ang-2 in a dose-dependent manner 
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[Maisonpierre et al, 1997; Witzenbichler et al, 1998]. 
Structurally, the amino acid sequences of Ang-2 and Ang-1 are about 60% 
identical [Maisonpierre et al,, 1997; Stratmann et al, 1998; Witzenbichler et al., 
1998]. Most notably, both Ang-1 and Ang-2 bind with similar affinity to Tie 2 
receptor tyrosine kinase. However, in the study of cultured endothelial cells, 
receptor phosphorylation of Tie 2 appears to be mediated through Ang-1 but not 
Ang-2. The human Angiopoietin 2 gene has been assigned to chromosome 8 
[Cheung et al., 1998]. In general, Ang-2 shares a striking structural similarity with 
Ang-1; that is, both of them have a characteristic protein structure with an NH^-
terminal coiled-coil domain and a COOH-terminal fibrinogen-like domain together 
with a secretion signal peptide. However, unlike the Ang-1 protein, the inferred 
Ang-2 protein is about 496 amino residues long [Maisonpierre et aL, 1997; Geva & 
Jaffe, 2000]. Immunoprecipitation analysis of de novo Ang-2 protein synthesis in 
^^S-labeled cell lysates revealed a single band of 55 kDa approximately. However, 
the calculated molecular weights of the non-glycosylated and glycosylated forms of 
Ang-2 protein have been reported to be 57 kDa and 70 kDa respectively, since Ang-2 
contained several potential glycosylation sites [Oh et al., 1999]. 
The prominent expression of Ang-2 at sites of vascular remodeling as well 
as at the leading edge of invading vascular sprouts strongly implies that Ang-2 plays 
a facilitative role in vascular destablization, sprouting and angiogenic remodeling 
[Hanahan, 1997; Maisonpierre et al., 1997; Asahara et aL, 1998; Mandriota & 
Pepper, 1998; Oh et al., 1999; see reviews by Gale & Yancopoulos, 1999; 
Yancopoulos, 2000]. In fact, autocrine induction of Ang-2 in endothelium inhibits 
constitutive stabilizing action or the maturation function of paracrine Ang-1, thereby 
reverting vessels to a more plastic and tenuous state. Such inhibition leads to 
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cessation of vessel growth and even causes frank vascular regression in the absence 
of other associated growth factors. Conversely, destabilization by Ang-2 in the 
presence of high VEGF levels is associated with cessation of vascular regression, and 
onset of continued remodeling or the initiation of vascular sprouting. 
In addition to normal physiological role of Ang-2 in angiogenesis, Ang-2 
participates in gastric cancer angiogenesis, probably via corporation with VEGF 
[Etoh et al., 2001]. This is evident from the intense autocrine expression of Ang-2 in 
ECs of tumour-associated vessels. Both autocrine and paracrine Ang/Tie 2 pathways 
may be responsible for the regulation of the induction of proteases in ECs by Ang-2 
during tumour angiogenesis under the presence of VEGF. These signaling pathways 
are very similar to the model for the coordinated interaction between the VEGF and 
angiopoietin families mediating endothelial movement (as mentioned later in Section 
1.4). The regulation of proteases such as MMP-1 (matrix metalloproteinase-1), 
MMP-9 (matrix metalloproteinase-9), and uPA (urokinase plasminogen activator) by 
common promoter regions c-Etsl (c-erythroblast transformation specific domain 1) 
represents a crucial prerequisite for a tumour-associated angiogenic response in 
gastric carcinoma. The presence of Ang-1 is found to inhibit the activity of c-Etsl 
and subsequent production of these proteases. However, Ang-2, the natural 
antagonist for Tie 2, is able to inhibit autophosphorylation of Tie 2 receptor by Ang-
1 in human ECs. When VEGF is expressed in the presence of Ang-2, Ang-2 
significantly upregulates these proteases to degrade vessel basement membranes via 
activation of c-Etsl to enhance tumour progression. A dysregulated balance for 
Ang-2/VEGF mRNA expression is observed in cancer cells. Thus, angiogenesis in 
human gastric carcinoma is characterized mainly by the overexpression of Ang-2 
together with VEGF expression and Ang-2 can potentiate VEGF-induced 
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angiogenesis，probably by enhancing the initiation of neovascularization. 
Despite the antagonizing effect of Ang-2 on Ang-1-induced receptor 
1 phosphorylation in endothelial cells, Ang-2 is able to activate Tie 2 expressed in NIH 
I 3T3 fibroblasts or hemangioblast precursor cells [Maisonpierre et al., 1997; 
, Witzenbicheler et al., 1998]. Interestingly, the equivalent contribution of Ang-1 and 
Ang-2 to Tie 2 phosphorylation [Maisonpierre et al,, 1997] and a specific 
chemotactic response to both Ang-1 and Ang-2 [Witzenbicheler et al., 1998] were 
previously demonstrated in an experiment performed in NIH 3T3 fibroblasts 
I expressing transfected Tie 2 receptors. On the basis of these observations, Ang-2 
1 acts as an antagonist for Tie 2 receptor in endothelial cells but not in other cell types. 
^ Since hypoxia is well known to be a primary inducer of neovascularization 
j in a variety of pathological conditions, such as tumour angiogenesis, collateral vessel 
formation in cardiovascular diseases, and proliferative retinal neovascularization, and 
I it has been shown that hypoxia can trigger an up-regulation of VEGF expression (as 
mentioned in Section 1.2.3), it would be of interest to discuss whether hypoxia and 
VEGF can selectively enhance Ang-2 expression in endothelial cells. First of all, the 
up-regulation of Ang-2 expression by VEGF has been well demonstrated in bovine 
endothelial cells and mouse model of ischemia-induced retinal angiogenesis in vivo. 
The mechanism by which VEGF increases Ang-2 expression is however partially 
understood. Using several inhibitors of specific signal transduction pathways，Oh et 
al. (1999) revealed predominant roles of both MAPK activation and tyrosine 
phosphorylation in VEGF-induced Ang-2 mRNA expression of bovine retinal 
endothelial cells (BRECs), but a more minor contribution of the protein kinase C-
dependent pathway. 
In addition to VEGF, hypoxia has also been reported to selectively up-
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regulate Ang-2 mRNA expression and protein synthesis of Ang-2 in BRECs [Oh et 
al., 1999]. The exposure of BRECs to hypoxic conditions results in a peak Ang-2 
mRNA expression at 2 hours after treatment, followed by a gradual decline to the 
i basal level after 4 hours of stimulation. In view of the fact that hypoxia is the major 
stimulus for VEGF induction and VEGF increases Ang-2 expression in the study, it 
must be further determined whether hypoxia-induced VEGF is involved in the 
observed hypoxic regulation of Ang-2 in BRECs. Further experiment confirmed that 
in BRECs under normoxic or hypoxic conditions, there was no significant effect of 
‘ the anti-VEGF neutralizing antibody on Ang-2 mRNA expression. It would then 
appear that hypoxia produced a direct stimulation of Ang-2 mRNA levels in BRECs. 
V In agreement with the above findings, Mandriota & Pepper (1998) used RNase 
protection assay and demonstrated that 30 ng/mL of VEGF and hypoxia induced a 
2.9-fold and a 5.6-fold increase in Ang-2 mRNA levels in adrenal cortex-derived 
BME cells respectively. A possible explanation for the observed upregulation of 
Ang-2 expression by hypoxia and VEGF in hypoxic retina and neovascular vessels in 
vivo is that since Ang-2 has been reported to be a natural antagonist for Tie 2 
receptor, the angiogenic stimuli of hypoxia and VEGF may probably well deteriorate 
the integrity of the vasculature by suppressing Ang-1 activation of Tie 2 receptor. 
Human umbilical vein endothelial cell (HUVEC) cDNA analysis has yielded 
the identification of a novel alternatively splice variant of the human Ang-2 gene 
(4ng2州)[Kim et al, 2000a]. It is derived from alternative splicing in which part of 
the coiled-coil domain (amino acids 96-148) is deleted and hence it lacks 53 amino 
acids. The structure of Ang-2443 contains a secretory signal peptide and four of the 
six potential glycosylation sites. Ang-2443 binds to the Tie 2 receptor but it is 
incapable of stimulating Tie 2 phosphorylation. It may therefore act as a functional 
； 2 3 
antagonist of Ang-1-induced Tie 2 phosphorylation by interfering with binding of 
i Ang-1 to Tie 2 receptor. 
The fiinctional roles and expression pattern of Ang-l^^^ have also been 
described. It is of interest that Ang-2443 mRNA was mainly present in primary 
endothelial cells, several nonendothelial tumor cell lines, and primary tumor tissues. 
Macrophage differentiation might be probably associated with temporary 
upregulation of Ang-2443 expression. Such distribution pattern is consistent with a 
functional role for Ang-2443 as a major regulator of angiogenesis during some 
tumorigenic and inflammatory processes. 
Three different Ang-2 mRNA species encoding Ang-2A, Ang-2B and Ang-
2C isoforms are produced by alternative splicing of the chicken Ang-2 gene 
[Mezquita et al., 1999, 2000]. Although Ang-2 isoforms have been successfully 
identified in two different species, human and chicken, it remains to be elucidated 
whether Ang-2 isoforms can be expressed in other species such as rat and mouse. 
1.3.3 Angiopoietins 3 and 4 (Ang-3 and Ang-4) 
Using homology-based cloning approaches, the angiopoietin family has 
recently been expanded following the isolation of two new members, mouse-specific 
Angiopoietin 3 (Ang-3) and human-specific Angiopoietin 4 (Ang-4) [Valenzuela et 
al, 1999; Brown et al., 2000]. Similar to Ang-1 and Ang-2, both Ang-3 and Ang-4 
possess characteristic protein structures containing coiled-coil domains in the N-
terminal region, fibrinogen-like domain as well as a secretory signal peptide. An 
important message from chromosomal localization analyses of all of the 
angiopoietins in mouse and human is that both Ang-3 and Ang-4 represent the mouse 
and human counterparts of the same gene locus. However, compared with 99% and 
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87% amino acid identity within the fibrinogen-like domains (FDs) of mouse and 
human counterparts of Ang-1 and Ang-2, the structural divergence of mouse Ang-3 
and human Ang-4 is evident from only 54% and 65% overall amino acid identity 
‘ within their FDs respectively. On the basis of such amino acid identity, it seems 
likely that the similarity between mouse Ang-3 and human Ang-4 is much less than 
1 that between the mouse and human counterparts of Ang-1 and Ang-2, suggestive of 
diverging functions of the gene products in the two species. 
Although the respective roles of both mouse Ang-3 and human Ang-4 in 
angiogenesis and vascular maintenance are not yet fully elucidated, it is now well 
appreciated that they exert opposing activities on the Tie 2 receptor [Valenzuela et 
al., 1999]. The observation that Ang-3, like Ang-2, was able to phosphorylate Tie 2 
when expressed by fibroblasts, indicates that in endothelial cells other regulatory 
mechanism(s) prevail leading to their antagonistic activity. On the contrary, Ang-4, 
as is Ang-1, acts as a Tie 2 agonist in either human or mouse endothelial cells as well 
as mouse fibroblasts. Based on this current evidence, both Ang-3 and Ang-4 appear 
to be true members of the angiopoietin family, as judged by their specific binding to 
the Tie 2 receptor, and it would be tempting to speculate their differences in the 
biological effects at the molecular and cellular level. 
1.4 Interaction among VEGF, angiopoietin and Tie in maintenance of 
vasculature 
Highly coordinated interaction between two families of angiogenic factors, 
vascular endothelial growth factor (VEGF) and angiopoietins, has provided novel 
and important insights into physiological regulation of vasculogenesis, vessel 
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maturation and maintenance, angiogenesis, and regression during vascular 
development, as schematically shown in Figure 1.1 [Hanahan, 1997; Maisonpierre et 
1 al., 1997; Kwak et al., 1999; Holash et al, 1999; see reviews by Peters, 1998; Gale 
！ 
& Yancopoulos, 1999; Yancopoulos et al., 2000]. Such model system still maintains 
I 
the position of VEGF as the most critical molecular player of vascular development, 
with VEGF-mediated activation of VEGFR-2 eliciting differentiative, proliferative 
and chemotactic responses from endothelial cells, followed closely by the induction 
of endothelial cell interactions and capillary tube formation via VEGF/VEGFR-1 
interaction. Most notably, Angiopoietin 1 (Ang-1)/Tie 2 system is a predominant 
\� and potent regulator of vascular function and integrity, acting to mediate vessel 
maturation from simple endothelial tubes into more elaborate vascular structures 
composed of several cell types and subsequently to maintain the quiescence and 
stability of the mature vasculature. The enhancement of endothelial cell interactions 
with surrounding support cells and matrix is a prerequisite to form a stable 
vasculature. Unlike Ang-1, Angiopoietin 2 (Ang-2) has been identified as a naturally 
occurring antagonist of Ang-1 activation of Tie 2 during angiogenesis even though 
Ang-2 can still promote vascular remodeling. Ang-2 is specifically required to 
counteract Ang-1-mediated blood vessel stability by allowing the endothelial cells to 
revert to a more plastic and destabilized state reminiscent of developing vessels. 
Such destabilized vessels could be prone to two fates. On the one hand, these vessels 
become more sensitive to angiogenic changes induced by simultaneously available 
angiogenic factors such as VEGF, essentially recapitulating an early embryonic 
situation in which VEGF acts prior to the involvement of Ang-1. On the other hand, 
the absence of VEGF co-expression triggers endothelial cell death, likely by 
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1.5 Tyrosine kinase with immunoglobulin and EGF factor homology 
domains - Tie 1 and Tie 2 
The biological actions of angiopoietins have been found to manifest through 
one form of transmembrane tyrosine kinase receptors (as mentioned earlier in 
Section 1.3)，termed Tie 2. Both Tie 1 and Tie 2 receptors are absolutely critical for 
the later stage of angiogenesis rather than vasculogenesis and they belong to the 
receptor tyrosine kinase (RTK) family specifically expressed in developing vascular 
endothelial cells [Maisonpierre et al., 1993; Sato et al., 1995; Partanen et al., 1996; 
Asahara et al., 1998; Witzenbichler et al., 1998; Papapetropoulos et al., 1999; 
Uchida et al., 2000]. Both Tie 1 gene and Tie 2 gene have been localized to mouse 
chromosome 4 homologous to human chromosome Ip [Sato et al., 1993; Korhonen 
et al., 1994]. Different from other tyrosine kinase receptors, this putative RTK is 
composed of two intracellular tyrosine kinase domains and two unique extracellular 
immunoglobulin-like domains straddling three tandem EGF-like motifs, followed by 
three fibronectin (FN) type III repeat sequences located near the transmembrane 
domain [Maisonpierre et al., 1993; Iwama et al., 1993; Sato et al., 1993; Hashiyama 
et al., 1996; Batard et al., 1996; Geva & Jaffe, 2000]. The extracellular domains of 
both Tie 1 and Tie 2 share about 50% amino acid similarity in all three EGF-like 
repeats, but minimal homology within their two immunoglobulin-like loops (20-
30%). This is in contrast to 80% amino acid identity within the cytoplasmic domains 
of Tie 1 and Tie 2. 
The mechanism of action of Tie proteins is similar to that of other growth 
factor transmembrane tyrosine kinase receptors [Maisonpierre et al., 1993; Sato et 
j al., 1993; Wong et al., 1997; Jones et al, 1999; Geva & Jaffe, 2000]. The binding of 






loops, and FN IE-like repeats in the extracellular domain of the Tie 2 protein induces 
receptor activation, an event that immediately leads to ligand-dependent receptor 
autophosphorylation. As with VEGF receptor signaling, this autophosphorylation 
enables the p85 subunit of the lipid kinase phosphatidylinositol (PI) 3'-kinase, the 
SH2-containing protein tyrosine phosphatase 2 (SHP2), and the adaptor proteins -
growth factor receptor-bound protein 2 (Grb2), Grb7, and Grbl4, to bind probably 
via their Src-homology-2 (SH2) domains in vitro, and subsequently activate intact PI 
3'-kinase signal transduction pathway. This pathway is partially implicated in 
promotion of endothelial cell migration and survival, suggestive of the dependence 
of endothelial cell maintenance upon PI 3'-kinase signaling pathway through Tie 2. 
Consistent with constitutive expression of Tie 2 in both angiogenic endothelium and 
quiescent vasculature in the adult rat，it appears that tyrosine phosphorylation of Tie 
2 plays a facilitative role not only in angiogenesis but also in vascular maintenance 
[Wong et al., 1997]. Interestingly, a multisubstrate docking site Tyr^ ^^^ located in 
the C-terminal tail of Tie 2 permits Grb2, Grb7 and p85 (via its C-terminal SH2 
domain) to associate with the receptor both in vivo and in vitro after Ang-1 
stimulation of Tie 2. The observation of endothelial cell migration in response to 
Ang-1 mediated by p85 signaling and Tyr^刚 requirement of both p85 and Grb7 
phosphorylation strengthen the suggestion of the involvement of this multisubstrate 
： docking site in Tie 2-mediated endothelial cell sprouting [Jones et al., 1999]. 
However, the ligand(s) for Tie 1 remain unknown at present and no angiopoietin has 
been described that binds to Tie 1 [Hanahan, 1997]. 
The creation and characterization of mice in which either Tie 1 gene or Tie 2 
！ gene has been disrupted have demonstrated that these two RTKs are not functionally 





and/or angiogenesis. Deficiency of Tie 1 gene and Tie 2 gene in vivo results in 
embryonic lethality due to abnormalities of blood vessel formation during 
embryogenesis [Dumont et al, 1994; Sato et al., 1995]. Tie 2 knockout mice die 
during embryogenesis at day 9.5 and 10.5 because blood vessels are immature and 
lack branching networks, capillary sprouting from the primitive vascular network, 
and proper organization into large and small vessels, as observed in Ang-1 null mice 
and transgenic mice overexpressing Ang-2. The observations in these Tie 2 null 
mice have been interpreted as evidence for the role of Tie 2 system in regulating the 
endothelial cell recruitment of stromal cells which are required to encase and to 
stabilize the structure of blood vessels. Thus the Ang-1/Tie 2 pathway has a critical 
involvement in embryonic vascular development. Mice deficient in Tie 1 display 
embryonic lethality between day 14.5 and birth as a result of edema and hemorrhage. 
The finding of edema and hemorrhage in these mice can be attributed to poor 
structural integrity of the endothelial cells and firmly establishes the role of Tie 1 
signaling in modulation of the hemodynamics of transcapillary fluid exchange. 
Based on the above-mentioned knockout phenotype, Tie 1 is thought to act as a 
regulator of angiogenesis and vascular maturation [Loughna et al., 2001]. 
Although both angiopoietins and VEGF have been observed to regulate 
angiogenesis in vitro and in vivo, their roles in vascular polarity have not yet been 
fully elucidated. The molecular and genetic basis for vascular polarity should be 
investigated since there is a differential effect on right-hand side (RHS) and the left-
hand side (LHS) venous formation system in double-knockout mouse embryos for 
Ang-1 and Tie 1. Their RHS venous formation is disrupted, whereas that is normal 
for LHS venous network. A possible explanation for this observation is that 
polarized expression of Ang-1 in combination with the Tie 1 signaling pathway(s) 
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only contributes to the formation of the RHS venous network rather than the LHS 
network. Distinct signal transduction pathways exist between the RHS and the LHS 
venous systems during their early stages of formation. Identification of functional 
ligand(s) for the Tie 1 receptor would be important for the investigation of the 
mechanism of left-right asymmetry of the venous development system. 
The remodeling of blood vessels at the fetal-maternal interface and the 
formation of the placental fetal vascular tree have been studied based on the 
expression of Tie 2 receptor in fetal and maternal endothelial cells and endovascular 
invasive trophoblasts, and the expression of the ligand Ang-2 in syncytiotrophoblast 
[Goldman-Wohl et al., 2000]. Ang-2 produced by the fetal syncytiotrophoblast 
migrates to both fetal and maternal endothelial cells where Tie 2 is expressed, due to 
the ligand-receptor pair Ang-2 and Tie 2. The primary fiinction of an appropriately 
timed vascular remodeling is to sustain the pregnancy. 
The pathological effects of Tie 1 and Tie 2 receptor tyrosine kinases include 
synovial proliferation and angiogenesis of rheumatoid arthritis [Uchida et al., 2000] 
and breast-cancer angiogenesis by Tie 2/angiopoietin system [Stratmann et al., 
2001]. Rheumatoid arthritis (RA) is mainly characterized by angiogenesis [Uchida 
et al.’ 2000]. Using immunohistochemistry and reverse transcriptase-polymerase 
chain reaction (RT-PCR) analysis, it was found that both Tie 1 and Tie 2 receptors 
were expressed not only in vessel walls but also in synovial lining cells, stromal cells 
and pericytes. There is also a differential distribution pattern of Tie 1 expressing 
cells and Tie 2 expressing cells in synovial lining and stromal cells. The expression 
of these receptors reflects the degree of vascularity and synovial proliferation. The 
restricted expression of Tie 2 in CD69-/vimentin+ cells provides strong evidence for 
the role of Tie 2 in the differentiation of these cells from fibroblastic phenotype. 
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There should be the direct involvement of Tie 2 in the proliferation of lining cells, as 
demonstrated in the overexpression of PCNA in Tie 2 positive basal layered cells. 
The possible mechanisms of Tie receptors may be their interaction with the secreted 
^ angiopoietins in the endothelium itself or in the surrounding undifferentiated cells for 
I further growth of the vessels, following the differentiation of CDS4 positive 
‘ endothelial progenitor cells into endothelial cells within synovial tissue from 
I 
1 peripheral blood. In fact, the expression of Tie 1 and Tie 2 receptors in the 
i 
I pathologically abnormal synovial tissue of RA shed some light on their possible 
j 
I functional involvement in angiogenesis and proliferation of RA synovium. 
Similar to the previously mentioned human gastric carcinoma (Section 1.32) 
and other types of cancer, breast cancer is known to be angiogenesis-dependent 
i [Stratmann et al., 2001]. The expression patterns of VEGFR-2 and Tie 2 in the 
I human carcinoma samples suggest their biologic importance in tumour-associated 
angiogenesis. VEGFR-2 expression was mainly detected in endothelial cells in the 
tumour stroma and in small vessels within tumour islets, whereas there is a 
preferential expression of Tie 2 in endothelial cells in stromal vessels. Tie 2/Ang-1 
signaling pathway may also be partly responsible for breast tumour growth. This is 
supported by the abundant expressions of both Tie 2 and Ang-1 in a murine breast-
； cancer cell line M6378 tumours as well as in tumours with marked hypoxia-inducible 
： VEGF expression. The involvement of Ang-1 in tumour-associated angiogenesis 
reveals its functions in supporting the association of endothelial cells with smooth 
muscle cells and pericytes and in vascular sprouting. In contrast, reduction of both 
Tie 2 and VEGFR-2 would inhibit the growth of M6378 tumours. 
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1.6 Angiopoietin expression in female reproductive tissues (ovary) 
Recently, the mechanism of angiopoietin action in the angiogenesis of the 
female reproductive system has become the focus of intense interest. In female 
adults, physiological angiogenesis is of particular significance in follicular 
development, corpus luteum formation, and uterine endometrial proliferation during 
the ovarian cycle. Recent studies demonstrated Ang-1 and Ang-2 rtiRNA expression 
in the ovary of rat [Maisonpierre et al, 1997], cow [Goede et al., 1998] and monkey 
[Hazzard et al., 1999; Hazzard et al., 2000]. 
Ovaries from gonadotrophin-induced ovulating rats have been selected as 
targets and angiopoietin expression was compared with VEGF RNA expression 
1 during vascular remodeling in the rat ovary [Maisonpierre et al., 1997]. Using in situ 
hybridization approach, the mRNA expression of VEGF, Ang-1 and Ang-2 was 
localized in sections corresponding to four successive developmental stages: a small 
vesicular follicle, a large preovulatory follicle, a nonproductive follicle undergoing 
atretic regression and a developing corpus luteum at 8 h after ovulation. VEGF and 
Ang-2 expression were upregulated in the developing corpus luteum before vessel 
invasion. There were also abundant VEGF and Ang-2 transcripts at the front of 
vessels invading the developing corpus luteum. A possible scenario therefore was 
that the collaboration of Ang-2 with VEGF at the front of invading vascular sprouts 
enabled the endothelial cells to revert to a more plastic state so that the blood vessels 
would become more responsive to angiogenic changes induced by simultaneously 
available angiogenic factors such as VEGF. In agreement with a later role of Ang-1 
than VEGF in angiogenesis, Ang-1 mRNA expression was observed to follow or 
coincide with, rather than precede, vessel ingrowth into the early corpus luteum. The 
autocrine induction of Ang-2 blocked the constitutive stabilizing influence of 
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paracrine Ang-1. The atretic follicle and aged corpus luteum were characterized by 
uniformly high expression of Ang-2, with subsequent vascular regression under the 
absence of VEGF expression. High Ang-2 levels in the absence of a strong VEGF 
induction suggested a destabilization of blood vessels that finally led to vessel 
regression. 
Goede et al. (1998) investigated the molecular mechanisms underlying the 
processes of blood vessel maturation in the cyclic midstage bovine ovarian corpus 
luteum. The relative expression of Ang-2 over Ang-1 was examined in corpus 
rubrum mid-stage corpora lutea (CL), and regressing CL using quantitative PCR-
based technique. Results from this study demonstrated similar mRNA levels for 
Ang- 1 and Ang-2 in angiogenic corpus rubrum as well as in the nonangiogenic 
corpus luteum. In contrast, the relative expression of mRNA for Ang-2 to Ang-1 
was up-regulated during vessel regression when compared to that in the corpus 
rubrum and in the mid-stage CL. This would be in agreement with the previously 
published studies of Maisonpierre et al (1997), which also showed the relative 
overexpression of Ang-2 during blood vessel regression. 
Hazzard and his co-workers (1999) were the first to report on time-specific 
angiopoietin expression during the ovarian cycle in mono-ovular species, primates. 
As one of the pilot experiments in this study, the time-dependent effect of 
recombinant human gonadotrophins (rhCG) in inducing Ang-1 and Ang-2 mRNA 
expression was examined in peri-ovulatory follicles at a final concentration of 1000 
lU. hCG was shown to induce a dramatic increase (30-fold) in Ang-1 mRNA levels 
in granulosa cells at 36 h hCG treatment (around ovulation), an event that closely 
followed a 10-fold decrease in Ang-1 mRNA levels at 12 h after hCG administration. 
This would be expected since Ang-1 production is augmented to stabilize vasculature 
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i: by recruiting pericytes to developing capillaries after the breakdown of the basement 
membrane close to the time of ovulation. In contrast, no changes in Ang-2 mRNA 
levels were observed in primate granulosa cells of periovulatory follicles at 12 or 36 
hours after hCG administration. This might reflect the constant expression of Ang-2 
in the maturing follicle during the peri-ovulatory interval. Such observation was in 
line with the decline of Ang-1 mRNA expression at 12 hours after hCG treatment 
and could be related to the initiation of plasticity increase and loosening of the 
capillary support matrix during angiogenesis. 
In the study of gonadotrophin and steroid regulation of Ang-1 and Ang-2 
mRNA expression during the peri-ovulatory interval, one group of monkeys received 
3p-HSD inhibitor Trilostane (TRL) treatment. For the restoration of progestin 
concentration, another group of monkeys received TRL plus the non-metabolizable 
progestin R5020 (Promegestrone) treatment. The effects were examined following 
12- and 36-hour treatment periods and compared with the above-mentioned effects of 
hCG administration (without any additional treatment) at each time point for both 
groups of animals. The non-responsiveness of Ang-1 mRNA expression to TRL or 
TRL+R5020 at 12 h after hCG treatment was related to the direct regulation of Ang-
1 mRNA expression by hCG rather than progesterone around the time of ovulation. 
Although the up-regulation of Ang-1 was significantly overcome by the inhibitory 
effect of TRL in the late peri-ovulatory interval, a partial restoration of Ang-1 
mRNA to time-matched control levels by progestin occurred at 36 h after hCG 
treatment. The observation would suggest that there was a gonadotrophin-dependent 
j regulation of Ang-1 mRNA expression during the early stage of peri-ovulatory 
1 
！ period but a steroid-dependent regulation during the late peri-ovulatory stage (at 36 h 
after hCG treatment). In sharp contrast to Ang-1 expression, the inhibitory effect of 
I 
1 35 i
TRL on Ang-2 expression was observed at 12 h after hCG treatment but Ang-2 
I mRNA levels could not be brought to control values by progestin replacement. Also, 
neither TRL nor TRL+R5020 were shown to exert any effects on Ang-2 expression 
at 36 h after hCG treatment. It was likely that Ang-2 expression was regulated by 
steroid during the peri-ovulatory interval (at 12 h after hCG treatment) rather than 
during the late-ovulatory period (at 36 h after hCG treatment), as indicated by the 
lack of progestin effect at 12 h after hCG treatment. 
More recently, Hazzard et al (2000) demonstrated the expression of Ang-1 
and Ang-2 mRNA in the primate corpus luteum throughout the luteal lifespan in the 
menstrual cycle. Corpus luteum was collected from rhesus monkeys at different time 
points. The time intervals chosen for this study were early- (3-5 days post-LH 
surge), mid- (6-8 days), mid-late (10-12 days), and late (14-16 days) luteal phase of 
the menstrual cycle, and at menstruation (17-18 days). Ang-1 and Ang-2 mRNA 
expressions during different stages of the luteal lifespan in the menstrual cycle were 
assessed by semi-quantitative RT-PCR approach. The possible association of Ang-1 
with its natural antagonist Ang-2 in facilitating the development and regression of 
vasculature in the primate corpus luteum was characterized by their similar 
expression patterns during the luteal phase. Both Ang-1 and Ang-2 mRNA levels 
remained low at early to mid-luteal phase, peaked during corpus luteum regression at 
late luteal phase and then declined towards the basal by the time of menstruation. 
The results obtained by Goede et al. (1998) appear to be totally different from 
those obtained from Hazzard et al. (2000). Similar expression patterns of Ang-1 and 
Ang-2 during the luteal phase were observed in the study carried out by Hazzard et 
al. (2000), whereas Goede et al. (1998) demonstrated an up-regulation of the relative 
expression of mRNA for Ang-2 to Ang-1 in the late luteal phase in the cow. Goede 
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et al. (1998) realized that these observations could be explained simply by the 
j regression of capillaries at late luteal phase. Hazzard et al (2000) disagreed with 
I 
‘ such observations and suggested a new concept of compartmentalized expression of 
Ang-1 and Ang-2. This concept was supported by the localization of Ang-1 and 
Ang-2 mRNA in different areas of the mouse corpus luteum using in situ 
hybridization by Maisonpierre et al (1997). According to this revised concept, the 
decrease in functional interaction among these angiogenic factors might influence 
vascular development or regression. In addition, based on an in vitro study 
performed by Mandriota & Pepper (1998), there was evidence for the inhibition of 
Ang-2 expression by angiogenic repressors in bovine microvascular endothelial cells 
under the presence of Ang-1. Nevertheless, it remains unclear whether the 
expression patterns of Ang-1 and Ang-2 during the luteal phase are species-specific 
or whether the stimulation of gonadotrophins, mainly LH/hCG, is involved in the 
regulation of VEGF mRNA levels and subsequent Ang-1 and Ang-2 expressions in 
the ovarian follicles and corpora lutea. 
1.7 Testicular angiogenesis 
There have been very few studies that identify the regulators of testicular 
angiogenesis and establish the molecular mechanisms underlying angiogenesis in 
! 
testis under physiological and pathological conditions. Using RT-PCR and 
immunohistochemical staining, VEGF transcripts and proteins have been localized 
mainly to Leydig cells and Sertoli cells in the testes of both human [Ergun et al, 
1997] and rodents species [Wan et al, 1996; Collin et al, 1996; Au et al., 1997]. It 
i has also been proposed that besides the possible involvement of VEGF in testicular 
angiogenesis, VEGF may play an important role in Leydig cell-testicular 
macrophage interaction [Au et al, 1998]. Using a cell migration assay, VEGF has 
I been shown to induce chemotactic movement of testicular macrophages suggesting 
that VEGF produced by Leydig cells could be involved in the recruitment of 
testicular macrophages, allowing the two cell types to establish a close structural and 
^ functional association [Hutson, 1998]. 
Since the process of angiogenesis involves not just VEGF and its receptors as 
previously thought but also the interaction of angiopioetins with their Tie 2 receptors. 
The interaction of the latters is important in determining the stability of the blood 
vessels either by stabilizing the endothelial cell interaction with the surrounding cells 
to maintain the structure of the blood vessels or to interfere with such interaction 
leading to either increased angiogenic potential or degeneration through apoptosis. 
Although VEGF and its receptors have previously been demonstrated in the testis 
where they occur in specific cell types, information of angiopoietins and Tie is 
entirely missing. In order to better understand the process of testicular angiogenesis 
and its possible control, it would therefore be interesting to determine whether and 
1 how the expression of angiopoietins is spatially related to the known distribution of 
VEGF in the testis. 
j 
1.8 Aims of the present study 
Apart from VEGF and its receptors, in order to gain further insight into the 
possible involvement of angiopoietins and Tie in the control of testicular 
angiogenesis, the present study examined the expression and cellular localization of 




in the rodent testes and testicular cell lines using a combination of techniques. These 
include RT-PCR, Western immunoblotting and immunohistochemistry. The use of 
！ testicular cell lines from rat and mouse allows the possible sources of angiopoietins 
1 
二 from the two major somatic cell types within testis to be differentiated In addition， 
； testicular tissues and primary testicular cells were used to confirm angiopoietin 
i 
^ expression in vivo and to correlate with the findings obtained in vitro from testicular 
J 
j cell lines which may have changed their phenotypic expression after multiple 
passages in culture. 
j Also in view of the recent reports on the expression of multiple Ang-1 
isoforms in the human megakaryocyte cell line CHRF [Huang et al, 2000] and two 
a 
[' Ang-2 isoforms from human umbilical vein endothelial cells [Kim et al., 2000a], the 
present study was extended to determine whether such isoforms could be expressed 
in animal species such as the rat and mouse, and in particular for tissues such as the 
testis. Such possibilities were being examined in the present study using RT-PCR 
i and specific primers that were designed based on information gathered from the 
i study of human. 
I 
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2. Materials and methods 
2.1 Preparation of primary cells from rat testes 
2.1.1 Sertoli cell preparation 
Sertoli cells were prepared from 20-day-old Sprague-Dawley rats 
following the methods described by Gorczynska et al (1993) and Gnessi et al. 
: (1995) with some modificiations. The animals were killed by carbon dioxide 
asphyxiation. Testes were excised using sterile instruments and placed into 10 
mL sterile Hanks' balanced salt solution containing 0.01% of deoxyribonuclease 
(#DN25, Sigma，St. Louis, MO, USA) (HBSS-DNase). Subsequent procedures 
were carried out in a laminar flow hood using aseptic technique. After rinsing 
with HBSS-DNase, the testes were decapsulated and the contents transferred to 5 
mL fresh HBSS-DNase. The seminiferous tubules were teased apart and 
chopped into small pieces for 15 minutes. The minced tissue was transferred into 
a sterile 50 mL-Falcon tube and washed twice in HBSS-DNase made up to a total 
volume of 50 mL. Every time after washing, the tissue was recovered by 
centrifiigation at 250 g for 3 minutes, and the supernatant was discarded. The 
tubule fragments were then digested in 10 mL HBSS containing 0.01% DNase, 
0.1% trypsin (#T8003, Sigma, St. Louis, MO, USA), 0.1% hyaluronidase 
(#H2251, Sigma, St. Louis, MO, USA) and 0.01% collagenase (#C9891, Sigma, 
St. Louis, MO, USA) in a shaking water bath (180 cycles per minute) at 32 for 
25 minutes. After digestion, the tissue was transferred to a sterile 50 mL-Falcon 
tube and again washed twice in HBSS-DNase in a final volume of 50 mL. The 
supernatant was discarded each time after centrifiigation at 250 g for 3 min at 
room temperature. At the end, the tissue pellet was resuspended in 12 mL 
Dulbecco's Modified Eagle Medium: Ham's F12 medium (DMEM/F-12, 1:1，v/v) 
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(Gibco BRL, Grand Island, NY, USA, Cat. No. 12500-062) supplemented with 
10% fetal bovine serum (Gibco BRL, Grand Island, NY, USA), 5 ^ig/mL human 
； transferrin (#18158, Sigma, St. Louis, MO, USA), 10 |Lig/mL bacitracin (#B0125, 
Sigma, St. Louis, MO, USA), 2.5 ng/mL epidermal growth factor (#E4127, 
Sigma, St. Louis, MO, USA) and 10 |Lig/mL bovine insulin (#15500, Sigma, St. 
Louis, MO, USA). The cells were plated onto six sterile culture plates (100 x 20 
mm; Falcon, Becton Dickinson Labware, Franklin Lakes, NJ, USA) and placed in 
a water-jacketed carbon dioxide incubator (Napco Model 5100) maintained at 32 
under a humidified atmosphere of 5% carbon dioxide in air. The medium was 
changed the next day. On the day of culture, the cultures were subjected to 
hypotonic treatment in 20 mM TRIS (pH 7.4) for 2.5 minutes to lyse the residual 
germ cells. This was then followed by three washes with DMEM/F-12. On the 
4th day of culture, the medium was aspirated and the cells that remained in the 
culture dish represented an enriched Sertoli cells preparation. They were ready 
for RNA or protein extraction. 
2.1.2 Germ cell preparation 
Germ cells were isolated from testes of 90-day-old male Sprague 
Dawley rats using the method described by Woodruff et al. (1992) with minor 
modifications. The testes were decapsulated and the tissue was transferred to a 
clean milk bottle. Twelve millilitres of DMEM/F-12 containing 30 mg bovine 
serum albumin (#A3294, Sigma, St. Louis, MO, USA) and 3 mg collagenase 
(Type I; Worthington Biochemical Corporation, Halls Mill Road, Freehold, New 
Jersey) were added and after replacing the screw cap, the bottle was tightly sealed 
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with parafilm. The digestion process was carried out in a shaking water bath 
(110 cycles per minute) at 32 for 20 minutes. At the end, the tubules were 
dispersed in 50 mL DMEM/F-12 and shaken gently. Then the tissue was allowed 
to sediment for 5 minutes and the supernatant was discarded. The tubules were 
fiirther washed three times with 100 mL 10 mM phosphate-buffer saline (PBS, 
pH 7.4, containing 9 g/L sodium chloride and 1.56 g/L sodium dihydrogen 
phosphate monohydrate) and shaken gently. Each time the tissue was allowed to 
sediment for 10 minutes and the supernatant was discarded each time. The 
resulting tubules were thoroughly minced with scissors for 10 minutes and the 
minced tissue was transferred to a clean 50 mL-Falcon tube. PBS was then 
added to the tube to make up the final volume to 50 mL. After gentle shaking， 
the chucks of tissue fragments were pelleted by centrifugation at 6 g for 2 
minutes. The supernatant collected after centrifugation was allowed to pass 
through a nylon pantyhose to remove aggregated cells and larger debris. The 
above steps were repeated two more times with the tissue pellets remaining at the 
bottom of the centrifuge tube. The resulting filtrate was added to a funnel packed 
with glass wool to remove the spermatozoa and then centrifliged at 100 g for 4 
minutes. The supernatant was discarded and the pellet at the bottom of the tube 
was washed twice with 50 mL PBS. At the end，the pellet was resuspended in 10 
mL PBS and the cell suspension was filtered through a 20 陣 nylon mesh. The 
final filtrate was centrifliged at 1500 g for 5 minutes. After pipetting off the 
supernatant, the cell pellet containing predominantly germ cells was ready for 
RNA or protein extraction. 
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2.1.3 Interstitial cell and Leydig cell preparation 
The procedures used for preparing interstitial cells and Leydig cells were 
adopted from Murono et al (1992) and Gnessi et al. (1995). Both cell 
preparations were derived from testes of 90-day-old adult Sprague Dawley rats. 
Testicular interstitial cells were obtained after collagenase digestion of the testes 
i 
i followed by crude cell separation by centrifugation. Leydig cells were obtained 
1 
I after subjecting the interstitial cells to a further purification step ofPercoll density 
I 
gradient centrifugation. 
After the animals were killed by carbon dioxide asphyxiation, their testes 
！ were removed and decapsulated. The tissue was placed in a milk bottle 
containing 24 mL or 12 mL 0.025% collagenase (Type I; Worthington 
Biochemical Corporation, Halls Mill Road, Freehold, New Jersey) solution in 
Medium 199 (Gibco BRL, Grand Island, NY, USA; Cat. No. 21200-076) or 
DMEM/F-12 supplemented with 60 mg BSA, 10 units/mL penicillin G sodium 
and 10 |ig/mL streptomycin sulphate (Gibco BRL, Grand Island, NY, USA) for 
the preparation of Leydig cells and interstitial cells, respectively. Enzyme 
digestion was allowed to proceed in a shaking water bath (110 cycles per minute) 
at 32 for 20 minutes. At the end, 80 mL DMEM/F-12 supplemented with 
antibiotics and 0.2% BSA (for interstitial cell preparation) or 50 mL Medium 199 
supplemented with antibiotics (for Leydig cell preparation) was added to the milk 
bottle and the testicular tissue was allowed to sediment for 5 minutes. The 
supernatant was pipetted off to 50 mL-Falcon tubes. For preparing Leydig cells, 
25 mL Medium 199 was again added to the tubes. Similarly, for preparing 
I interstitial cells, DMEM/F-12 with 0.2% BSA was added to the tubes to make up 
the final volume to 50 mL. The cells were collected in the supernatant after 
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I 
gently swirling and unit sedimentation. 
After the above steps, the supernatant was pooled and centrifuged at 350 
g for 10 minutes. For preparing interstitial cells, 10 mL PBS was added to wash 
I 
the cell pellet twice. The tubes were centrifuged at 350 g for 5 minutes and the 
supernatant was then discarded each time. The cell pellet was finally ready for 
^ protein extraction. 
I For preparing Leydig cells, the cell pellet was recovered and resuspended 
in a small volume of Medium 199: BSA (50 mL of Medium 199 supplemented 
with 10 units/mL penicillin G sodium, 10 )ag/mL streptomycin sulphate and 50 
mg BSA). The cells were pooled and layered on top of a discontinuous Percoll 
(Amersham Pharmacia Biotechnology, Buckinghamshire, UK) gradient with 
\ density of 1.030, 1.040，1.055, 1.065, 1.070 and 1.096 g/L set up in 50 ml Falcon 
centrifuge tube. The gradient was centrifuged at 900 g for 20 minutes. Cells 
localizing at percoll gradient density of 1.070 g/L were saved as the Leydig cell 
enriched fraction. Medium 199: BSA (50 mL of Medium 199 supplemented with 
10 units/mL penicillin G sodium and 10 \xg/mL streptomycin sulphate and 50 mg 
BSA) was added to wash the Leydig cells three times, with centrifugation at 350 
g for 10 minutes in between each washing step. The resulting Percoll purified 
^ Leydig cells were then ready for RNA extraction. In view of the large number of 
I animals required to get enough purified Leydig cells for protein analysis, Western 
immunoblotting was not performed on Leydig cell lysates, but rather just on the 
interstitial cell lysate. 
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2.2 Cell cultures 
2.2.1 Reagents and cell lines 
Testicular cell lines (TM3，TM4, MLTC-1, R2C and LC540), and rat C6 
glioma cell line were obtained from the American Type Culture Collection 
(Rockville, MD) and maintained under recommended conditions. 1:1 Dulbecco's 
i Modified Eagle Medium (DMEM):Ham's F12 Medium (Cat. No. 12500-062)， 
RPMI 1640 medium buffered with 25 mM HEPES (Cat. No. 23400-021)， 
Ham's FIO medium (Cat. No. 81200-040), Minimum Essential Medium (Eagle) 
in Earle'sBSS (Cat. No. 41500-067), fetal bovine serum, horse serum, penicillin 
G (sodium salt) and streptomycin sulphate were purchased from Gibco BRL, 
Grand Island, New York, USA. Sodium bicarbonate and D-glucose were 
obtained from BDH Chemicals Ltd, Poole England. HEPES (without sodium 
salt) was purchased from Boehringer Mannheim, Germany. Tissue culture plates 
(100 X 20 mm; Polystyrene; Nonpyrogenic) were from Becton Dickinson 
Labware, Becton Dickinson and Company, Franklin Lakes, NJ, USA. 
2.2.2 Cell lines of mouse TM3 Leydig cells and TM4 Sertoli cells 
I 
Based on information provided by the supplier (ATCC), both TM3 
Leydig cells and TM4 Sertoli cells are clonal cell lines isolated respectively from 
primary cultures of Leydig cell-enriched preparations and Sertoli cell-enriched 
preparations from normal testes of 11- to 13-day-old BALB/c nu/+ mice. They 
were maintained in a 1:1 mixture of Dulbecco's Modified Eagle Medium 
I (DMEM)/Ham's F12 medium supplemented with 4.5 g/L glucose, 1.2 g/L 
j sodium bicarbonate, 15 mM HEPES, 10 units/mL penicillin G (sodium salt) and 
j 10 [ig/mL streptomycin sulphate, 5% horse serum and 2.5% fetal bovine serum. 
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The cultures were kept at 37�C in a water-jacketed CO2 incubator (Nuaire, US 
Autoflow, Techcomp) and media were changed every 3 days. The cells were 
passaged at a dilution ratio of 1:5 after a period of 3-5 days and harvested at 80-
: 90% confluence. 
2.2.3 Mouse MLTC-1 Leydig tumour cells 
According to the information provided by the supplier, MLTC-1 is a 
tumour cell line of mouse Leydig cells derived from the M5480P transplantable 
Leydig cell tumour carried in C57BL/6 mice. Significant stimulation of 
j membrane adenyl cyclase activity could be observed in these cells after treatment 
with human chorionic gonadotrophin (hCG), luteinizing hormone, cholera toxin, 
sodium fluoride and guanyl-5'-ylimidodiphosphate. The cells were cultured in 
RPMI 1640 medium containing 25 mM HEPES, 10% fetal bovine serum, 10 
I units/mL penicillin G sodium and 10 \ig/mL streptomycin sulphate at 37 under 
a humidified atmosphere of 5% CO2 in air. The medium was replaced every 3 
] days and the cells were passaged at a split ratio of 1:3 at 5-6 days intervals. 
j 2.2.4 Rat R2C Leydig tumour cells 
A tumour cell line of rat Leydig cells (R2C) is derived from testes of 
two-month-old male rat. The cells were cultured in Ham's FIO medium 
I 
•1 
I supplemented with 15% horse serum, 2.5% fetal bovine serum, 10 units/mL 
penicillin G sodium and 10 |ag/mL streptomycin sulphate but the medium for 
i culture of rat glial cells (C6) had additional supplements of 1.5 g/L sodium 
bicarbonate and 2 mM L-glutamine. The cells were kept at 37 in a humidified 
50/0 CO2 atmosphere and the cells were fed every 3 days. They were passaged 
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upon confluency at a split ratio of 1:3 at 3-5 days intervals. 
2.2.5 Rat LC540 Leydig tumour cells 
LC540 Leydig cells are derived from Fischer male adult rat. They were 
grown in Minimum Essential Medium (Eagle) in Earle's BSS supplemented with 
non-essential amino acids, 1 mM sodium pyruvate and 10% fetal bovine serum. 
The medium also had 10 units/mL penicillin G sodium and 10 g/mL 
streptomycin sulphate added as antibiotics. The cells were kept in a humidified 
5% CO2 atmosphere at 37 and the medium was changed every 3-4 days. The 
cells were passaged at a split ratio of 1:3 after a period of 3-5 days. 
2.2.6 Rat C6 glioma cells 
According to information provided by the supplier and other published 
studies, C6 is a tumour cell line of rat glial cells (C6). The medium for culture of 
‘ this cell line was the same as that for culture of rat R2C Leydig cells, except that 
it had additional supplements of 1.5 g/L sodium bicarbonate and 2 mM L-
glutamine. The cells were kept at 37 in a humidified 5% CO2 atmosphere and 
the cells were fed every 3 days. They were passaged upon confluency at a split 
： ratio of 1:3 at 3-5 days intervals. 
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2.3 Analyses of Angiopoietin 1，Angiopoietin 2，Angiopoietin 3，Tie 1 
receptor, and Tie 2 receptor mRNA in testicular cell lines and 
testicular tissues 
I 2.3.1 Extraction of total RNA from testicular cell lines and testicular 
tissues 
Total RNA was isolated from testicular cell lines and testicular tissues 
i using TRIzol reagent following the procedure suggested by the manufacturer 
1 (Gibco BRL, Grand Island, NY, USA). One mL TRIzol reagent was used for 50-
100 mg testicular tissue. After the addition of TRIzol reagent, the tissue was 
hand-homogenized in a 3-mL glass homogenizer with a clearance of 0.004-0.006 
inch (Kontes Scientific Glasswarer/ Instruments, Vineland, NJ, USA). During 
tissue homogenization, the homogenzier was kept cooled inside an ice bucket. 
The tissue lysate was centrifuged at 12,000g for 10 minutes at 4 °C in an 
Eppendorf Refrigerated Centrifuge (Eppendorf 5804R, Hamburg, Germany) and 
the resulting clear supernatant was transferred to a new 1.5 mL microcentrifiige 
tube. 
Testicular cell lines grown in monolayer were lysed directly in culture 
dishes by adding 1 mL TRIzol reagent to each 10 cm^ of culture. Subsequently 
the cell suspension was passed several times through a 1 mL syringe to disrupt 
the cells. 
Phase separation was carried out for both tissue lysate and cell lysate. 
1 The homogenized samples were incubated at room temperature for 15 minutes to 
I permit complete dissociation of nucleoprotein complexes. 200 i^L of chloroform 
^ was added per 1 mL of TRIzol reagent initially used for homogenization. The 
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sample tubes were capped securely and then hand-shaken vigorously for 15 
seconds. After further incubation of the samples at room temperature for 3 
minutes they were subjected to centrifiigation at 12,000 g for 15 minutes at 4 ""C. 
！ Following centrifugation, the mixture was separated into a lower red, phenol-
chloroform phase, an interphase, and a colourless upper aqueous phase. The 
upper aqueous phase containing RNA was then transferred into a new 1.5 mL 
microcentrifuge tube. RNA was precipitated by the addition of 500 \iL isopropyl 
alcohol per 1 mL of TRIzol reagent used for the initial homogenization and then 
1 
I the samples were incubated at room temperature for 10 minutes. The samples 
j _ 
were subjected to centrifugation at 12,000g for 10 minutes at 4 "^C and RNA 
should be visible on the side and bottom of the tube. The supernatant was then 
discarded and the RNA pellet was washed once with 1 mL 70% ethanol per 1 mL 
I of TRIzol reagent used initially for homogenization. This was done by vortexing 
the microcentrifuge tube to dislodge the pellet and then collecting the pellet again 
after centrifiigation at 7,500g for 5 minutes at 4 The supernatant was 
j carefully discarded and the RNA pellet was vacuum-dried briefly for 5 to 10 
I 
minutes using the SpeedVac (DNA SpeedVac 110, Savant Instruments Inc., NY, 
USA) to remove residual ethanol. Nontheless the pellet should not be overdried 
since this would make the redissolving more difficult. The RNA was dissolved in 
j 
I an appropriate volume of diethylpyrocarbonate (DEPC)-treated water and the 
solution was passed a few times through a pipette tip to facilitate dissolution. The 
resulting RNA samples could then be stored at - 7 0 � C until use. 
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2.3.2 Quantitation of total RNA 
RNA concentrations and purity were determined by spectrophotometry 
I (Ultrospec Spectrophotometer, Amersham Pharmacia Biotechnology, 
Buckinghamshire, UK) based on the absorbance at 260 nm (A260) and 280 nm 
(A280). Each RNA sample was diluted a hundredth time before being placed in a 
curvette which had previously been rinsed with DEPC-treated water to remove 
any contaminants or residual RNA/DNA from previous samples. DEPC-treated 
water was used as a reagent blank to compensate for the loss of light caused by 
reflections from the surface of the cuvette and the absorbance of the solvent (i.e. 
DEPC-treated water). RNA concentration, total yield and the purity of each 
sample could then be calculated according to the following formulae: 
RNA concentration of original sample (in \ig per |liL) = (40 x A260 x dilution 
factor) / 1000 
Total yield (in \ig ) = RNA concentration x total volume of RNA sample (in |jL) 
RNA purity = A260 / A280 
An absorbance of 1 unit at 260 nm corresponds to 40 \ig of RNA per mL (A260 = 
1 = 40 lag per mL) and this relationship is valid only for measurements in water. 
Absorbance readings at 260 nm measure RNA concentration and they should be 
greater than 0.15 to ensure significance. The ratio of absorbance readings taken 
at 260 nm and 280 nm (A260 � A280) provides an estimate of the purity of the RNA 
sample. Only when this ratio lies between 1.5 and 1.9 would the RNA 
preparation be considered acceptably pure. When this ratio is lower than 1.5, the 
RNA is considered contaminated (with protein). 
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2.3.3 First strand cDNA synthesis by reverse transcription (RT) 
Reverse transcription was firstly performed by heating a 12 i^L reaction 
I mixture containing 5 total RNA and 0.5 \xg/[iL oligodeoxythymidine primers 
(Gibco BRL, Grand Island, NY, USA) to 70 for 10 minutes. After immediate 
, chilling of the sample in ice for 2 minutes, 7 |liL mixture containing 5x first strand 
buffer, 0.1 M dithiothreitol (DTT) and 10 mM each of the 
deoxynucleotidetriphosphates (dNTPs) (Gibco BRL, Grand Island, NY, USA) 
was added to each RNA sample and then heated to 42 for 2 minutes. 1 \xL of 
； Superscript II RNase H' Reverse Transcriptase (200 units) (Gibco BRL, Grand 
Island, NY, USA) was then added to each sample in a final volume of 20 |iL and 
: incubated for 50 minutes at 42 followed by a final extension time of 15 
minutes at 7 2 � C . All cDNA preparations were kept at - 2 0 � C until use for RT-
PCR. 
mRNA 5' AAAAAAA] 3, 
M W B H Oligo (dT) primer 
First strand Reverse Transcriptase 
cDNA synthesis + dNTPs 
mRNA 5’ I AAAAAAA I 3, 
3 ， | i m i m i n i i i m ^ Q Q j 5, 







2.3.4 Normalization of the amounts of cDNA used in polymerase chain 
j 
I reaction (PCR) 
I 
i The amounts of cDNA used in polymerase chain reactions (PCR) were 
adjusted based on a house-keeping gene - (3-actin. Amplification of cDNA for P-
actin serves to verify successful RNA isolation, reverse transcription from total 
RNA to cDNA and equal loading ofcDNA in PCR. 
One fiftieth of synthesized cDNA was used as a template in the PCR 
reaction for p-actin containing 2 \iL lOx PCR buffer, 1 |iL 10 mM each dNTP, 1 
jiL each of sense and antisense primers (20 pmoles per [iV), 0.5 \iL Taq DNA 
polymerase (Gibco BRL, Grand Island, NY, USA) and 2.0 mM magnesium 
chloride in a final volume of 20 [iL. Samples were pre-heated to 94 for 3 
minutes, followed by 18 PCR cycles (94 for 1 minute, 58 "C for 45 seconds, 
72 for 1 minute 30 seconds) and a final extension step at 72 for 10 minutes, 
using a PTC 200 thermal cycler (Thermal Cycler, PTC-200, MJ Research, San 
Fancisco, USA). Based on earlier studies, the number of cycles (i.e. 18 cycles) 
chosen for the amplification of P-actin cDNA was found at the exponential phase 
of the PCR. The following primer sequences specific for p-actin were selected: 
sense primer 5'-TCACCGAGGCCCCTCTGAACCCTA-3' 
antisense primer 5 ‘ -GGCAGTAATCTCCTTCTGCATCCT-3 ‘ 
They correspond to sequences 1642-1665 bp and 2814-2837 bp，respectively 
(GenBank™ Accession Number J00691)，and should give rise to a PCR product 
\ with the expected size of 645-bp. All primers used in the present study were 
purchased from Gibco BRL, Grand Island, NY, USA. 10 \iL of each PCR 
"i 






I (electrophoresis grade, Gibco BRL, Grand Island, NY, USA) containing 0.5 
j mg/mL ethidium bromide in TAE buffer (40 mM TRIS, 20 mM sodium acetate, 1 
I � 
mM EDTA, pH 7.2). The position and relative intensities of the bands were 
recorded and compared using a gel documentation system (Fluorchem™ 8000 
Advanced Fluorescence, Chemiluminescence and Visible Light Imaging System, 
Alpha Innotech Corporation). Based on the difference in band intensities for P-
actin, the amounts of templates used in subsequent PCR reactions for the 
transcripts of special interest were adjusted accordingly to approximate equal 
loading. 
2.3.5 Polymerase chain reaction (PCR) 
Before performing the PCR for specific gene products the reaction 
conditions were optimized for primer annealing temperature, concentration of 
magnesium chloride, PCR cycle number and initial amounts of cDNA template 
used for each primer set. A series of RT-PCR experiments was then conducted 
using pairs of specific primers for Ang-1, Ang-2, Ang-3, Tie 1 and Tie 2. Table 
2.1 summarizes the primer sequences designed from published DNA sequences 
whereas Table 2.2 summarizes the determined optimal primer annealing 
temperature, optimal concentration of magnesium chloride, optimal PCR cycle 
number and the expected product size for each PCR. 
PCR was performed in thin wall 0.6 mL PCR tubes (Robbins Scientific 
Corporation, San Aleso Avenue, Sunnyvale, CA) with variable amount of 
template, variable amount of 50 mM magnesium chloride, 2 [iL of lOX PCR 
buffer, 1 [xL of 10 mmoles each dATP, dCTP, dGTP and dTTP, 1 |iL each of the 
53 
I 
sense and antisense primers (20 pmoles), and 0.5 jjL of 5 units per \xL Taq DNA 
polymerase (Gibco BRL, Grand Island, NY, USA). Amplifications were carried 
out in 20-|liL volumes using PTC-200 Thermal Cycler (M. J. Research, Inc., San 
Fancisco, USA) and the following parameters: 3 minutes 94 °C initial 
denaturation followed by optimal temperature cycles of denaturation at 94 for 
..I 
'' 1 minute, primer annealing for 45 seconds, and extension at 72 for 1 minute 30 
seconds. The final cycle was followed by an additional extension at 72 for 10 
minutes. The number of PGR cycles was 35 for Ang-3, Tie 1 and Tie 2. Master 
mixes were used whenever possible to reduce tube-to-tube variations. 
For Ang-1 and Ang-2, a nested PCR approach was used in which the 
primary PCR product was used as the template for a second PCR using another 
pair of internal primers (or nested primers). For Ang-1, the PCR conditions were 
as follows: 
(a) r t PCR using SI sense and ASS anti-sense primers: 94 for 3 minutes 
followed by 25 cycles of 1 minute at 94 T , 45 seconds at the primer annealing 
i temperature of 60 1 minute 30 seconds at 72 and a final extension of 10 
minutes at 7 2 � � • 
(b) 2nd PCR using S2 sense and AS2 anti-sense primers: 1 \\L of primary 
PCR product was used as the template and heated to 94 "C for 3 minutes 
followed by 25 cycles of 1 minute at 94 45 seconds at the primer annealing 
temperature of 55 1 minute 30 seconds at 72 and a final extension of 10 
minutes at 72 
i 
For Ang-2, the PCR conditions were as follows: 
(a) r t PCR using SI sense and ASl anti-sense primers: 9 4 � C for 3 minutes 
I 
followed by 19 cycles of 1 minute at 94 45 seconds at the primer annealing 
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temperature of 55 1 minute 30 seconds at 72 and a final extension of 10 
minutes at 72 
(b) 2nd pcR using S2 sense and AS2 anti-sense primers: 1 i^L of primary 
PCR product was used as the template and heated to 94 for 3 minutes 
followed by 25 cycles of 1 minute at 94 45 seconds at the primer annealing 
temperature of 58 1 minute 30 seconds at 72 and a final extension of 10 
minutes at 72 
To examine the expression of Ang-1 isoforms in adult rat testis and 
several testicular cell lines, four sets of primers corresponding to different regions 
and isoforms of the Ang-1 nucleotide sequences were designed for a series of 
PCR experiments, based on the nucleotide and amino acid sequences of the 
coding region of the four Ang-1 isoforms published in Huang et al., 2000，as 
shown in Table 2.3 and Table 2.4. 
After PCR, aliquots of the reaction product (10 |iL) were electrophoresed 
in 1.2% agarose gel containing 0.5 mg/rtiL ethidium bromide in TAE buffer (40 
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Table 2.1 Primers used for the PCR amplification of Ang-1, Ang-2, 
Ang-3, Tie 1 and Tie 2 
Target Primer Sequences (5，to 3，） 
Ang-1 SI: CCG GAT TTC TCT TCC CAG AAA C (nt. 227-248) 
3 S2: CAA CTG GAG CTC ATG GAC ACA G (nt. 752-773) 
； AS 1: CCA GCT TGA TAT ACA TCT GCA CAG TCT C (nt. 1157-
i 
1184) 
i AS2: AGC ATG TAC TGC CTC TGA CTG GT (nt 1097-
； 1 1 1 9 ) 
ASS: CCT GCT GTC CCT GTG TGA CCT TTT (ntl216-
丨 1 2 3 9 ) 
(GenBank Accession No.: U83509)  
Ang-2 SI: CTG ATG TGG AAG CCC AAG TAC TAA (nt. 638-661) 
S2: CAG AC(C/G) AC(A/G) AGA CT(C/T) GA(A/G) CT(T/G) 
CAG C (nt. 664-688) 
S3: TGT CCA ATG C(C/T)G TGC AGA GGG A (nt. 392-413) 
ASl: GTC ACA GAT GGC CTT GAT CTC (nt. 1132-1152) 
AS2: GTG TAG ATG CCA (C/T)T(T/G) GTG GTG (A/T)GT 
(nt. 1082-1106) 
AS3: CAC TGG TCT G(A/G)T CCA AAA TCT G (nt. 727-748) 
AS4: TCA TG(C/T) TGC TGC TTC TGA AG (nt. 940-959) 
(GenBank Accession No.: AF004326)  
Ang-3 S: GTG TTC CAG GAC TGT GCA GA (nt. 877-896) 
AS: AAT TAG TGC CAG CGG ATG CC (nt. 1450-1469) 
(GenBank Accession No.: AF113707)  
Tiel S: GTC AGA CCG GAT CCC CCA GAT CCT C (nt. 1390-1414) 
AS: CCT GGG GCCGGT AGT GCA GGC GG (nt. 1792-1814) 
(GenBank Accession No.: X80764)  
\ ~ f i ^ ~ S: CAA CAT AGG ATC AAG CAA CCC AGC C (nt. 2296-2320) 
i AS: GTC CCT GTG ATC ATC TTT GGA GGC (nt. 2729-2752) 
I (GenBank Accession No.: L06139)  
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Table 2.2 Optimal primer annealing temperatures, optimal 
concentration of magnesium chloride and optimal PCR 
cycle number used for each specific reaction 
Target Annealing MgCb PCR cycle number 
temperature concentration  
i Ang-1 
j S1+AS3 60 OC 2.0 mM 25 cycles 
1 S2+AS2 55 °C 1.5 mM 25 cycles 
1 
I Ang-2 
‘ Sl+ASl 55 °C 2.0 mM 19 cycles 
丨 S2+AS2 58 2.0 mM 25 cycles 1 1 I  
I Ang-3 58 2.0 mM 35 cycles 
1 T i ^ 55 2.0 mM 35 cycles 




Table 2.3 Expected product sizes used for each specific reaction 
Primers Types of Ang-1 Expected product size for 
or Ang-2 each Ang-1 isoform 
isoforms detected  
Ang-1.5 kb 1013 bp “ 
Ang-1.3 kb 846 bp 
Ang-1 (SI + ASS) Ang-0.9 kb 374 bp 
Ang-0.7 kb 207 bp 
Ang-1 (S2 +AS3) Ang-1.5 kb 488 bp 
Ang-1.3 kb 321 bp 
Ang-1 (SI + AS2) Ang-1.5 kb 893 bp 
Ang-0.9 kb 254 bp 
Ang-2 (S2+AS2) A n g ^ 443 bp 
Ang-2 (S3+AS3) A n g ^ 357 bp 
Ang-2443 198 bp 
Ang-2 (S3+AS4) A n g ^ 568 bp 
Ang-2443 409 bp 
Ang-3 - 593 bp 
T i ^ - 425 bp 
T i ^ - 457 bp 
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Figure 2.2 Positions of the primer sequences for the amplification of the four 
alternatively spliced species of Ang-1 from Huang et al (2000). The positions 
of the primer sequences are boxed. The amino acid sequence of Ang-1.5 kb is 
shown above the nucleotide sequence. Dotted lines indicate the spliced sequences. 
Amino acid and nucleotide residues are numbered to the right of each sequence 
according to the mouse Ang-1 cDNA sequence submitted to GenBank with the 
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Figure 2.3 Schematic diagrams showing the generation of various 
lengths PCR products using a combination of primers, when in the 
presence of alternatively spliced variants of Ang-1 mRNA. Ang-1.5 kb 
encodes the full-length Ang-1. The thick solid lines represent fragments derived 
from various forms of Ang-1 and are not drawn to scale. The alternatively 
spliced parts of Ang-1 are shown as broken lines. The nucleotide sequence is 
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Figure 2.4 Genomic organization of the human Angiopoietin 2 
gene. Exons are marked inside of boxes, Exon 1, Exon 2 and Exon 3. 
Lower numbers denote amino acid numbers. Alternative splicing of Exon 2 












^ ^ Nucleotide 
^ ^ Sequence 
I — — A A A A A A A 








< Quantitation (Optional) 
PCR 
i ‘ 
EtBr Gel Electroohoresis 
• • 
• 
j • • • Validation of PCR products 
" " Figure 2.5 Schematic Diagram 






2.3.6 Purification of PGR products 
The amplification products were purified using Gene-Clean Kit II (Bio 
101). The specific bands identified on gel electrophoresis separation of PCR 
products were excised in a minimal volume of ethidium bromide-stained agarose 
I 
gel with a razor blade under transillumination using long-wave ultraviolet light for 
as short a time as practical to avoid nicking of DNA. The agarose gel slices were 
i 
： placed inside a pre-weighed 1.5 mL microcentrifuge tube and the net weight of the 
I gel was determined on an electronic balance. The approximate volume of the gel 
slices was estimated by equating 0.1 gram of gel to a volume of 100 |aL. Three 
volumes of 6M sodium iodide were added to the agarose gel and incubated in a 
water bath at 55 with occasional mixing for 5 minutes or until the agarose had 
completely dissolved in the sodium iodide solution. 5 \iL GLASSMILK 
suspension from the Gene-Clean Kit II (Bio 101) was then added to the tube, 
mixed and then incubated at room temperature for 5 minutes to allow the binding 
of the DNA. The GLASSMILK suspension is a specially prepared aqueous 
suspension of proprietary silica matrix that binds single and double stranded DNA 
j but not other contaminants. Each sample was occasionally mixed for every 1-2 
minutes to ensure that the GLASSMILK suspension remained suspended. At the 
end of the incubation, the GLASSMILK was separated by centrifugation at 
i ll,600g for 5 seconds. The supernatant was discarded and the pellet was washed 
three times with 500 i^L ‘New Wash Solution'. This solution is a concentrated 
solution of sodium chloride, TRIS and EDTA to which water and ethanol are 
added. In each wash the pellet was completely resuspended by pipetting up and 
down a pipette tip and eventually the contents from two centrifuge tubes were 
pooled into one during the final wash. After the final centrifugation, as much ‘New 
I 65 
Wash Solution' was removed from each tube as possible. The pellet was 
resuspended in 5 i^L DEPC-treated water and then incubated in a water bath at 55 
for 2-3 minutes twice. The tube was then centrifliged for 30 seconds at 
ll，600g and the supernatant was collected into a new 0.5 mL microcentrifuge 
tube. Resuspension and incubation of the pellet in DEPC-treated water were 
repeated one more time to recover DNA from the supernatant. One microlitre of 
the reconstituted PCR product was mixed with 8 i^L of DEPC-treated water and 1 
|LXL of bromophenol blue-xylene cyanol FF loading buffer, and loaded on to 1.2% 
ethidium bromide-stained agarose gel. A low DNA mass ladder (Gibco BRL, 
Grand Island, NY, USA) was also included to estimate the quantity of DNA 
recovered. The authenticity of the PCR product was verified, after purification 
from the PCR reaction, by either forward or reverse sequencing (or both). 
2.3.7 Confirmation of PCR product authenticity by automated DNA 
sequencing 
Sequencing was performed using a dRhodamine Terminator Cycle 
Sequencing Kit (Perkin Elmer, Applied Biosystems, California, USA) and an 
automated sequencer (Advanced ABI 310 Genetic Analyzer, Perkin Elmer, Tokyo, 
Japan). A 20-|iL reaction mixture containing the following was subjected to the 
following cycling parameters: 26 cycles of 1 minute at 96 ^C, 1 minute at 50 
and 4 minutes at 60 It included 30-50 ng PCR product purified using the 
Gene-Clean Kit II, 2 pmoles per ]iL of either sense or antisense primer, 8 |LIL 
Terminator Ready Reaction Mix (dRhodamine) (PE Bio Systems, California, USA) 
and DEPC-treated water. Cycling was performed on a [M. J. Research, Inc. PTC-
66 
200] Thermal Cycler (PTC-200, M. J. Research, Inc., San Francisco, USA). The 
reaction product was then added to a 0.6 mL thin wall PCR tube (Robbins 
Scientific Corporation, San Aleso Avenue, Sunnyvale, CA) containing 2 |aL 3 M 
sodium acetate and 50 jjJL 95% ethanol. The content was vortexed for a few 
seconds and then incubated at room temperature for 15 minutes to precipitate the 
extension products. Afterwards it was centriftiged at ll，600g for 20 minutes and 
the supernatant was immediately pipetted off with great care. The pellet which is 
often invisible was rinsed twice with 250 [iL 70% ethanol and recovered after each 
wash by high speed centrifugation. Finally the pellet was dried under SpeedVac for 
5-10 minutes and then reconstituted in 20 \iL Template Suppression Buffer (TSR) 
(PE Applied Biosystems, USA). After further subjecting the sample to thorough 
mixing and incubation at 95''C for 2 minutes, it was quickly chilled on ice and 
loaded on to the automated DNA sequencer (Advanced ABI310 Genetic Analyzer, 
Perkin-Elmer, CA, USA). Sequencing data were submitted to the BLAST Search 
(NCBI, National Centre for Biotechnology Information; 
http://www.ncbi.nlm.nih.gov.BLAST) to confirm the authenticity of the nucleotide 




2.4 Western blot analysis 
2.4.1 Preparation of cell lysates from primary testicular cells and testicular 
cell lines 
Cytosolic protein was extracted from cell pellets of testicular cell lines and 
primary testicular cells. The cell pellet was washed three times with 10 mM 
phosphate-buffered saline (PBS, pH 7.4) to remove non-cellular proteins or other 
contaminants before resuspended in 4 volumes of lysis buffer (10 mM TRIS-HCl, 
pH 7.4) with the following protease inhibitors added (10 ^g/|LiL leupeptin, 5 ^ig/jiL 
aprotonin, 100 mM phenylmethylsulfonyl fluoride PMSF, 100 mM sodium 
orthovanadate, 200 mM EGTA and 200 mM EDTA). The cells were lysed by 
three repeated cycles of freezing and thawing which involved snap-freezing the cell 
pellet in lysis buffer in liquid nitrogen and followed immediately by thawing at 
room temperature. After that the cell lysates were cleared by centrifiigation at 
12,000 rpm for 15 minutes at 4 T and the resulting supernatant was transferred to 
a new 1.5 mL microcentrifuge tube ready for protein determination. 
2.4.2 Preparation of mouse testicular and adult rat testicular tissue lysates 
Adult rat testes and mouse testes were decapsulated and had the testicular 
subcapsular artery removed before being homogenized in lysis buffer (with the 
same composition and protease inhibitors added as indicated in Section 2.4.1). 
Approximately 1 mL ice-cold lysis buffer was used for every 50-100 mg of 
testicular tissue being hand-homogenized using a 3 mL glass homogenizer with a 
clearance of 0.004-0.006 inch (Kontes Scientific Glasswarer/Instruments, Vmeland, 
NJ, USA). The tissue homogenate was kept cold all the time by placing the 





lysates were transferred into 1.5 mL microcentrifuge tubes and cleared by 
centrifugation at 12,000 rpm for 15 minutes at 4 T . The resulting supernatant was 
collected for protein determination. 
Tissue lysate of the testicular subcapsular artery was prepared from 
i 
.1 pooled samples. They were homogenized in ice-cold RIPA buffer (1% NP40, 
.‘� 0.5% sodium deoxycholic acid, 0.1% SDS in 98mL PBS) supplemented with the 
1 protease inhibitors (10 \xg/ [xL leupeptin, 5 \ig/ \ iL aprotonin, 100 mM 
I phenylmethylsulfonyl fluoride PMSF, 100 mM sodium orthovanadate, 200 mM 
j 
EGTA and 200 mM EDTA). The tissue homogenate was left on ice in the RIPA 
buffer for 30 minutes before cleared by centrifugation at 20,000g for 20 minutes at 
4 The resulting supernatant was collected for protein determination. 
2.4.3 Determination of protein concentration 
Protein determination was performed using the Bio-Rad DC Protein 
Assay (Bio-Rad, CA, USA) according to the manufacturer's instructions. A series 
of bovine serum albumin (BSA) standards of different concentrations was prepared 
using the same lysis buffer as the samples (0.1-2.0 mg/mL). The unknown samples 
were diluted to a ratio of 1/10, 1/20 or 1/50 and mixed well before being assayed. 
5 |iL of the above working standards, blank (the same lysis buffer for sample 
preparation) or diluted unknown samples were added to the wells of a 96-well 
ELISA plate (Nunclon) and assayed in duplicate. Working reagent A was prepared 
by mixing 1 mL reagent A with 20 i^L Reagent S and 25 i^L were added into each 
sample well and mixed gently by tapping and rocking. This was followed by the 
； addition of 200 jiL reagent B and the assay mixture was incubated at room 
1 
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temperature for 15 minutes. At the end, absorbance in each well was read using an 
ELISA plate reader (Dynatech Laboratories HK Ltd). The protein concentrations 
of unknown samples were calculated based on the standard curve. Samples were 
then aliquoted in an appropriate volume that contained the desired amount of total 
protein (usually 150 |ig) and the ampoules were stored frozen at -80°C until use 
for Western immunoblotting. 
2.4.4 Reagents for Western blot analysis 
A 10% sodium dodecyl-sulphate (SDS) solution was prepared by adding 
10 g electrophoretic-grade reagent (#L3771; Sigma, St. Louis, MO, USA) to 100 
mL deionized water. 
A 4x stock TRIS-glycine electrophoresis buffer was prepared by first 
dissolving 30 g electrophoretic-grade TRIS base (Bio-Rad, CA, USA) and 144 g 
electrophoretic-grade glycine (Bio-Rad, CA, USA) in 2000 mL deionized water. 
The pH was then adjusted to 8.3 before the final volume was made up to 2.5 litres 
using deionized water. Working TRIS-glycine electrophoresis buffer was prepared 
just before use by mixing 175 mL 4x stock solution with 7 mL 10% SDS and 
making up to a final volume of 700 mL using deionized water. 
A Transfer Buffer with SDS was prepared by dissolving 5.82 g TRIS base 
(Bio-Rad, CA, USA) and 2.93 g glycine (Bio-Rad, CA, USA) in deionized water, 
and after adding in 3.75 mL 10% SDS and 200 mL methanol, the final volume was 
made up to 1 litre using deionized water without any adjustment of pH. 
A phosphate buffer saline tween-20 (PBST) solution was prepared by 
adding 80 g sodium chloride (BDH Chemicals Ltd, Poole England), 15.601 g 
hydrated sodium dihydrogen phosphate monohydrate (Merck, Darmstadt, 
70 
i 
Germany) and 2 g potassium chloride (Merck, Darmstadt, Germany) to 2.5 litres 
deionized water. The pH was adjusted to 7.4-7.5 before 50 mL Tween-20 
(polyoxyethylene sorbitan monolaurate) (#P1379, Sigma, St. Louis, MO, USA) 
was added and the final volume made up to 10 litres using deionized water. 
A 30% acrylamide/bisacrylamide solution was prepared by dissolving 29.2 
g electrophoretic-grade acrylamide (Bio-Rad, CA, USA) and 0.8 g bisacrylamide 
(N,N'-bis-methylene-acrylamide) in 100 mL deionized water. It was then filtered 
and stored in the dark at 4°C until use. 
A 1.5 M Lower TRIS buffer was prepared by dissolving 18.17 g 
electrophoretic-grade TRIS base (Bio-Rad, CA, USA) and 4 mL 10% SDS in 60 
mL deionized water. The pH was adjusted to 8.8 before the final volume was 
made up to 100 mL using deionized water. A 0.5M Upper TRIS buffer was 
prepared by adding 6.057 g electrophoretic-grade TRIS base (Bio-Rad, CA, USA) 
and 4 mL 10% SDS to 70 mL deionized water. The pH was adjusted to 6.8 before 
the final volume was made up to 100 mL with deionized water. 
All reagents for Western blot analysis were stored at 4 before use. 
2.4.5 Preparation of protein samples and markers for Western blot analysis 
One volume of stock P-mercaptoethanol (Amresco) was added to 9 
I volumes of 2x electrophoresis sample buffer (125 mM TRIS-HCl, pH 6.8; 4% 10% 
SDS; 20% glycerol and 0.06% bromophenol blue) just before use. The protein 
samples were diluted using 10 mM TRIS-HCl (pH 7.4) to give 150 |ig total 
I protein in 25 fiL and this was then added to an equal volumes of 2x electrophoresis 




sample (in electrophoresis sample buffer) contained 60 \ig total protein. The 
protein samples, together with the biotinylated and prestained markers used in the 
gel electrophoresis, were denatured by boiling in a water bath at 100�C for 5 
minutes before 20 i^L were loaded on to the gel. The biotinylated marker 6B 
(#B8146, Sigma, St. Louis, MO, USA), or 7B (#B2787, Sigma, St. Louis, MO, 
USA) was diluted 1/20 by mixing 5 (iL stock with 45 [oL 10 mM TRIS-HCl (pH 
7.4) followed by the addition of 50 |iL 2x electrophoresis sample buffer (with P-
i mercaptoethanol). The prestained markers - M2 (#G6017, M.W. 116 kDa) and 
M3 (#G6017, M.W. 35.2 kDa) (Sigma, St. Louis, MO, USA), were similarly 
prepared. 
2.4.6 Sodium dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
The Mini-PROTEAN II Electrophoresis Cell Assembly (Bio-Rad 
Laboratories, Hercules, California, USA) was used to prepare 10% SDS-PAGE of 
0.75 mm thick and 60 mm (H) x 85 mm (W) in area. Sixty jig of proteins in 20 |iL 
were added to each sample well. 
Ten percent (10%) lower separating gel layer was prepared by mixing 3.34 
mL deionized water, 2.0 mL 1.5 M Lower TRIS bufifer (pH 8.8) and 2.66 mL 30% 
acrylamide/bisacrylamide solution in a glass vial. The mixture was degassed under 
vacuum for 20 minutes since oxygen in the solution could inhibit the subsequent 
polymerization step. Also, the presence of gas would lead to the formation of gas 
bubbles in the gel during the process of electrophoresis. 10% ammonium 
persulphate (APS) solution (Amersham Pharmacia Biotechnology, 
i 
Buckinghamshire, UK) was freshly prepared by adding 0.05 g APS to 500 jiL 
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deionized water in a 1.5 mL microcentrifuge tube. 8 jaL N，N，N，-N，-
tetramethylethylene-diamine (TEMED, Bio-Rad, CA, USA) and 80 ^L freshly 
prepared 10% APS were then added to the degassed acrylamide/bisacrylamide 
I solution to initiate the polymerization reaction. 3.7 mL of this separating gel 
j 
i solution was immediately poured into the space between the two glass plates of the 
I 
gel casting cassette. Care was taken to minimize the mixing of this solution with 
1 
air. 200 jiL isopropyl alcohol was carefully layered on the top of this gel layer to 
I prevent its contact with air and to ensure its interface with the stacking gel is 
] leveled. The gel was left to polymerize for 40 minutes. Afterwards the overlay 
isopropyl alcohol was poured off and deionized water was used to completely rinse 
off any residues that remained. The last drop of water above the separating gel 
was removed by absorption with filter paper without damaging the surface of the 
gel. 
Four percent (4%) stacking gel mixture was prepared by mixing 1.9 mL 
deionized water, 0.75 mL 0.5M Upper TRIS buffer (pH 6.8)，0.4 mL 30% 
丨 acrylamide/bisacrylamide, 6 jiL of TEMED and 28 jiL of APS. One mL of this 
•i 
solution was layered on top of the separating gel until overflow. The sample comb 
was then inserted and placed centrally in a levelled position. The stacking gel was 
1 
, allowed to polymerize for 40 minutes. The sample comb was then carefully 
removed and the wells were thoroughly rinsed with Running Buffer before they 
were completely filled using the same buffer. 
The heat denatured protein samples and markers were loaded individually 
into each sample well cast in the stacking gel. And after filling the upper and lower 
buffer chamber with the Running Buffer, electrophoretic separation of the proteins 
was carried out at 135 volts (PowerPac 200 Power Supply, Bio-Rad Laboratories, 73 
Hercules, California, USA) until the prestained molecular weight marker had 
migrated to the desired position. 
！ 2.4.7 Transfer of proteins to membrane 
After gel electrophoresis was completed, the gel was carefully removed 
1 from the electrophoretic unit and placed face up. The upper portion representing 
the stacking gel was cut away. 
Polyvinylidene difluoride membrane (PVDF, Immobilon-pSQ, Millipore 
Corporation, Bedford, USA) cut to a size of 9 cm x 5 cm was wetted with 
methanol for 15 seconds and then thoroughly rinsed with transfer buffer before use. 
The SDS-PAGE gel was also allowed to equilibrate in the transfer buffer for 20 
minutes with mixing over a Gyro Rocker (STR9, Stuart Scientific，Staffordshire, 
UK) before subjected to electro-blotting. 
Electro-blotting was carried out using a Trans-Blot Semi-Dry 
Electrophoretic Transfer Cell (#170-3940, Bio-Rad Laboratories, Hercules, 
j California, USA), following the supplier's instruction. The gel was placed on top 
of a PVDF membrane and then sandwiched between sheets of Extra Thick Blot 
Absorbent Filter Paper (#170-3960, Bio-Rad Laboratories, Hercules, California, 
USA) (one sheet underneath and two sheet above) pre-soaked in transfer buffer, 
j The stack was placed between the electrodes of the semi-dry transfer cell and 
electroblotting was allowed to proceed at 19V for 50 minutes. 
« 
I 2.4.8 Blocking of the membrane 
I 
After transfer, the membrane was briefly rinsed three times with 
deionized water. Blocking of non-specific binding sites on the blot was achieved 
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by immersing the blot in 1% gelatin-PBST (0.6 g gelatin and 60 mL PBST) 
j (#G9391, Sigma, St. Louis, MO, USA) with rotary mixing inside a hybridization 
1 
oven (Biometra, Germany) maintained at 25°C for 45 minutes. After that the 
membrane was briefly rinsed in three changes of PBST (10 minutes each) at room 
temperature to remove the blocking solution. 
2.4.9 Immunoblotting 
For the immunoblotting of Ang-1, three commercially available 
antibodies (Santa Cmz Biotechnology, Inc. Santa Cruz, California) had been 
tested. One is a rabbit polyclonal antibody [Ang-1 (H-98), #sc-8357] raised 
against the amino acids 400-498 mapping at the carboxyl terminus of Ang-1 of 
human origin. The other two are goat polyclonal antibodies mapping to epitope at 
the carboxy terminus of human Ang-1 [Ang-1 (CM 9), #sc-6320] and amino 
terminus of human Ang-1 [Ang-1 (N-18), #sc-6319]，respectively. Based on 
information provided by the supplier, Ang-1 (H-98) exhibits cross-reactivity with 
Ang-2, while the other two antibodies are Ang-1 specific. For the immunoblotting 
of Ang-2, only one commercially available antibody (Santa Cruz Biotechnology, 
Inc. Santa Cruz, California) had been tested. This antibody is a goat polyclonal 
antibody mapping to epitope at the carboxy terminus of human Ang-2 [Ang-2 (C-
19)，#sc-7015]. These primary antibodies were used at a dilution of 1:500 in 
PBST and incubated with the blot overnight at room temperature on a Roller 
Mixer (SRI, Stuart Scientific, Staffordshire, UK). 
j 
] 
j After incubation with the primary antibody, the blot was washed three times 
� 
(20 minutes each) with PBST before exposing to horse radish peroxidase (HRP)-
conjugated protein-A or HRP-conjugated secondary antibody. This allowed the I 75 
detection and amplification of signals originating from primary antibody binding to 
specific protein bands on the blot. For rabbit polyclonal primary antibody, protein 
A-conjugated HRP (Santa Cruz Biotechnology, Inc.) was used at 1:5000 dilution 
while for goat polyclonal primary antibody, rabbit anti-goat IgG-conjugated HRP 
(Zymed Laboratories, South San Francisco, California) was used at 1:2500 
I 
dilution. They were incubated with the blot for 30 minutes at room temperature. 
Finally after fiirther rinsing with PBST, the antibody binding was visualized 
i 
using ECL Western blotting detection reagent (Amersham Pharmacia 
Biotechnology, Buckinghamshire, UK). The blot was incubated with the ECL 
reagent for 1 minute at room temperature without agitation. The excess reagent 
was drained off and the blot was wrapped in GladWrap. The pattern of 
chemiluminescence on the blot was recorded by exposing it to an X-ray (Biomax 
MS scientific imaging film, Kodak Eastman, Rochester, NY, USA) at room 
temperature inside a film cassette for a duration dependent on the intensity of the 
positive signals. The position of biotinylated protein molecular size markers was 
subsequently determined through another incubation of the blot with streptavidin-
conjugated HRP (1:5000 dilution, Zymed Laboratories) at room temperature for 
30 minutes, and then followed by the exposure to ECL reagents and then the X-ray 
film. 
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2.5 Immunohistochemical staining for Ang-1, Ang-2, Ang-3, Tie 1 and 
Tie 2 in rat testes 
Ang-1, Ang-2, Ang-3, Tie 1 and Tie 2 were localized in rat testis 
^ sections using affinity-purified goat polyclonal [Ang-1 (N-18),弁sc-6319]，[Ang-2 
(C-19), #sc-7015] and [Ang-1/4 (C-19)，#sc-9360] antibodies and affinity-
1 purified rabbit polyclonal [Tie 1 (C-18), #sc-342] and [Tie 2 (C-20), #sc-324] 
antibodies that are commercially available from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). The [Ang-1 (N-18), #sc-6319] and [Ang-2 (C-19), #sc-7015] 
j antibodies are raised against a peptide mapping at the N-terminus of Ang-1 of 
human origin and C-terminus of Ang-2 of human origin, respectively. [Ang-1/4 
(C-19), #sc-9360] antibody is raised against a peptide mapping at the C-terminus 
of Ang-4 of human origin. Tie 1 [(C-18),存sc-342] and Tie 2 [(C-20), #sc-324] 
antibodies are raised against the first 20 amino acids in the C-terminus of Tie 1 of 
human origin and Tie 2 of mouse origin, respectively. Based on information 
provided by the supplier, all these antibodies cross-react with the corresponding 
antigens in mouse, rat and human. [Ang-1/4 (C-19), #sc-9360] antibody exhibits 
I 
cross-reactivity with both Ang-1 and Ang-3 of mouse and rat origin, and Ang-1 
and Ang-4 of human origin. 
The testes were collected from adult Sprague-Dawley rats and individually 
placed inside a mould made out of aluminum foil and filled with the embedding 
medium (OCT compound; Miles Scientific, Elkhart, IN). They were then rapidly 
i frozen in liquid nitrogen to create a more uniform block to facilitate sectioning. 
The testes once embedded were kept frozen at -80 until use for cryostat 
sectioning. Six microns sections were prepared on a cryotome (Shandon 
AS620E, Cryotome, Cheshire, UK) and mounted on glass slides (Sail Brand, 
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China) coated with 1% 3 -aminopropyltriethoxysilane (APES) (Sigma, St, Louis, 
丨 MO, USA) in ethanol. For [Ang-1 (N-18), #sc-6319], [Ang-1/4 (C-19), #sc-
9360]，[Tie 1 (C-18), #sc-342] and [Tie 2 (C-20), #sc-324] antibodies, the 
sections were lightly fixed in freshly prepared 4% paraformaldehyde at room 
temperature. For [Ang-2 (C-19), #sc-7015] antibody, the sections were fixed in 
cold acetone at -20 "^ C for 10 minutes. After that, they were processed for 
streptavidin-biotin-peroxidase complex immunostaining. The acetone-fixed 
sections had to be air-dried completely at room temperature before proceeding 
with staining. The sections were equilibrated in three washes (2 minutes each) of 
10 mM phosphate-buffered saline (PBS, pH 7.4) and the endogenous peroxidase 
activity was quenched in 0.6% freshly prepared hydrogen peroxide solution in 
PBS for 20 minutes. This was followed by blocking with neat fetal bovine serum 
(FBS) for 15 minutes at room temperature to reduce the non-specific binding. At 
the end of incubation, the FBS was simply poured off and the primary antibody 
added. The sections were incubated with a 1:100 dilution of primary antibody in 
a solution of 20% fetal bovine serum in PBS for 1 hour at room temperature for 
[Tie 1 (C-18), #sc-342], [Tie 2(C-20),括sc-324] and [Ang-1/4 (C-19), #sc-9360] 
antibodies or 1 hour at 37 "^ C for [Ang-1 (N-18), #sc-6319] and [Ang-2 (C-19)， 
#sc-7015] antibodies in a moist chamber. After the primary antibody incubation, 
the sections were rinsed with three washes (2 minutes each) of PBS before the 
corresponding biotinylated secondary antibody was added and incubated for 10 
minutes at room temperature. For [Ang-1 (N-18), #sc-6319], [Ang-2 (C-19), 
#sc-7015] and [Ang-1/4 (C-19), #sc-9360] antibodies, biotin-rabbit anti-goat 
secondary antibody was used, whereas for [Tie 1 (C-18), #sc-342] and [Tie 2 (C-
20)，#sc-324], biotin-goat anti-rabbit secondary antibody was used. Both 
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secondary antibodies were from Zymed Laboratories (South San Francisco, 
California, USA) and used at 1:75 dilution in PBS. After further washes (3 times, 
2 minutes each) with PBS, streptavidin-conjugated horse radish peroxidase 
(Zymed Laboratories) diluted 1:400 in PBS was added to the sections and 
incubated for 10 minutes at room temperature. This was followed by further 
washings with PBS (3 times, 2 minutes each) and incubation at room temperature 
with the chromogen - 3 -amino-9-ethylcarbazole (AEC) (Zymed Laboratories), for 
the localization of specific primary antibody binding to the testis sections. The 
duration of incubation with chromogen depended on the intensity of the colour 
development on the testis section. This was determined by regular checking 
under light microscope and terminated by washing with deionized water. The 
sections were then mounted in aqueous mountant consisting of 1 g/mL polyvinyl 
pyrrolidone, 1 mL glycerol, a small crystal of thymol in 25 mL deionized water, 
with or without prior counterstaining with haematoxylin, and covered with glass 
cover slips (22 x 22mm or 22 x 40 mm; Deckglaser, Germany). The sections 
were examined under light microscope (Optiphot-2, Nikon, Japan) and areas of 
specific staining were recorded using the Nikon Microflex photographic system. 
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3. Results 
3.1 Expression of Ang-1 and Ang-l alternatively spliced transcripts in the 
testis and other testicular cell types 
3.1.1 Detection of Ang-l expression in the testis and testicular cell types by 
nested PCR 
In the preliminary studies using the RT-PCR approach, it was found that 
Ang-1 mRNA expression was weak in some testicular cell lines or increasing the 
cycle number resulted in multiple non-specific products. This could be explained 
by the low gene copy number of mRNA transcripts and the interference caused by 
contaminants or RNA degradation commonly found in nucleic acid preparations. 
Therefore, nested PCR was performed to increase the specificity and sensitivity of 
the mRNA detection (as shown in Figure 3.2). 
: The product from the first stage of the PCR reaction was diluted to an 
overall ratio of 1/1000 for the subsequent second stage of the PCR reaction. A 
housekeeping gene - p-actin，was used as an internal control to adjust the amount of 
template used in each PCR reaction, while C6 rat glioma cells served as a positive 
control(s) for the gene expressions of Ang-1 [Holash et al., 1999a] and Ang-2 
[Mandriota & Pepper, 1998] analysed. Despite the use of equal volumes of RT 
products for the first stage of the PCR reaction, there was some variability in the 
expression levels of P-actin, which was used as an internal control, probably due to 
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I. 
differences in the efficiency of the reverse transcription reaction and inaccuracy in 
the quantitation of total RNA (Figure 3.1). In this respect, the use of p-actin as an 
i internal control could avoid the problem of additional variation in PCR efficiency 
with large differences in the amount of template used. 
Using the first pair of PCR primers [Ang-1 (S1+AS3)], a product of 1013 
bp resulted. Then using a second pair of internal primers [Ang-1 (S2+AS2)] a 
product of 368 bp was formed. As shown in Figure 3.1, agarose gel analysis of 
ethidium bromide stained PCR products showed only a single band corresponding 
to the expected size of368 bp. This was found to be present in total testicular tissue, 
primary Leydig cells, primary Sertoli cells, primary germ cells, rat testicular blood 
vessel, mouse testis as well as the positive control _ C6 rat glioma cells. 
3.1.2 Detection of Ang-1 expression in testicular cell lines by nested PCR 
Based on the experiment using testicular tissues and primary cells, the 
results for the expression of Ang-1 in testicular cell types obtained from Section 
3.1.1 were not conclusive since they were not pure cell populations and were 
susceptible to cross-contamination from other cell types. Thus the cell lines 
provide us with an alternative tool to determine whether it would be the Leydig 




lOObp Adult Leydig Sertoli Germ testicular Mouse C6 
i DNA rat cell cell cell blood testis 
Ladder testis vessel 
� 5 bp 
Figure 3.1 Analysis of Ang-1 expression in the adult rat testis and 
primary rat testicular cells using nested PCR. Products from the second 
stage of the nested PCR were separated in a 1.2% ethidium bromide-stained 
DNA agarose gel. The positive bands show the product of interest, which 
correspond to the expected size of 368 bp for Ang-1. The lower panel shows 
the corresponding signal intensity for P-actin using the same amount of 
template. 
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mouse Leydig cell, TM4 mouse Sertoli cell, LC540 rat Leydig tumour cells, 
MLTC-1 mouse Leydig tumour cells and R2C rat Leydig tumour cells. Similar 
nested PCR approach was used employing the same sets of external primers and 
internal primers for generating the results shown in Section 3.1.1. The product 
from the first stage of the PCR reaction was diluted to an overall ratio of 1/1000 
(but 1/500 for MLTC-1 cells) for the subsequent second stage of the PCR reaction. 
The weak expression of p-actin in MLTC-1 and LC540 testicular cells 
appeared to be resulted from an overestimation of RNA concentrations. 
Nevertheless, LC540 testicular cells could still strongly express Ang-1. 
After nested PCR amplification, a 368-bp band of expected size was 
amplified and observed (as shown in Figure 3.2). Among these testicular cell lines, 
TM4, LC540 and R2C testicular cells were shown to express Ang-1 mRNA. On 
the contrary, the expression of Ang-1 was almost undetectable in TM3 and 
MLTC-1 Leydig cells. Although the signal for P-actin was low for LC540 rat 
Leydig tumour cells, suggesting that the amount of template used was low, Ang-1 
transcripts could still be detected in this cell line using RT-PCR. 
3.1.3 Sequence analysis of Ang-1 transcript amplified from adult rat testis 
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Figure 3.2 Analysis of Ang-1 expression in testicular cell lines using 
nested PCR. Products from the second stage of the PCR reaction were 
separated in a 1.2% ethidium bromide-stained DNA agarose gel. The 
: positive bands correspond to the product of interest having the expected 
size of 368 bp for Ang-1. The lower panel shows the corresponding 





was confirmed by sequencing the product from PCR reaction using a pair of 
primers which gave reasonably strong signal for the rat testis but not for the other 
testicular cell lines. However, the primer sets used in this part are different from 
those in the first part of the study so that it was unable to confirm the identity of the 
nested PCR products shown in Figure 3.1 and Figure 3 1 (Sections 3.1.1 and 3.1.2). 
For PCR amplification of Ang-1 using cDNA prepared from adult rat testis as 
template, the upstream primer sequence was 
5‘-CCGGATTTCTCTTCCCAGAAAC-3'(SI), corresponding to nt 227-248， 
whereas the downstream primer sequence was 
5'-CCAGCTTGATATACATCTGCACAGTCTC-3'(AS1), corresponding to nt. 
1157-1184 (GenBank Accession Number-mouse Ang-1: U83509). These primers 
were designed based on the consensus regions of the mouse (GenBank Accession 
Number: U83509) and human (GenBank Accession Number: U83508) Ang-1 
cDNA sequences. With this primer pair, Ang-1 mRNA was readily detected in 
adult rat testis without the need for nested PCR, and the product was targetted for 
the cDNA sequencing. The concentration of magnesium chloride used in the PCR 
reactions was 1.5 mM. The PCR parameters were denaturation at 9 4 � C for 1 
minute, primer annealing at 61 ®C for 45 seconds and extension at 72 ""C for 1 






the expected size of 626 bp. 
By searching Standard Nucleotide-nucleotide BLAST Database as 
described under Materials and Methods (Section 2.3.7), the nucleotide sequence of 
the PCR products obtained from adult rat testis was found to agree well with the 
known partial nucleotide sequence of rat Ang-1 (96.7% identity) (as shown in 
Figure 3.3). Therefore, the PCR products obtained using this pair of PCR primers 
[Ang-1 (Sl+ASl)] could be proved to be the authentic fragments of Ang-1. 
3.1.4 Detection of alternatively spliced species of Ang-1 mRNA in the testis 
and other testicular cell lines 
In the first series of experiments, Ang-1 expression was investigated in 
the testis, primary testicular cells and several testicular cell lines using nested 
RT-PCR approach. The full-length Ang-1.5kb is encoded by a single-copy gene, 
that engenders multiple transcripts coding for the alternatively spliced transcripts of 
Ang-1, Ang-1.5 kb, Aiig-1.3 kb, Ang-0.7 kb and Ang-0.9 kb [Huang et al, 2000]. 
RT-PCR was performed to analyze the expression of the four 
alternatively spliced species of Ang-1 mRNA with Ang-1 (S1+AS2), Ang-1 
(S2+AS3) and Ang-1 (S1+AS3) primer pairs，and if so to determine whether 
specific differences exist in the mRNA isoform(s) in adult rat testis when compared 
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r-testis agaggtacca acaacaacag tgttctgcag aagcaacaac tggggtgcat ggacacagcc 
rAng-1 
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rAng-1 
I hAng-1 cacaaccttg tcaatctttg cactaaagaa ggtgttttac taaagggagg aaaaagagga 
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Figure 3.3 Comparing the nucleotide sequence of the PCR product 
obtained using specific Ang-1 primers and cDNA from adult rat 
testis as template, against known partial sequence of rat Ang-1 and 
the corresponding regions of mouse and human Ang-1 cDNA 
sequence. mAng-1, rAng-1 and hAng-1 represent the published 
sequence of mouse, rat and human Ang-1, respectively (GenBank 
Accession Numbers - mAng-1: U83509, rAng-1: AF030376, and hAng-1: 
彳 U83508). r-testis represents the nucleotide sequence of the PCR product 
amplified from adult rat testis using Ang-1 (Sl+ASl) primers. The 
primer sequences are shown in italics and boldface. The positions of 
those nucleotide bases from r-testis that show exact match with the 
corresponding published sequence in the mouse and rat sequence, are 
indicated by short vertical bars. The numbering of nucleotide bases for 






To confirm the presence of these transcripts in testis, new sets of primers 
were designed with the 5'end straddling the apparent splice junction site and the 
positions of the primer sequences were shown in Figures 2.2 and 2.3. Ang-1 
(S1+AS3) primer pair was used for the detection of four alternatively spliced 
transcripts of Ang-1 (Ang-1.5 kb，Ang-1.3 kb，Ang-0.9 kb and Ang-0.7 kb) to give 
the predicted 1013-bp band, 846-bp band, 374-bp band and 207-bp band 
respectively. Ang-1 (S2+AS3) primer pair was used to detect the 1.5-kband 1.3-kb 
isoforms and designed to give the predicted 488-bp band and 321-bp band 
respectively. Ang-1 (S1+AS2) primer pair was used to detect the 1.5-kb and 0.9-kb 
isoforms and designed to give the predicted 893-bp band and 254-bp band 
respectively. 
Ang-1 (S1+AS3) primer pair was initially used for analyzing the 
expression of multiple isoforms of Ang-1 in primary testicular cells and testicular 
cell lines using RT-PCR, as it could detect all of the four alternatively spliced 
mRNA species of Ang-1. Since these isoforms were readily detectable in several 
human tumour cell lines [Huang et al, 2000]，therefore it would be interesting to 
determine whether testicular tumour cells would similarly express the various 
alternatively spliced transcripts of Ang-1. After normalization of cDNA samples 
90 
i 
using p-actin primers，it could be noted that PCR product for p-actin was visible in 
all lanes and the product bands were of comparable intensities in all cDNA samples. 
In Figure 3.4，the results seen by RT-PCR analysis revealed the correctly sized PCR 
product only for the full length Ang-1.5 kb (1013 bp) in adult rat testis, C6 rat 
glioma cells, rat testicular blood vessel, primary germ cells, primary Sertoli cells, 
mouse testis as well as LC540, MLTC-1 and R2C testicular cell lines but not in 
TM3 and TM4 testicular cell lines. These seem to be contradictory to the detection 
of Ang-1 expression in TM3 and TM4 using nested PCR approach as mentioned in 
Section 3.1.2. A possible explanation of these observations was the relatively 
lower sensitivity of RT-PCR when compared with nested PCR approach. 
Although no Ang-1 isoforms could be detected in primary testicular cells 
and other testicular cell lines using Ang-1 (S1+AS3) primer pair, it was possible 
that other Ang-1 primer pairs were able to detect the presence of these isoforms in 
testis. Therefore, RT-PCR coupled with another primer pair was employed. Ang-1 
(S1+AS2) primer pair was used to detect the 0.9-kb and 1.5-kb transcripts but no 
254-bp product (corresponding to the 0.9-kb isoform) was detected, regardless of 
the magnesium chloride concentration and primer annealing temperature being 
tested in the PCR reaction (as shown in Figure 3.5). Only an 893-bp product band 





lOObp TM3 TM4 Rat C6 TBV LC540 MLTCl R2C Germ Sertoli Mouse 
DNA testis ceU cell testis 
Ladder 
I . : 1013 bp 
[ 6 4 5 bp 
Concentration of magnesium chloride: 1.5 mM 
PCR condition: 94 for 1 minute; 6 0 � C for 45 seconds; 7 2 � C for 1 
minute 30 seconds for 35 cycles. 
Primers: sense (SI): 5'-CCGGATTTCTCTTCCCAGAAAC-3' (nt 227-
248) 
antisense (AS3): 5'-CCTGCTGTCCCTGTGTGACCTTTT-3' 
(nt. 1216-1239) 
(GenBank Accession No.: U83509) 
Figure 3.4 Detection of the four alternatively spliced species of 
Ang-1 mRNA in the adult rat testis and testicular cell types using 
RT-PCR PCR products were separated in a 1.2% ethidium bromide-
stained DNA agarose gel. The positive bands occur at the expected size 
of 1013 bp which corresponds to the presence of transcripts for the full-
length form of Ang-1 (i.e. Ang-1.5 kb). PCR products that correspond to 
alternatively spliced transcripts for the shorter forms of Ang-1 (i.e. Ang-
1.3 kb, Ang-0.9 kb and Ang-0.7 kb) are absent. The lower panel shows 
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Ladder Ladder 
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Lane 1: 1.5 mM magnesium chloride; primer annealing temperature of 
58 OC. 
Lane 2: 1.5 mM magnesium chloride; primer annealing temperature of 
55 "C. 
Lane 3: 2.0 mM magnesium chloride; primer annealing temperature of 
55 X . 
Lane 4: 2.5 mM magnesium chloride; primer annealing temperature of 
55 OQ 
PCR condition: 94 "C for 1 minute; 55 V or 58 "C for 45 seconds; 72 V 
for 1 minute 30 seconds for 35 cycles. 
Primers: sense (SI): 5'-CCGGATTTCTCTTCCCAGAAAC-3' (nt 227-
248) 
antisense (AS2): 5'-AGCATGTACTGCCTCTGACTGGT-3' 
(nt. 1097-1119) 
(GenBank Accession No.: U83509) 
Figure 3.5 Detection of alternatively spliced species of Ang-1 mRNA (Ang-
1.5kb and Aiig-0.9kb) in the adult rat testis using RT-PCR. PCR products 
were separated in a 1.2% ethidium bromide-stained DNA agarose gel. The 
positive bands (indicated by the arrow) occur at the expected size of 893 bp, 
which correspond to the presence of transcripts only for full-length form of Ang-
1 (i.e. Ang-1.5 kb). The PCR product that corresponds to the Ang-0.9 kb 




testicular cell types or cell lines analyzed (as shown in Figure 3.4), no expression of 
other alternatively spliced Ang-1 transcripts was found with Ang-1 (S1+AS2) 
primer pair (Figure 3.5), thus strongly suggesting that the full-length Ang-1.5 kb is 
the only or the most abundant form of Ang-l in testis. Taken together, only 
Ang-1.5 kb (full-length) was detected in adult rat testis. 
3.2 Expression of Aiig-2 and Ang-2 isoforms in the testis and various 
testicular cell types 
3.2.1 Detection of Aiig-2 expression in the testis and testicular cell types by 
nested PCR 
Nested PCR analysis was used to demonstrate the expression of Ang-2 in 
the testis and several testicular cell types. Primers with 1-2 degenerated nucleotide 
bases were designed based on a highly conserved region of the mouse and human 
Ang-2 mRNA. The product from the first stage of the PCR reaction was diluted to 
an overall ratio of 1/500 for the subsequent second stage of the PCR reaction. C6 
rat glioma cells were included in this experiment as a positive control. After nested 
PCR amplification, a product corresponding to the expected size of 443 bp was 
amplified from adult rat testis, primary Leydig cells, primary Sertoli cells, primary 
germ cells, rat testicular blood vessel, mouse testis and C6 rat glioma cells. 
i 





lOObp Adult Leydig Sertoli Germ testicular Mouse C6 
DNA rat cell cell cell blood testis 
Ladder testis vessel 
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Figure 3.6 Analysis of Ang-2 expression in the adult rat testis and 
primary rat testicular cells using nested PCR. Products from the 
second stage of the nested PCR were separated in a 1.2% ethidium 
bromide-stained DNA agarose gel. The positive bands (indicated by the 
arrow) correspond to the product of interest having the expected size of 
443 bp for Ang-2. The lower panel shows the corresponding signal 







3.2.2 Detection of Ang-2 expression in testicular cell lines by nested PCR 
As a next step, Ang-2 expression was investigated in testicular cell lines 
using nested PCR approach with the same primer pair as the one described in 
Section 3.2.1. The product from the first stage of the PCR reaction was diluted to a 
ratio of 1/500 for the subsequent second stage of the PCR reaction. The expression 
pattern of Ang-2 in testicular cell lines was found to be different from that of Ang-1. 
As shown in Figure 3.7, faint bands were observed in TM3 and TM4 cells but not 
other testicular cell lines. They corresponded to the expected size of PCR product 
(i.e. 443 bp) from the amplification of Ang-2 mRNAs. The amplification of P-actin 
was used as the control for comparable amount and quality of mRNA among 
samples. After the first stage of the PCR reaction, the product bands for p-actin 
were of comparable intensities in all samples. Before nested PCR was carried out, 
a single PCR reaction with the external primers was performed several times on 
testicular cell lines using cDNA from the same preparation of total RNA used for 
subsequent experiments. But Ang-2 mRNA expression was not detectable in TM3 
cells even after 40 cycles of PCR amplification (data not shown). Therefore, Ang-2 
mRNA could be demonstrated in TM3 mouse Leydig cells only by the nested PCR 
approach. With the primer pair used in this part of the study, product bands 






DNA rat C6 TM3 TM4 LC540 MLTCl R2C 
Ladder testis 
645 • r i i B ^ ^ J I 
Figure 3.7 Analysis of Ang-2 expression in testicular cell lines using 
nested PCR Products from the second stage of the PCR reaction were 
separated in a 1.2% ethidium bromide-stained DNA agarose gel. The 
positive bands (indicated by the arrow) correspond to the product of 
interest having the expected size of 443 bp for Ang-2. The lower panel 
shows the corresponding signal intensity for P-actin using the same 
amount of template. 
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and C6 rat glioma cells (used as a positive control). Ang-2 transcripts could not be 
detected in other testicular cell lines such as LC540, MLTC-1 and R2C testicular 
cells. In general, the results obtained in Sections 3.2.1 and 3.2.2 suggested that the 
Ang-2 mRNA expression was detected in Sertoli cells, Leydig cells and possibly 
germ cells of the testis. 
3.2.3 Sequence analysis of Ang-2 transcript amplified from adult rat testis 
At the start of the study, the presence of Ang-2 transcripts in the rat testis 
was confirmed by sequencing the product from PCR reaction using a pair of 
primers which gave reasonably strong signal for the rat testis. However, this primer 
pair was different from the ones used in subsequent parts of the study. So strictly 
speaking, the sequencing result from the testis could not be applied to confirm the 
authenticity of the nested PCR products shown in Figure 3.6 and Figure 3.7 
(Sections 3.2.1 and 3.2.2). For the generation of PCR product used in the sequence 
analysis of Ang-2 cDNA fragment from adult rat testis，the upstream primer 
sequence was 5'-CTGATGTGGAAGCCCAAGTACTAA-3' (SI), corresponding 
to 638-661 bp, whereas the downstream primer sequence was 
5,-GTCACAGTAGGCCTTGATCTC-3, (AS 1)，corresponding to 1132-1152. The 







submitted to GenBank with the following accession number of #AF004326. The 
concentration of magnesium chloride used in the PCR reactions was 1.2 mM. The 
PCR parameters were denaturation at 94 for 1 minute, primer annealing at 55 
for 45 seconds and extension at 72 ^C for 1 minute 30 seconds for 35 cycles. Using 
this set of primers, the PCR product for Ang-2 was located at 515 bp. 
Using the BLAST search, it can be seen that there was a considerable 
degree of similarities in the region of the Ang-2 transcript that was amplified from 
the rat (and in this particular case, from the rat testis) when compared that reported 
in the mouse (92.7%) and human (82.7%) (as shown in Figure 3.8). Alignment of 
the known nucleotide sequence of mouse Ang-2 with the nucleotide sequence of 
PCR product amplified from adult rat testis showed that the mouse Ang-2 and rat 
Ang-2 gene sequence are highly conserved. 
3.2.4 Detection of the expression of Ang-l isoforms in adult rat testis 
Three isoforms of Ang-2 (Ang-2A, Ang-2B and Ang-2C) was reported in 
immature chicken testis, adult quiescent chicken testis and regressed adult chicken 
testis [Mezquita et aL, 1999; Mezquita et al, 2000]. Also, a cDNA encoding a 
novel shorter form of Ang-2 (Ang-2443) was isolated from human umbilical vein 




^ hAng-2 721 gatagaaata gggacaaacc tgttgaacca aacagctgag caaacgcgga agttaactga 
r-testis  
inAng-2 gatagagatt ggaaccagct tgctgaacca gacagcagca caaactcgga aactgactga 
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mAng-2 tatttctacc aacaaattgg aaaagcagat tttggatcag accagtgaaa taaacaagct 
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mAng-2 acaaaataag aacagcttcc tagaacagaa agttctggac atggagggca agcacagcga 
hAng-2 961 ccaactacag tcaataaaag aagagaaaga tcagctacag gtgttagtat ccaagcaaaa 
r-testis gcagctgcag tccatgaagg agcagaagga ccagcttcag gtgctggtgt ccaagcagag 
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mAng-2 gcagctacag tccatgaagg agcagaagga cgagctccag gtgctggtgt ccaagcagag 
hAng-2 1021 ttccatcatt gaagaactag aaaaaaaaat agtgactgcc acggtgaata attcagttct 
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r-testis tcagaagcag cagcatgatc taatggagac ggtcaacagc ttgctgacca tgatgtccac 
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mAng-2 tcagaagcag cagcatgacc taatggagac cgtcaacagc ttgctgacca tgatgtcatc 
hAng-2 1141 atcaaactca gctaaggacc ccactgttgc taaagaagaa caaatcagct tcagagactg 
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inAng-2 tgcggaaatc ttcaagtcag gactcaccac cagtggcatc tacacactga ccttccccaa 
hAng-2 1261 ttctacagaa gagatc&agg cctactgtga catggaagct ggaggaggcg ggtggacaat 
r-testis — 
mAng-2 ctccacagag gagatcaagg cctactgtga catggacgtg ggtggaggag ggtggacagt 
Figure 3.8 Comparing the nucleotide sequence of the PCR product 
obtained using specific Aiig-2 primers and cDNA from adult rat testis as 
template，against the corresponding regions of the published mouse and 
human Aiig-2 cDNA sequence. mAng-2, and hAng-2 represent the published 
sequence of mouse and human Ang-2, respectively (GenBank Accession 
Numbers - mAng-2: AF004326 and hAng-2: AF004327). r-testis represents 
the sequencing result of the PCR product amplified from adult rat testis using 
Ang-2 (Sl+ASl) primers. The primer sequences are shown in italics and 
boldface. The numbering of nucleotide bases for hAng-2 is shown to the left 





Ang-2 (S3+AS4) primers with 1-2 degenerated nucleotide bases was designed 
based on highly conserved regions of the mouse and human Ang-2 cDNA 
sequences to investigate whether the different Ang-2 mRNA isoforms could be 
expressed in adult rat testis (Figure 2.4). The primer sequences were numbered 
according to the mouse Ang-2 cDNA sequence submitted to GenBank with the 
following accession number of #AF004326. 
First of all, a much-relaxed PCR condition (2.5 mM magnesium chloride 
and primer annealing temperature of 55 OQ was used for amplification of template 
from adult rat testis. The band of interest (indicating the possible presence of 
Ang-2443 as found in human) with a size close to 409 bp was excised from the gel 
for purification (Figure 3,9) and subjected to a second PCR amplification using the 
same PCR condition and the same set of primers (S3+AS4). The purified product 
from the first stage of the PCR reaction was diluted to an overall ratio of 1/100 
(Lane 1) and 1/1000 (Lane 2) for the second PCR amplification. After the second 
PCR amplification, a major band slightly smaller than the expected size (409 bp) 
and an additional smaller band were found (data not shown). Although the main 
product band was found not to match the expected size of Ang-2443 in human, it was 
possible that other splice variants of Ang-2 in the rat could produce a RT-PCR 
product of a different size. Automated DNA sequencing analysis was therefore 




D N A 1 2 3 4 5 6 7 8 
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300 bp 军•^T::年？巧 
i Lane 1 to 4: Ang-2 (S3+AS3) primer pair 
Lane 5 to 8: Ang-2 (S3+AS4) primer pair 
Concentration of magnesium chloride: Ang-2 (S3+AS3) primer pair: 2.5 mM 
Aiig-2 (S3+AS4) primer pair: 2.5 mM 
PCR condition: Ang-2 (S3+AS3) primer pair: 94 ^C for 1 minute; 5 8 � C for 45 
seconds; 7 2 � C for 1 minute 30 
seconds for 25 cycles. 
Ang-2 (S3+AS4) primer pair: 9 4 � C for 1 minute; 5 5 � C for 45 
seconds; 7 2 � �f o r 1 minute 30 
seconds for 25 cycles. 
Ang-2 (S3+AS3) primer pair: 
sense (S3): 5‘-TGTCCAATGC(C/T)GTGCAGAGGGA-3‘ (nt 392-413) 
antisense (ASS): 5'-CACTGGTCTG(A/G)TCCAAAATCTG-3' (nt. 727-748) 
Ang-2 (S3+AS4) primer pair: 
sense (S3): 5'-.TGTCCAATGC(C/T)GTGCAGAGGGA- 3, (nt 392-413) 
antisense (AS4): 5 ‘-TCATG(C/T)TGCTGCTTCTGAAG-3 ‘ (nt. 940-959) 
(GenBank Accession No.: AF004326) 
Figure 3.9 Detection of alternatively spliced species of Aiig-2 mRNA in the 
adult rat testis using RT-PCR. PCR products were separated in a 1.2% ethidium 
bromide-stained DNA agarose gel. Lanes 1-4 show the use of cDNA from the adult 
rat testis as template and Ang2 (S3+AS3) as primers. Lanes 5-8 show the use of the 
same template but Ang2 (S3+AS4) as primers. In both cases, only the products that 
correspond to the expected sizes for the full-length Ang-2 transcript are present -
357 bp when using Ang2 (S3+AS3) primers and 568 bp when using Ang2 (S3+AS4) 
primers. PCR products that correspond in size to the truncated form of Ang-2 are 
absent — 198 bp for Ang2 (S3+AS3) primers and 409 bp for Ang2 (S3+AS4) primers. 
Also the absence of the truncated form of Ang-2 was confirmed by sequencing the 





performed to study the sequence of the major band but not the weaker and smaller 
band. Sequence analyses indicated that the main product was not Ang-2 or other 
Ang-2 isoforms (data not shown). 
3.3 Expression of Ang-3 in the testis and testicular cell types 
3.3.1 Detection of Ang-3 expression in the testis and primary testicular cells 
by RT-PCR 
This part of the study deals with the expression of Ang-3 in the testis, 
since Ang-4 is expressed in human while its counterpart in mice (and possibly also 
in other rodents such as the rat) is Ang-3 [Valenzuela et al, 1999]. It is important to 
note that so far there has been no report on the expression of Ang-3 in other species 
besides the mouse. 
Since in the mouse. Northern blot analysis showed high level of Ang-3 
expression in the lung, the same organ from adult rats was chosen as a positive 
control for RT-PCR analysis of Ang-3 expression in the testis and other testicular 
cell types [Valenzuela et a/.，1999; Brown et al., 2000]. 
The primer pair was designed based on the published mouse Ang-3 
cDNA sequences. Positive Ang-3 expression was found in all cDNA preparations 
being investigated. As shown in Figure 3.10, Ang-3 was expressed though poorly 
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Figure 3.10 Analysis of Ang-3 expression in the adult rat testis 
and primary rat testicular cells using RT-PCR. PCR products were 
separated in a 1.2% ethidium bromide-stained DNA agarose gel. The 
positive bands (indicated by the arrow) correspond to the product of 
interest having the expected size of 593 bp for Ang-3. The lower panel 
shows the corresponding signal intensity for p-actin using the same 






and rat testicular blood vessel. Of interest, a band of 593 bp, thus corresponding in 
size to the RT-PCR product expected from mouse Ang-3 mRNA，was more readily 
detectable in mouse testis. In contrast, the expression of Ang-3 was undetectable in 
C6 rat glioma cells. All of these cDNA preparations also an expected PCR product 
for P-actin with comparable band intensity, indicating successful RNA extraction, 
reverse transcription and comparable amounts of the templates being used. 
3.3.2 Detection of Ang-3 expression in testicular cell lines by RT-PCR 
RT-PCR analysis was performed on five testicular cell lines to determine 
which of the various testicular cell lines expressed Ang-3. The same set of primers 
mentioned in Section 3.3.1 was also applied in this part of the study. Similar to the 
results obtained from the study of primary Leydig cells, the levels of Ang-3 
expression were also low in Leydig cell lines，including TM3, LC540, MLTC-1 
and R2C testicular cells. The results were shown in Figure 3.11. Among all 
testicular cell lines being investigated, Ang-3 mRNA expression was only easily 
detectable in TM4 mouse Sertoli cells at relatively higher levels. 
3.3.3 Sequence analysis of Ang-3 transcripts amplified from TM4 mouse 
Sertoli cells and adult rat testis 
To demonstrate whether Ang-3 transcripts amplified from TM4 mouse 
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lOObp Adult lOObp Adult 
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Figure 3.11 Analysis of Ang-3 expression in testicular cell lines 
using RT-PCR. PCR products were separated in a 1.2% ethidium 
bromide-stained DNA agarose gel The positive bands (indicated by the 
arrow) correspond to the product of interest having the expected size of 
593 bps for Ang-3. The lower panel shows the corresponding signal 






Sertoli cells actually correspond to mouse counterpart of Ang-3 cDNA, automatic 
DNA sequencing analysis was performed using the same set of primer for 
generating the PCR product (as mentioned in Sections 3.3.1 and 3.3.2). Similarly, 
RT-PCR revealed the correct size PCR product for Ang-3 (593 bp) in adult rat testis. 
To confirm the identity of this PCR product from adult rat testis, automatic DNA 
sequencing analysis was performed using the same set of primer for generating the 
PCR product. 
By searching Standard Nucleotide-nucleotide BLAST Database as 
described under Materials and Methods (Section 2.3.7), a high degree of identity 
was found with cDNA generated from TM4 mouse Sertoli cells and the known 
partial nucleotide sequence of mouse Ang-3. The nucleotide sequence of Ang-3 
from TM4 mouse Sertoli cells was found to share 96.8% identity with the 
corresponding region of the mouse Ang-3 DNA sequence when the extra 
nucleotide residues present in the sequence of TM4 mouse Sertoli cells were 
ignored in the calculations (as shown in Figure 3.12). Therefore, the PCR products 
obtained in Sections 3.3.1 and 3.3.2 could be proved to be the authentic fragments 
of Ang-3. 
Using the BLAST search, it can be seen that a relatively high degree of 
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r-testis ctccg gggttaatac cagcggtgtc tataccatct atgagacaaa catgacaaag 
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mAng-3 961 cctctcaagg tgttctgtga catggagact gatggaggtg gctggaccct catccagcac 
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TM4 cctctcaagggtgttctgtga catggagact gatggaggtg gctggaccct catccagcac 
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r-testis cgggaggatg gaagcgtaaa tttccagagg a-ctgggaag -atacaaaga ggg-tttggt 
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； T M 4 cgggaggatg gaagcgtaaa tttccagagg gactgggaag aatacaaaga gggttttggt 
‘ r-testis aatgtgg-ca gagagcactg gctgg--cat gaggctgtgc ac--gctca- cagcag-acg 
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TM4 gaga-cttcc agctgg-cag cgagag-cag cg-tacagcc tctctgtgaa tgac-gcagc 
g r-testis cagttcagcag ggcgcaagaa ca-cctg-ct cctcagg-ca c-aagttcag ccccaa-gac 
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I TM4 atggacaatg ataactgcat gtgtaaatgt gctcagatgc tgtctggagg gtggtggttt 
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r-testis gatgcctgtg gcctctccaa cctcaatggc atctactatt cagttcatca gcac-tgcac 
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r-testis aagatcaa  
I I I I I I I I 
mAng-3 1441 aagatcaatg- gc»tccgctg g c a c t a c t t c cgaggcccca gctactcact gcacggcaca 
I I I i i I I I TM4 aagatcaa  
r - t e s t i s 
mAng-3 1501 cgcatgatgc tgaggccaat gggtgcctga 
TM4 
Figure 3.12 Comparing the nucleotide sequence of PCR products obtained 
using specific Aiig-3 primers and cDNAs from TM4 mouse Sertoli cells and 
adult rat testis as templates, against known partial sequence of mouse Aiig-3. 
mAng-3 represents the published sequence of mouse Ang-3 (GenBank Accession 
Number - mAng-3: AF113707). TM4 and r-testis represent the nucleotide 
sequence of PCR products from TM4 mouse Sertoli cells and adult rat testis, 
respectively. The present data show the first partial nucleotide sequence of rat 
Ang-3. Primer sequences are shown in italics and boldface. Gaps between 
nucleotide bases are indicated by dashes. Extra nucleotide bases were shown 
above and below the sequence for adult rat testis and TM4 mouse Sertoli cells, 
respectively. The numbering of nucleotide bases for mAngS is shown to the left 




nucleotide sequence of mouse Ang-3. The nucleotide sequence of Ang-3 from 
adult rat testis was found to be 94.3% identical to the corresponding region of the 
mouse Ang-3 DNA sequence when the extra nucleotide residues present in the 
sequence of template from adult rat testis were ignored in the calculations (as 
shown in Figure 3.12). Alignment of the known nucleotide sequence of mouse 
Ang-3 with the nucleotide sequence of PCR product amplified from adult rat testis 
indicated that the nucleotide sequences of mouse Ang-3 and rat Ang-3 are highly 
conserved. This study represented the first to report on the presence of the 
nucleotide sequence of Ang-3 in the rat species. 
3.4 Expression of Tie 1 and Tie 2 in the testis and testicular blood vessel 
3.4.1 Detection of Tie 1 and Tie 2 expression in the testis and rat testicular 
blood vessel by RT-PCR 
The expression of Tie 1 and Tie 2 was investigated in adult rat testis and 
rat testicular blood vessel. RT-PCR was performed using Tie 1 and Tie 2 specific 
primers to cDNA prepared from adult rat testis and isolated testicular subcapsular 
artery. Representative experiments were shown in Figures 3.13 and 3.14. Specific 
PCR products of Tie 1 and Tie 2 were noted in adult rat testis and rat testicular 
blood vessel. The PCR bands were located at 425 bp for Tie 1 and 457 bp for Tie 2. 
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i Figure 3.13 Analysis of Tie 1 expression in the adult rat testis and 
I testicular blood vessel using RT-PCR. PCR products were separated 
in a 1.2% ethidium bromide-stained DNA agarose gel. The positive 
bands correspond to the product of interest having the expected size of 
425 bps for Tie 1. The lower panel shows the corresponding signal 
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Figure 3.14 Analysis of Tie 2 expression in the adult rat testis and 
testicular blood vessel using RT-PCR. PCR products were separated in 
a 1.2% ethidium bromide-stained DNA agarose gel. The positive bands 
correspond to the product of interest having the expected size of 457 bps 
for Tie 2. The lower panel shows the corresponding signal intensity for p-
actin using the same amount of template. 





1 and Tie 2 transcripts amplified from adult rat testis and rat testicular blood vessel 
were confirmed by direct sequencing of PCR products. 
！ 
I { 
3.4.2 Sequence analysis of Tie 1 transcripts amplified from adult rat testis 
and rat testicular blood vessel 
To confirm the authenticity of the PCR products obtained from RT-PCR 
analysis coupled with Tie 1 primers in Figure 3.13, direct sequencing of the 
PCR-amplified products from adult rat testis and rat testicular blood vessel was 
performed. 
By searching Standard Nucleotide-nucleotide BLAST Database as 
described under Materials and Methods (Section 2.3.7)，there was a considerable 
degree of identity between Tie 1 transcripts amplified from adult rat testis or rat 
testicular blood vessel and the corresponding region of the mouse Tie 1 DNA 
sequence (as shown in Figure 3.15). Also, Tie 1 transcripts amplified from adult rat 
testis and rat testicular blood vessel had retained similarity to both mouse Tie 1 and 
human Tie 1, suggesting a conserved functional role of Tie 1 in these species. 
3.4.3 Sequence analysis of Tie 2 transcripts amplified from rat testicular 
blood vessel 
In order to determine whether the RT-PCR products shown in Figure 3.14 
I 
I actually corresponds to rat Tie 2 cDNA，DNA sequencing analysis was performed 
； 113 
I 
Figure 3.15 Comparing the nucleotide sequence of PCR products 
obtained using specific Tie 1 primers and cDNA from adult rat testis 
and rat testicular blood vessel as templates, against known sequences of 
mouse and human Tie 1. mTie 1 and hTie 1 represent the published 
sequences of mouse and human Tie 1, respectively (GenBank Accession 
Numbers - mTie 1: X80764 and hTie 1: X60957 S89716). r-testis and r-
TBV represent the nucleotide sequence of PCR products from adult rat testis 
and rat testicular blood vessel, respectively. Primer sequences are shown in 
italics and boldface. 'n' represents the unknown nucleotide base in the 
sequencing results. Gaps between nucleotide bases are indicated by dashes. 
Extra nucleotide bases are shown above and below the sequence for adult rat 
testis and rat testicular blood vessel, respectively. The numbering of 






r-testis - gccacagagc tggagttcaa 
m I I I 11 丨 m 111 丨 m 
I mTie 1 1381 ctgtgaaaag tcagaoogga. tcccccaqat cctcagtatg gccacagagg tggagttcaa 
I I丨丨丨丨丨丨 
‘； r-TBV agttcaa 
hTie 1 ctgtgagaag tcagaccgga, t c c c c c a g a t cctcaacatg gcctcagaac tggagttcaa 
； r-testis cttagggaca atgccccgga tcaactgtgc agctgccggg aatcccttcc cagtacgggg 
: I I丨I丨m 丨I丨m I m 11丨丨丨1111丨11丨111丨丨i I丨1111丨丨丨丨丨丨丨丨丨11丨丨丨 
iiiTie 1 1441 catagggacg atgccccgga tcaactgtgc agctgccggg aatcccttcc cagtgcgggg 
I M 丨 m 11 丨 111111 丨 11 1111111111 i 11111111 i 11 m 1111 M M I m 丨 
r-TBV catagggaca atgccccgga tcaactgtgc agctgccggg aatcc-ttcc cagtacgggg 
hTie 1 cttagagacg atgccccgga tcaactgtgc agctgcaggg aaccccttcc ccgtgcgggg 
r-testis cagcatggaa ctccgcaagc cagacggcac catgcttctg tctaccaaag ccattgtgga 
m 1111 H丨丨丨m m 1111丨m丨丨m丨丨！丨丨m i丨丨丨m 丨丨丨i丨丨m 
1 mTie 1 1501 cagcatgaaa cttcgcaagc cagatggcac catgcttttg tctaccaaag tcattgtgga 
I m m 11 i I丨m丨丨I mi i丨m丨丨丨丨m丨丨丨丨丨丨丨i丨丨丨丨丨m丨丨丨丨 
r-TBV cagcatggaa ctccgcaagc cagacggcac catgcttctg tcta-caaag ccattgtgga 
hTie 1 cagcatagag ctacgcaagc cagacggcac tgtgctcctg tccaccaagg ccattgtgga 
t c t 
r-testis gccagatagg accacagctg agtttggagt gccccgtttg actcttgggg acagcgggtt 丨丨丨11丨M i 111 i 111丨I丨111丨丨丨I丨I丨丨丨丨丨I丨丨丨丨丨丨丨丨丨丨丨丨MM丨丨m 
mTie 1 1561 gccagacagg accacagcag agtttgaagt gcccagtttg actcttgggg acagtgggtt 
m m I I I ！ m 1111 丨 m i 11 11 1111 丨 i m m 11 丨 i i i i m i 丨 m i 
j r-TBV gccagatagg accacagctg agttcgaggt gccccgtttg actcttgggg acagcgggtt 
hTie 1 gccagagaag accacagctg agttcgaggt gccccgcttg gttcttgcgg acagtgggtt 
tg t t t t 
r-testis ctgggaatgc cgtgtatcga cgtctggtgg ccaagaaagc cggcgcttca aggtcaatgt 
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r-TBV ctgggaatgc cgtgtatcca cgtctggtgg ccaagatagc cngcgcttcaaaggtcaatgt 
a c 
i hTie 1 ctgggagtgc cgtgtgtcca catctggcgg ccaagacagc cggcgcttca aggtcaatgt 
I r-testis caaagtaccc ccagtgcctc tgactgcacc tcggctcctg gccaagcaga gccgtcagct 
i I M 1111! I I m III III 11 M M M 11 11 i 1111 M m 111 m I ii i M i m i mTie 1 1681 caaagtaccc ccagtgcctt tgactgcacc tcgactcctg gccaagcaga gccgtcagct 
111 j 11丨m I丨m I 丨丨1 m I 丨丨丨i m丨丨丨丨丨m丨i i丨丨丨m i 
r-TBV tcaaagtaccc caattgctct gaactgcact ccggctcctg gcaaagcaaaanccgccagct 
t gc 
hTie 1 gaaagtgccc cccgtgcccc tggctgcacc tcggctcctg accaagcaga gccgccagct 
r-testis tgtggtctcc ccactgttct ccttcggtgg ggatggaccc  
丨i I m m I m丨丨I丨丨丨丨丨丨I m丨丨丨丨丨丨丨丨丨丨丨 
； mTie 1 1741 tgtggtctcc ccactggtct cctttagtgg ggatggaccc atctcctctg tccgcctgca. 
I m m 11 111 i 11 il 11丨丨I丨I I丨I丨I m丨I m丨m丨m丨丨丨i 
: r-TBV tgtggtc-cc ccactggtct cccttcgtgg ggatggaccc atctcctctg t  
a 
J hTie 1 tgtggtctcc ccgctggtct cgttctctgg ggatggaccc atctccactg tccgcctgca 
\ r-testis  
mTie 1 1801 ctAccggacc caggacagca cgattgcctg gtctgccatt gtggtggatc ccagtgagaa 
丨 r-TBV  
hTie 1 cteiccggccc cagrgacagta ccatggactg gtcgaccatt gtggtggacc ccagtgagaa 
115 
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on RT-PCR product from rat testicular blood vessel using the isolation and 
sequencing procedure outlined under Materials and Methods (Sections 2.3.6 and 
2.3.7). 
Using the BLAST search，it can be seen that there was a considerable 
degree of identity between the nucleotide sequence of Tie 2 transcripts amplified 
from rat testicular blood vessel and the corresponding region of the mouse Tie 2 
DNA sequence (as shown in Figure 3.16). The nucleotide sequence of Tie 2 from 
rat testicular blood vessel was almost identical to the rat Tie 2 DNA sequence. 
Therefore, the authenticity of the RT-PCR products obtained in Section 3.41 could 
be confirmed and these products were rat Tie 2 DNA sequence. 
Similarly, Tie 2 cDNAs amplified from rat testicular blood vessel 
demonstrates a high sequence identity to the nucleotide sequence of human Tie 2 
within the region between the upstream primer and downstream primer. The data 
suggested a conserved Tie 2 nucleotide sequence across species. 
3.5 Western blot analysis of Ang-1 and Ang-2 expression in testicular 
tissues, primary testicular cells and cell lines 
In order to determine the presence of angiopoietin proteins in testis, 
Western blot analysis were performed (published data from C.L. Au, L. Yeimg and 






Figure 3.16 Comparing the nucleotide sequence of PCR products 
obtained using specific Tie 2 primers and cDNA from rat testicular blood 
vessel as template against the known partial sequence of rat Tie 2 and the 
corresponding region of mouse and human Tie 2 cDNA sequence. hTie 2, 
mTie 2 and rTie 2 represent the published sequences of human, mouse and rat 
Tie 2, respectively (GenBank Accession Numbers - mTie-2: X71426, rTie-2: 
AF030423, and hTie-2: L06139). r-TBV represents the nucleotide sequence of 
the PCR product from rat testicular blood vessel. Primer sequences are shown 
in italics and boldface. Gaps between nucleotide bases are indicated by dashes. 




I hTie 2 2281 catttttgca g a g a a c a a c a taqggtcauiq c a a c c c a g c c ttttctcatg aactggtgac 
\ itiTie 2 tatttttgct gagaac a a c a taggatcaag c a a c c c a g c c ttttctcatg aactgaggac 
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rTie 2 tatttttgct g a g a a c a a c a t a g r g a t c a a g c a a c c c a g c c ttttcccaag aaattaggac 
hTie 2 2341 cctcccagaa tctcaagcac cagcggacct cggagggggg aagatgctgc ttatagccat 
mTie 2 gcttccacat tccccagcct ctgcagacct cggaggggga aagatgctac tcatagccat 
I I M I I 丨 丨 I I I I I 丨 
r-TBV acttccagcc cctaaagacc ttggaggggg a aagatgctac ttatagccat 
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rTie 2 acttccagcc cctaaagacc ttggaggggg a aagatgctac ttatagccat 
hTie 2 2401 ccttggctct gctggaatga cctgcctgac tgtgctgttg gcctttctga tcatattgca 
mTie 2 ccttgggtcg gctggaatga cttgcatcac cgtgctgttg gcgtttctga ttatgttgca 
I m丨I丨m丨111丨m 11丨丨i丨i丨m丨mm丨丨丨丨i丨i丨丨11丨丨丨丨丨11 m丨丨 r-TBV tcttgggtcg gctggaatga cttgcatcac cgtgctattg gcgtttctga ttatgttgca 
i i i i i i i i i i 11111 M 111 11 M 11 M 11 1111111111 m i m m 
rTie 2 tcttgggtcg gctggaatga cttgcatcac cgtgctattg gcgtttctga ttatgttgca 
hTie 2 2461 attgaagagg gcaaatgtgc aaaggagaat ggcccaagcc ttccaaaacg tgagggaaga 
mTie 2 actgaagaga gcaaatgtcc aaaggagaat ggctcaggca ttccagaaca gagaagaacc 
I I I丨I I I丨I I I I m I丨I I I I丨丨I I I I I I I I I丨I丨丨I I丨丨III I丨丨 I N I 
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rTie 2 actgaagaga gcaaatgtcc aaagaagaat ggcctaggcc ttccagaacg tgagagaaga 
hTie 2 2521 accagctgtg cagttcaact cagggactct ggccctaaac aggaaggtca aaaacaaccc 
mTie 2 age——tgtg cagtttaact caggaactct ggcccttaac aggaaggcca aaaacaatcc 
丨丨 III m 11 m I m 11 m I 丨 I m m III m 11 I I I M 丨 m 11 丨丨 
r-TBV accagctgtt cagttcaact caggaactct ggccctaaac aggaaggcca aaaaca--cc 
I 丨 m 111 丨 M 111 丨 I I I 11 丨 I I I I I I I 丨 I 丨 I 丨 m I m I I I 丨 m m m 111 11 
rTie 2 accagctgtt cagttcaact caggaactct ggccctaaac aggaaggcca aaaacaatcc 
hTie 2 2581 agatcctaca atttatccag tgcttgactg gaatgacatc aaatttcaag atgtgattgg 
mTie 2 ggatcccaca atttatcctg tgcttgactg gaatgacatc aagtttcaag acgtgatcgg 
111 M 111 M m丨丨I丨I丨I丨丨丨丨丨丨11 111 m丨m丨丨丨丨i丨丨丨丨丨丨丨丨丨丨丨丨 
r-TBV cggatcccaca att-atcctg tgcttga-tg gaatgacatc aagttccaag atgtgattgg 
c 
I I I I 
rTie 2 ggat  
hTie 2 2641 ggagggcaat tttggccaag ttcttaaggc gcgcatcaag aaggatgggt tacggatgga 
mTie 2 agagggcaac tttggccagg ttctgaaggc acgcatcaag aaggatgggt tacggatgga 
I m丨I m 丨 m I I I I 11丨i丨丨i丨丨丨i丨m丨丨丨11丨i m丨丨i丨m 111丨i丨i 
r-TBV agagggcaac tttggccag- ttatgaaggc gcgcatcaag aaggatg-gt tacggatgga 
g 
rTie 2 
hTie 2 2701 tgctgccatc aaaagaatga aagaatatgc c t c c a a a g a t gatcacaggg actttgcagg 
mTie 2 tgccgccatc aagaggatga aagagtat^c c t c c a a a g a t gatcacaggg acttcgcagg 







the amino acids 400-498 mapping at the carboxyl terminus of Ang-l of human 
origin was employed. Though this antibody was raised against Ang-1，the supplier 
indicated that it might cross-react with Ang-2 due to close similarity of the amino 
acid sequence in the carboxyl termini of these two peptides. Cell lysates prepared 
from primary testicular cells and testicular cell lines as well as tissue lysates from 
adult rat testis，testicular subcapsular artery and mouse testis were used. 
As shown in Figures 3.17 and 3.18, two prominent bands were 
consistently observed in the testis (rat and mouse)，C6 rat glimoa cells (used as a 
positive contro), primary rat testicular cells and the various testicular cell lines, 
with the exception of LC540 rat Leydig tumour cells which showed only a single 
band. The apparent molecular weights of the two positive bands (indicated by 
arrowheads) were found to be 58 kDa and 72 kDa, with the former showing a 
stronger intensity than the latter. They correspond to the reported molecular 
weights for the non-glycosylated and glycosylated of Ang-1 protein. In lysates 
prepared from Leydig tumour cell lines (i.e. MLTC-1, LC540, R2C), C6 rat glioma 
cells and adult rat testis (Figure 3.17), there might be an additional positive band of 
55 kDa. This would correspond to the expected molecular size for the 
non-glycosylated form of Ang-2 (Figure 3.19), and was detected due to the 




… f Rat 
〜鬚 testicular Adult 
,‘：^ C6 MLTCl blood TM3 TM4 LC540 R2C rat 
1 1 6 k D a vessel testis 
39.8 
29 
Figure 3.17 Western immunoblotting of Ang-1 (and Ang-2) in the rat testis and 
testicular cell lines [Lui M.C. & Au C.L.; unpublished data]. Molecular weight 
marker sizes shown on the left were used to estimate molecular masses. Sixty ^g of 
proteins extracted from LC540 testicular cells and C6 rat glioma cells，40 jig of 
proteins extracted from MLTC-1, R2C, TM3 and TM4 testicular cells and rat 
testicular blood vessel, as well as 50 \ig of proteins extracted from adult rat testis 
were loaded onto each lane. The samples were separated by 10% SDS-PAGE and 
blotted. Blots were probed using a rabbit polyclonal antibody [Ang-1 (H-98)， 
#sc>8357] (1:500) raised against Ang-1 but showed cross-reactivity to Ang-2. The 
protein bands that bind to the antibody was visualized using horse radish peroxidase 
(HRP)-conjugated protein-A secondary antibody (1:5000) and ECL. Arrowheads 
point to protein bands which correspond to the expected molecular sizes of Ang-1 (58 
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Figure 3.18 Western immunoblotting of Ang-1 (and Ang-2) in primary rat 
testicular cells and testicular tissues [Yeung L. & Au CX•； unpublished data]. 
Molecular weight marker sizes shown on the left were used to estimate molecular 
masses. Sixty fig of proteins extracted from interstitial cells, germ cells, Sertoli cells, 
rat testicular blood vessel, adult rat testis, mouse testis and C6 rat glioma cells were 
loaded onto each lane. The samples were separated by 10% SDS-PAGE and blotted. 
Blots were probed using a rabbit polyclonal antibody [Ang-1 (H-98), #sc-8357] 
(1:500) raised against Ang-1 but showed cross-reactivity to Ang-2. The protein 
bands that bind to the antibody was visualized using horse radish peroxidase 
(HRP)-conjugated protein-A secondary antibody (1:5000) and ECL. Arrowheads 
point to protein bands which correspond to the expected molecular sizes of Ang-1 (58 




protein bands that correspond to the expected size of Ang-1 could be identified in 
germ cells. 
Western blot analysis of Ang-2 with a specific goat polyclonal antibody 
[Ang-2 (C-19X #sc-7015] mapping to epitope at the carboxy terminus of human 
Ang-2 revealed two major protein bands of 55 kDa to 68 kDa in cell lysates 
prepared from C6 rat glioma cells (used as a positive control), rat and mouse testes, 
testicular subcapsular artery, primary rat testicular interstitial cells and Sertoli cells 
(Figure 3.19). These two proteins corresponded to the reported molecular weight 
for the non-glycosylated and glycosylated form of Ang-2. In rat testicular germ 
cells, no protein bands of the correct sizes could be identified. These data indicated 
that Ang-2 protein would occur in the testis mainly in Leydig cells, but also could 
be found in Sertoli cells and testicular blood vessels. 
Importantly, no protein bands were seen in any of the lanes in parallel 
Western blots in which the blots had been incubated overnight at room temperature 
using PBST without the primary antibodies, thus validating the specificity of these 
primary antibodies. 
3.6 Localization of Ang-1, Ang-2, Aiig-3, Tie 1 and Tie 2 proteins in adult 
rat testis by iminunohistocheinistry 
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Figure 3.19 Western immunoblotting of Aiig-2 in primary testicular cells and 
testicular tissues [Yeung L. & Au C.L.; unpublished data]. Molecular weight 
i marker sizes shown on the left were used to estimate molecular masses. Sixty \ig of 
proteins extracted interstitial cells, germ cells, Sertoli cells, rat testicular blood vessel, 
adult rat testis，mouse testis and C6 rat glioma cells were loaded onto each lane. The 
samples were separated by 10% SDS-PAGE and blotted. Blots were probed using a 
I goat polyclonal antibody Ang-2 [Ang-2 (C-19), #sc-7015] (1:500) specific for Ang-2 
j and visualized using horse radish peroxidase (HRP)-conjugated secondary antibody 
! (1:2500) and ECL. Arrowheads point to protein bands which correspond to the 










and to examine their specific sites of distribution within the testis，sections from 
normal adult rat testis were reacted with anti-Ang-1, anti-Ang-2, anti-Ang-1/3, 
anti-Tie 1 and anti-Tie 2 antibodies. 
In adult rat testis, a positive immimoreactivity to Ang-1 (Figure 3.21a) and 
Ang-2 (Figure 3.21b) was most prominently detected in vascular smooth muscle 
cells and vascular endothelial cells, respectively. 
Immunoreactivities for Tie 1 (Figure 3.19a) and Tie 2 (Figure 3.19b) 
receptors were localized mainly to vascular endothelial cells of testicular blood 
vessel. This was consistent with the expression of Tie mRNA in endothelial cell 
lines [Partanen et al” 1992]. Their distributions within the testis were similarly 
found in the vascular endothelium. 
Immunohistochemical data showed that Ang-3 was present in both the 
interstitial and tubular compartments of the testis as well as vascular smooth 
muscle cells of testicular blood vessels (as shown in Figures 3.20a & b). However 
in view of the fact that this particular antibody might show cross-reactivity to 
Ang-1, the possibility that part of the immimoreactivity might have been 
contributed by Ang-1 could not be entirely ruled out. 
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Figure 3.19 Immunohistochemical localization of Tie 1 and Tie 2 receptor 
tyrosine kinases on frozen sections of adult rat testes. Frozen sections were 
incubated with rabbit polyclonal [Tie 1 (C-18), #sc-342] and [Tie 2 (C-20)， 
#sc-324] antibodies (1:100). Arrows indicate red immunopositive signals for 
i (a) Tie 1 and (b) Tie 2 in rat testicular blood vessel (TBV). Magnification 
i x400. Sections were counterstained with haematoxylin. 
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i Figure 3.20 Immunohistochemical localization of Ang-3 protein on frozen 
sections of adult rat testes. Frozen sections were incubated with a goat 
polyclonal [Ang-1/4 (C-19), #sc-9360] antibody (1:100). Ang-4 
immunoreactivity was predominantly localized over the vascular smooth muscle 
of rat testicular blood vessel (TBV). The interstitial cells found between the 
seminiferous tubules also exhibited weak immunoreactivity for Ang 3. 
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Figure 3.21 Immunohistochemical localization of Ang-1 and Ang-2 on 
frozen sections of adult rat testes. Frozen sections were incubated with a 
goat polyclonal (a) [Ang-1 (N-18), #sc-6319] and (b) [Ang-2 (C-19), #sc-7015] 
antibody (1:100). Red coloured areas represented localization of Ang-1 and 
Ang-2 over vascular smooth muscle and endothelial cells of rat testicular blood 
I vessel (TBV) respectively. Magnification x400. Sections were 






3.7 Comparison of angiopoietin expression patterns in testis using RT-PCR, 
Western immunoblotting and immunohistochemistry 
Testis/testicular cell types/ Nested PCR or Western immunoblotting Immuno-
cell lines RT-PCR histochemistry 
Adult rat testis With Ang-1, Ang-2 With Ang-1 and Ang-2 protein expression With Ang-1, Ang-2 
and Ang-3 expression 肪 d Ang-3 
immunoreactivities 
Mouse testis With Ang-1, Ang-2 With Ang-1 and Ang-2 protein expression -
and Aiig-3 expression -
Rat testicular blood v e s s e l M t h Ang-1 ’ Ang-2 With Ang-1 and Ang-2 protein expression With Ang-1 and 
and Ang-3 expression Ang-3 
immunoreactivities 
in vascular smooth 





Primary Leydig cells With Ang-1, Ang-2 With Ang-1 and Ang-2 protein expression No Ang-1 and Ang-2 
and Ang-3 expression in primary interstitial cells immunoreactivities, 
but with Ang-3 
immunoreactivity 
in interstitial cells 
Primary Sertoli cells With Ang-1, Ang-2 With Ang-1 and Ang-2 protein expression No Ang-1，Ang-2 
and Ang-3 expression and Ang-3 
immunoreactivities 
Primary germ cells With Ang-1, Ang-2 No Ang-1 and Aiig-2 protein e x p r e s s i o n N o Ang-1, Ang-2 
and Ang-3 expression and Ang-3 
immunoreactivities 
~Mouse Leydig cell lines T M 3 “ Mth Ang-1 expression in With Ang-1 protein expression in TM3， -
and MLTC-1; LC540 and R2C, MLTC-1 and R2C and Ang-2 protein 
Rat Leydig cell lines LC540 Ang-2 expression in TM3 expression in MLTC-1, LC540 and R2C 
and R2C and Ang-3 expression in 
TM3, MLTC-1, LC540 
andR2C  
Mouse Sertoli cell line TM4 With Ang-1, Ang-2 With Ang-1 protein expression, but no -
and Ang-3 expression Ang-2 protein expression 
3.8 Comparison of Tie 1 and Tie 2 expression patterns in testis using 
RT-PCR and immunohistochemistry 
Testis/testicular b l o o d ” RT-PCR Immunohistochemistry 
vessel  
Adult rat testis With Tie 1 and Tie 2 expression With Tie i and Tie 2 immunoreactivities 
Rat testicular blood vessel With Tie 1 and Tie 2 expression With Tie 1 and Tie 2 immunoreactivities in 
vascular endothelial cclls 
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^ 4. Discussion 
I _ 
Although extensive studies have been carried out trying to define the role of 
j 
i angiopoietins in the process of angiogenesis [Hanahan, 1997], and in particular, its 
！ 
i interaction with VEGF, information regarding its tissue/organ distribution and 
{ 
regulation of expression is still scanty. This is especially true in the case of the 
male reproductive system which receives considerably less attention when 
compared with the female reproductive system [Geva and Jaffe, 2000]. The overall 
aim of the present investigation was therefore to study the expression of Ang-1, 
Ang-2, and Ang-3 in the testes since previous reports have demonstrated the 
j 
expression of VEGF in the two major testicular cell types, namely Leydig cells and 
Sertoli cells [Collin & Bergh, 1996; Au et al； 1997, Ergun et al., 1997]，and VEGF 
could be involved in hCG-induced testicular angiogenesis [Collin & Bergh, 1996] 
and Leydig cell-testicular macrophage interaction [Au et al； 1998]. In order to 
localize the expression of angiopoietin to specific cell types within the testis, 
testicular cell lines were also used to correlate the findings collected from whole 
testes and preparations of primary testicular cells. The studies involved three major 
techniques which included RT-PCR, Western blotting, and immunohistochemistry. 
j However as seen from the data present in the Results section and also from the 
•I 
following discussion, the localization of angiopoietin protein expression was 
hampered by the lack of highly specific antibodies that are commercially available. 
At the same time when the angiopoietin expression was being examined, their 
receptors Tie 2 and the closely related Tie 1 were also studied for their presence in 
the testis and in particular, the testicular blood vessel. 
Angiopoietins could come from a number of cellular sources in the testis. In 





one rat glioma cell line were chosen for investigation since the cell lines would 
provide pure cell preparations which would be free from other contaminating cells. 
This could not be achieved even when the most stringent purification procedure 
was used in the preparation of primary testicular cells. Nevertheless, the major 
drawback with the use of the cell lines is that the phenotypic characteristics of 
these clonal or tumour cells may have changed during prolonged passages in 
culture. To partly overcome such difficulties, the same cell type (e.g. Leydig cells) 
derived from different origins and animal species was used to determine whether a 
generalized pattern of expression could emerge. The rat C6 glioma cell line was 
included as a positive control since previous studies indicated that it expressed both 
Ang-1 and Ang-2. 
Both TM3 cells and TM4 cells are derived from primary culture of Leydig 
cell enriched preparations and Sertoli cell enriched preparations from normal testes 
of 11-13 day old BALB/c nii/+ mice, respectively. They exhibit characteristics 
similar to primary cultures of Leydig cells and Sertoli cells, and both of them are 
clonal cell lines. Also, their doubling times were relatively short compared with 
other cell lines so that RNA and proteins from these cell lines could be made 
available within a shorter period of time. 
MLTC-1 cells are established from the M5480P transplantable Leydig cell 
tumour carried in C57BL/6 mice. LC540 cells are derived from a spontaneous 
transplantable Leydig cell tumour in a Fischer strain rat R2C cells belong to a 
steriod-secreting Leydig tumour cell line derived from Wistar-Furth rats and are 
capable of secreting large quantities of steriod hormone even without stimulation 
with cAMP. These testicular cell lines have been commonly used by many 
investigators since they are commercially available. 
130 
Angiopoietin expression was also analysed in primary Leydig cells, Sertoli 
cells and germ cells using RT-PCR and Western blot analysis. The major reason 
for using primary testicular cells despite the problem with cell purity was that they 
are more likely to retain the normal characteristics of the corresponding cell types, 
！ and the information could be correlated to the ones obtained from the studies of 
] 
cell lines. 
Primary Sertoli cells were prepared from 20-day old immature Sprague-
Dawley (SD) rats instead of adult animals mainly for two reasons. The first is that 
unlike the adult Sertoli cells, they retain responsiveness to FSH. The second reason 
is that the contamination of the Sertoli cell preparation by germ cells is less since in 
immature animals, the testes still do not have the full complement of germ cells. 
Testicular tissues were obtained from adult Sprague-Dawley rats and ICR 
mice as their analyses would provide a broad picture on the expression of 
I angiopoietin and Tie in the testis. Also they are convenient source of tissues for 
pilot experiments and they represent commonly used laboratory animal species. 
4.1 Expression of Ang-1 mRNA and protein in adult rat testis, mouse testis, rat 
testicular blood vessel, primary testicular cells and testicular cell lines 
Using RT-PCR, both the rat and mouse testes were shown to express Ang-1 
transcripts. However when the study was extended to primary testicular cells and 
： testicular cell lines, some samples required the use of nested PCR in order to 
increase the specificity of the amplification reaction. Weak signals or multiple 
bands were obtained when using the first set of primers (Sl+ASl) alone, and this 
could be attributed to the design of the primers, the conditions chosen for the 
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amplification, the quality of mRNA preparations, or the low copy numbers of Ang-
ImRNA. 
When nested PCR was applied to the analyses of all samples, it was 
determined that the expression of Ang-1 in adult rat testes could be associated with 
the Leydig cells, Sertoli cells, germ cells and testicular artery (Figure 3.1). The 
latter is in turn made up of mainly vascular smooth muscle and endothelial cells 
(Figure 3.21a). The Ang-1 expression in immature rat Sertoli cells was again 
observed in the study of TM4 mouse Sertoli cells (Figure 3.2). However for the 
demonstration of Ang-1 mRNA expression in Leydig cells, the RT-PCR results 
were more variable since the positive signals could be identified in LC540 and R2C 
rat Leydig tumour cells but were absent from TM3 and MLTC-1 mouse Leydig 
cells (Figure 3.2). Although this could be explained by the difference in the 
characteristics of these Leydig cell lines once they have been passaged in culture 
for many generations, however the more likely explanation was that the negative 
findings in TM3 and MLTC-1 cells were the results of experimental errors. First, 
the primer sets were able to amplify Ang-1 cDNA from the mouse testes, thus they 
work well for both the rat and mouse species. Second, the absence of Ang-1 
transcripts in TM3 and MLTC-1 cells contradicted the presence of positive protein 
bands in these cell lysates when examined using Western immunoblotting. 
Therefore based on the RT-PCR results, it was possible to conclude that Ang-1 was 
expressed in the testis where it could have originated from the wall of blood vessels, 
Sertoli cells, Leydig cells and possibly germ cells. 
The present study demonstrated the expression of Ang-1 mRNA in the 
； testicular subcapsular artery. Also，using immunohistochemical staining, Ang-1 




muscle cells around the major arteries/arterioles (Figure 3.21a). This is in 
I 
agreement with earlier findings in other tissues where Ang-1 immunoreactivity was 
,j also found to be mainly localized in perivascular or vascular smooth cells, rather 
"i 
than endothelial cells of blood vessels. Using RT-PCR analysis, Mandriota & 
i 
Pepper (1998) revealed that none of endothelial cell types (i.e. bovine 
microvascular endothelial cells, aortic，pulmonary artery and transformed fetal 
aortic endothelial cells) expressed appreciable levels of Ang-1, whereas smooth 
muscle cells expressed both Ang-1 and Ang-2. Using the same approach, Kim et al 
(2000b) demonstrated the presence of Ang-1 mRNA in human umbilical vascular 
smooth muscle cells (HUVSMCs) but not in human umbilical vascular endothelial 
cells (HUVECs). Despite the fact that most studies failed to demonstrate Ang-1 
expression in vascular endothelial cells. Oh et al (1999) used the technique of 
Northern blot analysis and identified the presence of Ang-1 mRNA in both bovine 
retinal endothelial cells (BRECs) and bovine aortic endothelial cells (BAECs). 
Therefore it appeared that Ang-1 could come from both vascular smooth muscle 
cells (major) and endothelial cells (minor) to exert a paracrine or autocrine effect in 
stabilizing the vascular endothelium either by promoting cell-cell or cell-
I extracellular matrix interaction and/or by serving as a cell survival signal for the 
nonproliferating endothelial cells [Kim et al” 1999a]. 
In the present study, Ang-1 mRNA was detectable in adult rat and mouse 
testes using nested PCR analysis. The authenticity of the PCR products was also 
confirmed by DNA sequencing and agreed well with the published cDNA sequence 
； for rat Ang-1 (Figure 3.3). 
•J 
I In agreement with the demonstration of Ang-1 transcripts using RT-PCR, 
I 





testis, Sertoli cells, Leydig cells and testicular blood vessels (Figure 3.18). Previous 
studies have identified two forms of Ang-1 with different molecular sizes. They 
represent the newly synthesized Ang-1 which is non-glycosylated and the mature 
product which is glycosylated [Kwak et al, 1999; Kim et al., 1999b]. The non-
glycosylated Ang-1 is predominantly found in cell lysates while the glycosylated 
form is usually secreted from cells and found in the medium of cultured cells 
[Kwak et al； 1999; Kim et al., 1999b]. In line with these earlier findings, the 
present study also demonstrated the occurrence of two positive bands with apparent 
molecular sizes of 58 kDa and 72 kDa. This could be clearly seen in the lysates 
prepared from adult rat testis, mouse testis, testicular blood vessel, testicular 
interstitial cells, primary Sertoli cells, all testicular cell lines (with the exception of 
LC540)，and C6 rat glioma cells which was used as a positive control (Figures 3.17 
and 3.18). In these samples, the lower molecular size species representing the non-
glycosylated form invariably gave a stronger signal than the high molecular weight 
glycosylated form, again pointing to the predominance of newly synthesized, non-
glycosylated Ang-1 inside the cells. In LC540 cells, only the smaller molecular size 
protein band could be seen, and this could be explained by a low abundance of 
Ang-1 relative to the same amount of total proteins used for Western 
immunoblotting. In the germ cells, no protein bands of the correct sizes could be 
identified (Figure 3.18). Thus it remained unclear whether in this cell type, the 
presence of Ang-1 transcripts as revealed by RT-PCR represented the contribution 
from neighbouring Sertoli cells or the Ang-1 protein was processed differently in 
this mixed population of haploid (i.e. spermatids) and diploid cells (i.e. 




Detailed examination of the Western blots revealed that not only the lower 
molecular size band gave stronger signal, it might also encompass another protein 
band with a slightly lower molecular size ( � 5 5 kDa). As it would be discussed in 
the next section, it might represent the cross-binding of this particular antibody to 
Ang-2，which has a slightly smaller molecular weight than Ang-1 [Kim et al., 
2000a]. 
In the present investigation, it was not possible to demonstrate the presence of 
alternatively spliced Ang-1 mRNA in the adult rat testis and other testicular cell 
lines by RT-PCR (Figures 3.4 and 3.5). Since the original work was done in human, 
it does not necessary mean that this could be generalized to other species such as 
the rat and mouse. Even in the original publication [Huang et al” 2000], it could be 
seen that these alternatively spliced species had very limited distribution occurring 
only in a few human cell lines and fetal cells. In the cells where these spliced 
variants of Ang-1 mRNA were found, most of them only expressed two to three but 
not all four alternatively spliced species. Unfortunately in the present study, it was 
not possible to acquire these human cells to serve as positive controls, thus the 
observed negative findings might not be definitive. 
When the results obtained by RT-PCR and Western immunoblotting were 
compared with those by immunohistochemical staining, there appeared to be a 
discrepancy. Using the first two techniques, both Sertoli cells and Leydig cells 
were shown to express Ang-1 mRNA (Figures 3.1 and 3.2) and protein (Figures 
j 
3.17 and 3.18). However when frozen sections of adult rat testis were 
immunostained for Ang-1 using specific antibody, positive Ang-1 immimoreactivity 
was localized only over the blood vessels mainly in vascular smooth muscle cells 




for Western immunoblotting (Ang-1, H-98) was different from the one employed in 
immunohistochemcial staining (Ang-1, N-18). It is known that some antibodies 
are suitable only for Western immunoblotting (e.g. Ang-1, H-98) since they only 
recognize the denatured form but not the native form of the protein. Also in 
immunostaining, the ability of the antibody to recognize the antigen depends very 
much how well the antigen is preserved. It was possible that in frozen testis 
sections subjected to light fixation in paraformaldehyde, the Ang-1 protein was for 
some unknown reasons better preserved in blood vessels than in the Sertoli cells 
and Leydig cells (Figure 3.21a). In the present study，other fixatives had been 
tested together with the technique of antigen retrieval in the preparation of the testis 
sections for immunostaining (data not shown), however none of them gave more 
satisfactory results than the use of lightly fixed frozen sections. 
The expression of Ang-1 mRNA in rat C6 glioma cells was previously 
demonstrated in other studies by means of RT-PCR, Northern blot analyses and in 
situ hybridization [Holash et aL, 1999]. The ability to reproduce the findings here 
in demonstrating the presence of both Ang-1 mRNA and proteins using RT-PCR 
(Figures 3.1 and 3.2) and Western immunoblotting (Figures 3.17 and 3.18), 
respectively, had further added strength to the validity of the present results. 
4.2 Expression of Ang-2 mRNA and protein in adult rat testis, mouse testis, rat 
testicular blood vessel, primary testicular cells and testicular cell lines 
There has been much recent interest in the role of Ang-2 at sites of vascular 
remodeling in an otherwise stable adult vasculature [Mandriota & Pepper, 1998; 
i Maisonpierre et al , 1999; Holash et al., 1999; see review by Geva & Jaffe, 2000]. 
I 
Restricted expression pattern of Ang-2 was observed in ovary, uterus, placenta and 
.1 
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endothelial cells, which were the predominant sites of vascular remodeling in the 
normal adult [Hanahan, 1997; Maisonpierre et al, 1997; Shyu et al., 1998; Shinji et 
al., 1999; Kampfer et al., 2001], and the observation of cell type-specific 
expression of both angiopoietins [Stratmann et al., 2001]. 
Similar to the expression pattern of Ang-1 mRNA within the testis，the 
present data also showed the expression of Ang-2 mRNA in adult rat and mouse 
testes, Leydig cells, Sertoli cells, germ cells, and rat testicular blood vessel (Figures 
3.6 and 3.7). However it was not possible to compare the expression levels of Ang-
1 and Ang-2 mRNA in different testicular tissues and cell types since the PCR 
analysis was not performed in a quantitative manner. 
In the RT-PCR analysis of testicular cell lines, the expression of Ang-2 
appeared to be more restricted and found only in TM3 Leydig cells and TM4 
Sertoli cells (Figure 3.7), Surprisingly the three Leydig tumour cell lines (i.e. 
MLTC-1, LC540, R2C) were negative for Ang-2. Contrary to the present findings, 
previous studies indicate that tumour cells are more likely to express Ang-2 and this 
appears to tie in with the postulated role of Ang-2 in promoting angiogenesis 
(including tumour angiogenesis) in the presence of VEGF (Introduction: Section 
1.3.2.). Ang-2 expression had in the past been reported in human gastric tumour 
cells [Etoh et al., 2001], tumour cells of Kaposi's sarcoma and cutaneous 
angiosarcoma [Brown et aL, 2000] and human hepatocellular carcinoma [Tanaka et 
i al, 1999]. The inability to demonstrate Ang-2 mRNA expression in Leydig tumour 
cells remains unclear since in Western immunoblotting, there appears to be protein 
bands in the cell lysates of MLTC-1，LC540 and R2C cells，that could represent 
Ang-2 (Figure 3.17). In the Western immunoblotting of Ang-1 using an antibody 




(-55 kDa) than expected for the non-glycosylated form of Ang-1 ( � 5 8 kDa) was 
found in the rat testis, and testicular cell lines (i.e. TM3, MLTC-1, R2C and LC540) 
(Figure 3.17). According to the calculated molecular weight of nascent proteins, 
Ang-2 (56.4 kDa) is slightly smaller than Ang-1 (57,4 kDa), suggesting that the 
smaller band might represent Ang-2 due to the cross-reactivity of this particular 
antibody [Ang-1 (H-98)]. In the subsequent Western blot analysis using an 
antibody specific for Ang-2, two positive bands with apparent molecular sizes of 55 
kDa and 68 kDa could be identified in the lysates prepared from the testicular 
tissues (i.e. rat and mouse testes, testicular blood vessels), primary testicular cells 
(i.e. interstitial cells and Sertoli cells), and C6 rat glioma cells which was used as a 
positive control. However at this stage, the above study using the specific antibody 
against Ang-2 has not been successfully repeated on the testicular cell lines to 
confirm whether the Leydig tumour cells (i.e. MLTC-1, R2C and LC540) are in fact 
producing Ang-2 proteins despite low to undetectable levels of mRNA (as 
discussed above) 
Consistent with the expression of Ang-2 mRNA in adult rat testis, mouse 
testis, primary Sertoli cells and Leydig cells. Western immunoblotting 
demonstrated the occurrence of two positive bands with apparent molecular sizes 
of 55 kDa and 68 kDa (Figure 3.19). It is likely that they correspond to the non-
glycosylated and glycosylated form of Ang-2 since previous studies of human Ang-
2 have cited 56.9 kDa [Kim et al., 2000a] and 68-70 kDa [Dunk et aL, 2000; 
Kuroda et al, 2001], respectively for the native (i.e. non-glycosylated) and secreted 
(i.e. glycosylated) form of this protein. 
Though in RT-PCR analysis, germ cells were shown to express Ang-2 mRNA, 





blot analysis. Thus it is possible that Ang-2 transcripts found in germ cell 
preparation could have derived from the contamination of other neighbouring 
testicular cells (e.g. Sertoli cells) truly expressing this gene. 
In determining whether primary testicular cells express Ang-2 protein, the 
data from immunohistochemical staining (Figure 3,21b) failed to provide the 
needed information. In frozen sections of the adult rat testis, the failure to 
demonstrate Ang-2 immunoreactivity in Sertoli cells and Leydig cells could be due 
to the fact that the conditions of immunostaining had not been fully optimized 
(Figure 3.21b). Nevertheless, it would still be tempting to suggest that Ang-2 
mRNA and proteins are expressed in the Sertoli cell and Leydig cell of the rat and 
mouse testes, where Ang-1 was also found (Figure 3.18). In the human placenta, 
Ang-2 mRNA expression was identified in syncytiotrophoblasts [Goldman-Wohl et 
al,, 2000], which are also endocrine cells like Sertoli cells and Leydig cells. 
The present finding of Ang-2 mRNA expression in testicular blood vessel 
agrees well with the previous reports on Ang-2 expression in vascular smooth 
muscle cells [Yuan et al., 2000] as well as vascular endothelial cells [Mandriota & 
Pepper, 1998; Stratmann et al., 1998; Oh et al, 1999; Kim et al” 2000a; Kim et al.’ 
2000c; Kuroda et aL, 2001]. However in immunohistochemical staining, Ang-2 
immunoreactivity was only found to localized in endothelial cells but not vascular 
smooth muscle cells of testicular blood vessels (Figure 3.21b). 
Earlier studies reported that VEGF was expressed in Leydig and Sertoli cells 
of rat, mouse and human testes (as mentioned in Section 4.1). These testicular cell 
I 
I types would be the important sources of angiogenic factors during the development 
of the testis and/or following hormonal stimulation as seen in adult rats after 




& Bergh, 1996; Bergh et al,, 1996]. Taken together, these observations are in line 
with the proposed function of Ang-2, in which its expression facilitates 
angiogenesis in the presence of VEGF. Ang-2 works by blocking a constitutive 
stabilizing or maturing function for Ang-1 on blood vessels. Such Ang-2 negative 
signal would thus prime the blood vessels and facilitate their responsiveness 
towards other angiogenic inducers such as VEGF by loosening contacts between 
endothelium and peri-endothelial cells [Hanahan, 1997; Maisonpierre et al, 1997; 
Holash et al., 1999; see review by Yancopoulos et al, 2000]. 
Unlike the situation found in chicken testes [Mezquita et al., 1999，2000], 
human endothelial cells, some human nonendothelial tumour cell lines and tissues 
[Kim et al., 2000a] where alternatively spliced variants of Ang-2 were identified, 
the present study failed to demonstrate any variants of Ang-2 in the rat testis that 
might resemble the splicing found in human (Figure 3.9). A study performed by 
Kim et al. (2000a) has led to the discovery of a novel alternative splice variant of 
the human Ang-2 gene designated as Ang-2443 in primary endothelial cells, several 
nonendothelial tumour cell lines，and primary tumour tissues based on cloning and 
cDNA analysis. The present study however failed to demonstrate any Ang-2 
isoform expression that could be detected in the adult rat testis using RT-PCR 
approach with degenerate Ang-2 (S3+AS4) primers even after a second PCR 
amplification (Figure 3.9). The PCR products were confirmed negative by 
automated DNA sequence analysis. It is possible that alternatively splicing to 
generate multiple species of Ang-2 is species specific as demonstrated in human 
and chicken. 
丨 In a previous study, it was unable to detect Ang-2 mRNA transcripts by RT-




earlier report, the present study showed the presence of Aiig-2 mRNA in C6 rat 
glioma cells (Figures 3.6 and 3.7), suggesting its biologic importance in tumour-
associated angiogenesis. It is possible that the negative findings in the study by 
Mandriota & Pepper (1998) was due to the use of degenerate primers. 
4.3 Expression of Ang-3 mRNA and protein in adult rat testis, mouse testis, rat 
testicular blood vessel, primary testicular cells and testicular cell lines 
The present study provided the first demonstration of Ang-3 mRNA 
expression in rat testicular tissue. In the study by Valenzuela et al (1999) reporting 
on the identification of Ang-3 in mouse and Ang-4 in human, the expression of 
Ang-3 mRNA in mouse testicular tissue was demonstrated using Northern blot 
analysis. In line with this earlier report, the present study found an apparently 
higher level of Ang-3 mRNA expression in mouse testes and TM4 testicular cells 
(Figures 3.10 and 3.11). Nevertheless, Ang-3 mRNA was also detectable in rat 
testes, testicular blood vessel, primary Sertoli cells, Leydig cells, germ cells (Figure 
3.10). As for the other testicular cells (besides TM4) and C6 glioma cells, Ang-3 
transcripts were still detectable in rat (LC540 and R2C) and mouse (TM3 and 
MLTC-1) Leydig cell lines (Figure 3.11). Therefore, Leydig cells，Sertoli cells and 
germ cells are the possible sources of Ang-3 in the testis. Valenzuela et al (1999) 
proposed the role of Ang-3 in mouse and Ang-4 in human. Ang-3 and Ang-4 
represent the mouse and human counterparts of the same gene locus and their 
structural divergence appears to underlie diverging functions of these counterparts. 
While human Ang-4 is an agonist for the Tie 2 receptor, Ang-3 appears to act as an 








1 role of Ang-3 in testis remains not clearly defined but the current findings would 
encourage further studies to be carried out 
The identity of the Ang-3 product band amplified from adult rat testis had also 
been confirmed by automated DNA sequencing. Alignment of the known 
nucleotide sequence of mouse Ang-3 with the nucleotide sequence of PCR product 
amplified from adult rat testis indicated that the nucleotide sequences of mouse 
Ang-3 and rat Ang-3 are highly conserved (Figure 3.12). The present study 
represented the first to report on the nucleotide sequence of Ang-3 in the rat species, 
though the coverage was partial and only spanned over 543 bp. 
The lack of suitable antibodies for Western blotting precluded the correlation 
between Ang-3 mRNA and protein expression in testicular tissues，various primary 
testicular cells and testicular cell lines. With the commercially available anti-Ang-3 
antibodies, they were found to be relatively non-specific. As for another antibody 
which cross-reacts with Ang-1, mouse Ang-3 and human Ang-4, it was tested for 
immunohistochemical staining and found to give positive immimoreactivity over 
the vascular smooth muscle cells of testicular blood vessels and interstitial cells 
(Figures 3.20a and 3.20b). Since this antibody may cross-react with Ang-1, the 
results thus generated on its use to localize Ang-3 protein in rat testis sections have 
j 
i to be interpreted with great caution. At least, the positive Ang-3 immimoreactivity 
I 
i associated with testicular blood vessels and interstitial cells (Figures 3.20a and 
I 
j 
i 3.20b) would not contradict with the expression of Ang-3 transcript in rat testicular 
blood vessel and Leydig cells (Figure 3.10). Further investigation will be required 
to explore the reasons why testicular interstitial cells with stationary vasculature are 
still able to secrete angiogenic factors and the roles of both Ang-3 and Ang-4 in 
vascular development. 142 
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4.4 Expression of Tie 1 and Tie 2 mRNAs and proteins in adult rat testis and 
rat testicular blood vessel 
Tie 1 and Tie 2 are known to be endothelial cell-specific receptor tyrosine 
kinase. In the present study, use of RT-PCR demonstrated their mRNA expression 
in the adult rat testis and testicular blood vessels (Figures 3.13 and 3.14). However, 
it would be better to include an endothelial cell line as a positive control for RT-
PCR analysis and compare the expression of Tie receptor kinases between rat 
testicular blood vessel and this endothelial cell line. Using immunohistochemical 
staining, both Tie 1 and Tie 2 immunoreactivities were localized to endothelial 
cells of testicular blood vessels (Figures 3.19a and 3.19b). Thus the endothelial 
cells lining the testicular vasculature contain receptors (i.e. Tie 2) for angiopoietins, 
allowing them to mediate the actions of angiopoietins (e.g. Ang-1, -2 and -3) or 
other unidentified ligand for Tie 1 in controlling the integrity and remodelling of 
the testicular blood vessels. Such co-expression patterns have also been observed 
in other tissues，including the endothelium of large and small blood vessels, the 
atrial and ventricular endothelia of a 15-week human fetal heart [Partanen et al., 
1999] as well as in blood vessels, synovial lining and stromal cells in all 
rheumatoid arthritis (RA) tissues [Uchida et al., 2000]. A possible mechanism 
underlying such observed apparent co-expression of Tie 1 and Tie 2 is the 
combinations of ligands or ligand heterodimers for induction of endothelial 
responses by coengaging the two Tie receptors [Maisonpierre et al” 1993]. 
Recent studies have also identified the presence of Tie 1 and Tie 2 receptors 
in other non-endothelial cell types such as glandular epithelium of human 
endometrium (for Tie 2) [Geva & Jaffe, 2000], trophoblast of human placenta (for 
Tie2) [Dunk et aL, 2000; Goldman-Wohl et al., 2000], pigmented epithelial and 
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stromal cells of the retina [Otani et al” 1999], synovial lining cells and stromal 
cells of rheumatoid arthritis tissues [Uchida et al., 2000], and tumour cells of 
Kaposi's sarcoma and cutaneous angiosarcoma [Brown et al., 2000]. Therefore 
future works are required to examine whether Tie 1 and 2 could also be found in 
other testicular cell types. If such evidence could be found, it would offer the 
possibility of additional non-endothelial effects of angiopoietins on other aspects of 
testicular function under physiological or pathophysiological states. 
In the present study. Tie 1 and Tie 2 mRNA transcripts were detectable in 
adult rat testes and testicular blood vessels using RT-PCR analysis. The identity of 
the Tie 1 product bands amplified from adult rat testis and rat testicular blood 
vessel had also been confirmed by automated DNA sequencing. However, it was 
not possible to compare the nucleotide sequences of these PCR products directly 
with published sequence of rat Tie 1, but alignment of the known nucleotide 
sequence of mouse Tie 1 with the nucleotide sequences of PCR products amplified 
from adult rat testis and rat testicular blood vessel indicated that the nucleotide 
sequences of mouse Tie 1 and rat Tie 1 are highly conserved (Figure 3.15). The 
authenticity of the Tie 2 product band amplified from rat testicular blood vessel 
丨 was also confirmed by DNA sequencing and agreed well with the published cDNA 
； sequence for rat Tie 2 (Figure 3.16). 
I 
I The above-mentioned testicular cell lines and primary testicular cells were 
I 
I used for RT-PCR and Western blot analysis in the current investigation. The 
present data clearly showed the expression of Ang-1, Ang-2 and Ang-3 in Sertoli 
I 
cells, Leydig cells, germ cells, rat testicular blood vessel, adult rat testis and mouse 
testis, as well as the expression of Tie 1 and Tie 2 in rat testicular blood vessel and 
adult rat testis using RT-PCR analysis. Because of this striking similarity in 
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molecular structure, molecular weights and sequence homology between Ang-1 and 
Ang-2 proteins. Western immunoblotting for Ang-1 and Aiig-2 was performed with 
a rabbit polyclonal anti-Ang-1 antibody [Hanahan, 1997]. Since this rabbit 
polyclonal antibody [Ang-1 (H-98), #sc-8357] used in this study exhibited cross-
reactivity with Ang-2 and both Ang-1 and Ang-2 were reported to be secreted 
glycoproteins of the same molecular weight of 75 kDa approximately as described 
previously, it was impossible to distinguish which positive protein bands 
corresponded to either Ang-1 or Ang-2 for each sample and the expression of Ang-
1 could not be examined by immunoblot as the commercially available anti-Ang-1 
antibodies were not suitable for this application. The non-glycosylated and 
glycosylated forms of Ang-1 and Ang-2 proteins are found to express in Sertoli 
cells, interstitial cells, germ cells, rat testicular blood vessel and adult rat testis. 
Immunohistochemical examination of the rat testes using specific antibodies raised 
against Ang-1, Ang-2, Ang-3, Tie 1 and Tie 2 provided evidence for the 
localization of angiopoietins. Tie 1 and Tie 2 proteins in rat testicular blood vessel. 
4.5 Conclusion 
Taken together, both Leydig and Sertoli cells of rat and mouse testis are 
possible sources of Ang-1, -2, and -3. This would be analogous to the situation 
^ found in the ovary where granulosa cells of pre-ovulatoiy follicles were shown to 
express Ang-1 mRNA [Hazzard et al” 1999] and possibly also Ang-2 
[Masionpierre et al” 1997; Geva & Jaffe, 2000]. In view of the fact that both 
Leydig cell and Sertoli cell are important sources of VEGF within the testis [Collin 
& Bergh, 1996; Au et al., 1997; Ergun et al., 1997], therefore they appear to hold a 
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pivotal role in determining the integrity and angiogenic potential of the testicular 
vasculature through coordinated changes in the expression of those factors that are 
responsible for stabilizing the blood vessels (i.e. Ang-1) or for angiogenesis (i.e. 
VEGF, Ang-2). 
4.6 Further work 
In the present study，the mRNA expression of angiopoietins (Ang-1, Ang-2 
and Ang-3) and Tie receptor tyrosine kinases has been demonstrated by RT-PCR in 
the testis. In addition, the protein expression of angiopoietins. Tie 1 and Tie 2 have 
been demonstrated by Western blot analysis and localized in adult rat testis by 
immunohistochemistry. It is therefore of special interest in investigating the 
control of angiopoietin expression in the testes using the combination of RT-PCR 
: and capillary electrophoresis with laser-induced fluorescence detector (CE-LIF) for 
accurate quantitation of mRNA levels of angiopoietins in testicular tissue or on in 
vitro cultures of testicular cell lines within the linear range of PCR cycle-product 
curve and PCR template-product curves. The PCR amplification efficiencies of 
angiopoietins and the reference gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) or p-actin are determined according to these PCR-cycle product curve 
and PCR template-product curve. 
As the expression of Ang-2 mRNA has been shown in both TM3 and TM4 
I testicular cell lines by RT-PCR and Oh et al (1999) suggested that hypoxia 
probably produced a direct stimulation of Ang-2 mRNA levels in BRECs (as 
explained earlier in Section 1.3.2), the effect of hypoxia on Ang-2 expression in 
TM3 and TM4 cells is the next interesting issue to deal with. Similar to this 
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published study, an up-regulation of Ang-2 expression should be expected in both 
TM3 Leydig cells and TM4 Sertoli cells. Such in vitro findings of a hypoxic 
induction of Ang-2 expression in Leydig cells and Sertoli cells can be correlated 
with an in vivo situation. This can be done by investigating the effect of the 
ischaemic condition produced by testicular torsion in adult rats. Similar to in vitro 
findings, Ang-2 mRNA levels should also be increased in those testes that had been 
exposed to an ischaemic treatment caused by the surgical induction of spermatic 
cord torsion. 
The hormonal regulation of Ang-2 expression in the testis should be the next 
component for studying in order to provide useful information of the hormonal 
effects on the developmental changes of rat testis. MLTC-1 cells derived from 
Leydig cell tumour are known to retain their LH responsiveness even after repeated 
passages in culture rather than TM3 and TM4 testicular cells. In this regard, 
MLTC-1 testicular cells should be employed for studying the effects of hCG 
treatment on the expression of Ang-2 mRNA in these cells. After hCG treatment, 
Ang-2 mRNA expression should be increased significantly in MLTC-1 testicular 
cells and such stimulatory effects should be both time- and concentration-
dependent. Ang-2 mRNA levels can also be determined in the testes of adult rats 
after receiving a single subcutaneous injection of hCG in order to correlate with in 
\ vitro findings using MLTC-1 Leydig cell line. 
i Huang et al (2000) has previously demonstrated the existence of two Ang-1 
isoforms of Ang-1, Ang-1.5 kb and Ang-0.9 kb, in CHRF-288 human tumour cell 
line and prostate cancer cell line DU145, rather than Ang-1.3 kb and Ang-0.7 kb 
using Western immunoblot analysis with a specific rabbit anti-Ang-1 antibody. In 







; adult rat testis and other testicular cell types using RT-PCR approach with specific 
i primers (as mentioned in Section 4.1). Further investigations were necessary to 
confirm whether the protein isoforms of Ang-1 could be expressed in testis and 
other testicular cell types or not by Western blot analysis with an anti-Ang-1 
antibody specific for the N-terminal end (reactive with anti-1.5 kb and anti-1.3 kb 
isoforms) or C-terminal end (reactive with 1.5-kb isoform but not 1.3-kb isoform) 
and a goat anti-Ang-1 antibody specific for the N-terminal end (reactive with anti-
0.9 kb and anti-0.7 kb isoforms) or C-terminal end (reactive with 0.9-kb isoform 
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